id	sid	tid	token	lemma	pos
dpc-328	1	1	dermatology	dermatology	NOUN
dpc-328	1	2	:	:	PUNCT
dpc-328	1	3	practical	practical	ADJ
dpc-328	1	4	and	and	CCONJ
dpc-328	1	5	conceptual	conceptual	ADJ
dpc-328	1	6	review	review	NOUN
dpc-328	1	7	|	|	ADV
dpc-328	1	8	dermatol	dermatol	ADJ
dpc-328	1	9	pract	pract	NOUN
dpc-328	1	10	concept	concept	NOUN
dpc-328	1	11	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	1	12	15	15	NUM
dpc-328	1	13	dermatology	dermatology	NOUN
dpc-328	1	14	practical	practical	ADJ
dpc-328	1	15	&	&	CCONJ
dpc-328	1	16	conceptual	conceptual	ADJ
dpc-328	1	17	www.derm101.com	www.derm101.com	X
dpc-328	1	18	glutathione	glutathione	NOUN
dpc-328	1	19	for	for	ADP
dpc-328	1	20	skin	skin	NOUN
dpc-328	1	21	lightening	lightening	NOUN
dpc-328	1	22	:	:	PUNCT
dpc-328	1	23	a	a	DET
dpc-328	1	24	regnant	regnant	ADJ
dpc-328	1	25	myth	myth	NOUN
dpc-328	1	26	or	or	CCONJ
dpc-328	1	27	evidence	evidence	NOUN
dpc-328	1	28	-	-	PUNCT
dpc-328	1	29	based	base	VERB
dpc-328	1	30	verity	verity	NOUN
dpc-328	1	31	?	?	PUNCT
dpc-328	2	1	sidharth	sidharth	PROPN
dpc-328	2	2	sonthalia1	sonthalia1	PROPN
dpc-328	2	3	,	,	PUNCT
dpc-328	2	4	abhijeet	abhijeet	PROPN
dpc-328	2	5	k.	k.	PROPN
dpc-328	2	6	jha2	jha2	PROPN
dpc-328	2	7	,	,	PUNCT
dpc-328	2	8	aimilios	aimilios	PROPN
dpc-328	2	9	lallas3	lallas3	PROPN
dpc-328	2	10	,	,	PUNCT
dpc-328	2	11	geraldine	geraldine	PROPN
dpc-328	2	12	jain4	jain4	PROPN
dpc-328	2	13	,	,	PUNCT
dpc-328	2	14	deepak	deepak	PROPN
dpc-328	2	15	jakhar5	jakhar5	PROPN
dpc-328	2	16	1	1	NUM
dpc-328	2	17	skinnocence	skinnocence	NOUN
dpc-328	2	18	:	:	PUNCT
dpc-328	2	19	the	the	DET
dpc-328	2	20	skin	skin	NOUN
dpc-328	2	21	clinic	clinic	PROPN
dpc-328	2	22	&	&	CCONJ
dpc-328	2	23	research	research	PROPN
dpc-328	2	24	centre	centre	PROPN
dpc-328	2	25	,	,	PUNCT
dpc-328	2	26	gurugram	gurugram	PROPN
dpc-328	2	27	,	,	PUNCT
dpc-328	2	28	india	india	PROPN
dpc-328	2	29	2	2	NUM
dpc-328	2	30	department	department	NOUN
dpc-328	2	31	of	of	ADP
dpc-328	2	32	skin	skin	NOUN
dpc-328	2	33	&	&	CCONJ
dpc-328	2	34	vd	vd	PROPN
dpc-328	2	35	,	,	PUNCT
dpc-328	2	36	patna	patna	PROPN
dpc-328	2	37	medical	medical	PROPN
dpc-328	2	38	college	college	PROPN
dpc-328	2	39	,	,	PUNCT
dpc-328	2	40	patna	patna	PROPN
dpc-328	2	41	,	,	PUNCT
dpc-328	2	42	india	india	PROPN
dpc-328	2	43	3	3	NUM
dpc-328	2	44	first	first	PROPN
dpc-328	2	45	department	department	NOUN
dpc-328	2	46	of	of	ADP
dpc-328	2	47	dermatology	dermatology	NOUN
dpc-328	2	48	,	,	PUNCT
dpc-328	2	49	aristotle	aristotle	PROPN
dpc-328	2	50	university	university	PROPN
dpc-328	2	51	,	,	PUNCT
dpc-328	2	52	thessaloniki	thessaloniki	PROPN
dpc-328	2	53	,	,	PUNCT
dpc-328	2	54	greece	greece	PROPN
dpc-328	2	55	4	4	NUM
dpc-328	2	56	punarnawah	punarnawah	PROPN
dpc-328	2	57	medical	medical	PROPN
dpc-328	2	58	&	&	CCONJ
dpc-328	2	59	research	research	PROPN
dpc-328	2	60	centre	centre	PROPN
dpc-328	2	61	,	,	PUNCT
dpc-328	2	62	jaipur	jaipur	PROPN
dpc-328	2	63	,	,	PUNCT
dpc-328	2	64	india	india	PROPN
dpc-328	2	65	5	5	NUM
dpc-328	2	66	consultant	consultant	NOUN
dpc-328	2	67	dermatologist	dermatologist	PROPN
dpc-328	2	68	&	&	CCONJ
dpc-328	2	69	cosmetologist	cosmetologist	PROPN
dpc-328	2	70	,	,	PUNCT
dpc-328	2	71	new	new	ADJ
dpc-328	2	72	delhi	delhi	PROPN
dpc-328	2	73	,	,	PUNCT
dpc-328	2	74	india	india	PROPN
dpc-328	2	75	key	key	ADJ
dpc-328	2	76	words	word	NOUN
dpc-328	2	77	:	:	PUNCT
dpc-328	2	78	glutathione	glutathione	NOUN
dpc-328	2	79	,	,	PUNCT
dpc-328	2	80	skin	skin	NOUN
dpc-328	2	81	lightening	lightening	NOUN
dpc-328	2	82	,	,	PUNCT
dpc-328	2	83	intravenous	intravenous	ADJ
dpc-328	2	84	,	,	PUNCT
dpc-328	2	85	gsh	gsh	PROPN
dpc-328	2	86	,	,	PUNCT
dpc-328	2	87	gssg	gssg	ADJ
dpc-328	2	88	citation	citation	NOUN
dpc-328	2	89	:	:	PUNCT
dpc-328	2	90	sonthalia	sonthalia	PROPN
dpc-328	2	91	s	s	PART
dpc-328	2	92	,	,	PUNCT
dpc-328	2	93	jha	jha	PROPN
dpc-328	2	94	ak	ak	PROPN
dpc-328	2	95	,	,	PUNCT
dpc-328	2	96	lallas	lallas	PROPN
dpc-328	2	97	a	a	PROPN
dpc-328	2	98	,	,	PUNCT
dpc-328	2	99	jain	jain	PROPN
dpc-328	2	100	g	g	PROPN
dpc-328	2	101	,	,	PUNCT
dpc-328	2	102	jakhar	jakhar	PROPN
dpc-328	2	103	d.	d.	PROPN
dpc-328	2	104	glutathione	glutathione	PROPN
dpc-328	2	105	for	for	ADP
dpc-328	2	106	skin	skin	NOUN
dpc-328	2	107	lightening	lightening	NOUN
dpc-328	2	108	:	:	PUNCT
dpc-328	2	109	a	a	DET
dpc-328	2	110	regnant	regnant	ADJ
dpc-328	2	111	myth	myth	NOUN
dpc-328	2	112	or	or	CCONJ
dpc-328	2	113	evidence	evidence	NOUN
dpc-328	2	114	-	-	PUNCT
dpc-328	2	115	based	base	VERB
dpc-328	2	116	verity	verity	NOUN
dpc-328	2	117	?	?	PUNCT
dpc-328	3	1	dermatol	dermatol	NOUN
dpc-328	3	2	pract	pract	NOUN
dpc-328	3	3	concept	concept	NOUN
dpc-328	3	4	.	.	PUNCT
dpc-328	4	1	2018;8(1):15	2018;8(1):15	NUM
dpc-328	4	2	-	-	SYM
dpc-328	4	3	21	21	NUM
dpc-328	4	4	.	.	PUNCT
dpc-328	5	1	doi	doi	NOUN
dpc-328	5	2	:	:	PUNCT
dpc-328	5	3	https://doi.org/10.5826/dpc.0801a04	https://doi.org/10.5826/dpc.0801a04	NOUN
dpc-328	5	4	received	receive	VERB
dpc-328	5	5	:	:	PUNCT
dpc-328	5	6	june	june	PROPN
dpc-328	5	7	6	6	NUM
dpc-328	5	8	,	,	PUNCT
dpc-328	5	9	2017	2017	NUM
dpc-328	5	10	;	;	PUNCT
dpc-328	5	11	accepted	accept	VERB
dpc-328	5	12	:	:	PUNCT
dpc-328	5	13	november	november	PROPN
dpc-328	5	14	12	12	NUM
dpc-328	5	15	,	,	PUNCT
dpc-328	5	16	2017	2017	NUM
dpc-328	5	17	;	;	PUNCT
dpc-328	5	18	published	publish	VERB
dpc-328	5	19	:	:	PUNCT
dpc-328	5	20	january	january	PROPN
dpc-328	5	21	31	31	NUM
dpc-328	5	22	,	,	PUNCT
dpc-328	5	23	2018	2018	NUM
dpc-328	5	24	copyright	copyright	NOUN
dpc-328	5	25	:	:	PUNCT
dpc-328	5	26	©	©	PROPN
dpc-328	5	27	2018	2018	NUM
dpc-328	5	28	sonthalia	sonthalia	PROPN
dpc-328	5	29	et	et	PROPN
dpc-328	5	30	al	al	PROPN
dpc-328	5	31	.	.	PUNCT
dpc-328	6	1	this	this	PRON
dpc-328	6	2	is	be	AUX
dpc-328	6	3	an	an	DET
dpc-328	6	4	open	open	ADJ
dpc-328	6	5	-	-	PUNCT
dpc-328	6	6	access	access	NOUN
dpc-328	6	7	article	article	NOUN
dpc-328	6	8	distributed	distribute	VERB
dpc-328	6	9	under	under	ADP
dpc-328	6	10	the	the	DET
dpc-328	6	11	terms	term	NOUN
dpc-328	6	12	of	of	ADP
dpc-328	6	13	the	the	DET
dpc-328	6	14	creative	creative	ADJ
dpc-328	6	15	commons	common	NOUN
dpc-328	6	16	attribution	attribution	NOUN
dpc-328	6	17	license	license	NOUN
dpc-328	6	18	,	,	PUNCT
dpc-328	6	19	which	which	PRON
dpc-328	6	20	permits	permit	VERB
dpc-328	6	21	unrestricted	unrestricted	ADJ
dpc-328	6	22	use	use	NOUN
dpc-328	6	23	,	,	PUNCT
dpc-328	6	24	distribution	distribution	NOUN
dpc-328	6	25	,	,	PUNCT
dpc-328	6	26	and	and	CCONJ
dpc-328	6	27	reproduction	reproduction	NOUN
dpc-328	6	28	in	in	ADP
dpc-328	6	29	any	any	DET
dpc-328	6	30	medium	medium	NOUN
dpc-328	6	31	,	,	PUNCT
dpc-328	6	32	provided	provide	VERB
dpc-328	6	33	the	the	DET
dpc-328	6	34	original	original	ADJ
dpc-328	6	35	author	author	NOUN
dpc-328	6	36	and	and	CCONJ
dpc-328	6	37	source	source	NOUN
dpc-328	6	38	are	be	AUX
dpc-328	6	39	credited	credit	VERB
dpc-328	6	40	.	.	PUNCT
dpc-328	7	1	funding	funding	NOUN
dpc-328	7	2	:	:	PUNCT
dpc-328	7	3	none	none	NOUN
dpc-328	7	4	.	.	PUNCT
dpc-328	8	1	competing	compete	VERB
dpc-328	8	2	interests	interest	NOUN
dpc-328	8	3	:	:	PUNCT
dpc-328	8	4	the	the	DET
dpc-328	8	5	authors	author	NOUN
dpc-328	8	6	have	have	VERB
dpc-328	8	7	no	no	DET
dpc-328	8	8	conflicts	conflict	NOUN
dpc-328	8	9	of	of	ADP
dpc-328	8	10	interest	interest	NOUN
dpc-328	8	11	to	to	PART
dpc-328	8	12	disclose	disclose	VERB
dpc-328	8	13	.	.	PUNCT
dpc-328	9	1	all	all	DET
dpc-328	9	2	authors	author	NOUN
dpc-328	9	3	have	have	AUX
dpc-328	9	4	contributed	contribute	VERB
dpc-328	9	5	significantly	significantly	ADV
dpc-328	9	6	to	to	ADP
dpc-328	9	7	this	this	DET
dpc-328	9	8	publication	publication	NOUN
dpc-328	9	9	.	.	PUNCT
dpc-328	10	1	corresponding	correspond	VERB
dpc-328	10	2	author	author	NOUN
dpc-328	10	3	:	:	PUNCT
dpc-328	10	4	dr	dr	PROPN
dpc-328	10	5	.	.	PROPN
dpc-328	10	6	sidharth	sidharth	PROPN
dpc-328	10	7	sonthalia	sonthalia	PROPN
dpc-328	10	8	,	,	PUNCT
dpc-328	10	9	skinnocence	skinnocence	NOUN
dpc-328	10	10	:	:	PUNCT
dpc-328	10	11	the	the	DET
dpc-328	10	12	skin	skin	NOUN
dpc-328	10	13	clinic	clinic	PROPN
dpc-328	10	14	&	&	CCONJ
dpc-328	10	15	research	research	PROPN
dpc-328	10	16	centre	centre	PROPN
dpc-328	10	17	,	,	PUNCT
dpc-328	10	18	c-2246	c-2246	PROPN
dpc-328	10	19	,	,	PUNCT
dpc-328	10	20	suhridaya	suhridaya	PROPN
dpc-328	10	21	,	,	PUNCT
dpc-328	10	22	sunshant	sunshant	VERB
dpc-328	10	23	lok-1	lok-1	ADP
dpc-328	10	24	,	,	PUNCT
dpc-328	10	25	block	block	NOUN
dpc-328	10	26	c	c	NOUN
dpc-328	10	27	,	,	PUNCT
dpc-328	10	28	gurgaon	gurgaon	PROPN
dpc-328	10	29	,	,	PUNCT
dpc-328	10	30	122009	122009	NUM
dpc-328	10	31	,	,	PUNCT
dpc-328	10	32	haryana	haryana	PROPN
dpc-328	10	33	,	,	PUNCT
dpc-328	10	34	india	india	PROPN
dpc-328	10	35	.	.	PUNCT
dpc-328	10	36	email	email	NOUN
dpc-328	10	37	:	:	PUNCT
dpc-328	10	38	sidharth.sonthalia@gmail.com	sidharth.sonthalia@gmail.com	X
dpc-328	10	39	the	the	DET
dpc-328	10	40	recent	recent	ADJ
dpc-328	10	41	hype	hype	NOUN
dpc-328	10	42	surrounding	surround	VERB
dpc-328	10	43	the	the	DET
dpc-328	10	44	antimelanogenic	antimelanogenic	ADJ
dpc-328	10	45	properties	property	NOUN
dpc-328	10	46	of	of	ADP
dpc-328	10	47	glutathione	glutathione	NOUN
dpc-328	10	48	has	have	AUX
dpc-328	10	49	resulted	result	VERB
dpc-328	10	50	in	in	ADP
dpc-328	10	51	physicians	physician	NOUN
dpc-328	10	52	frequently	frequently	ADV
dpc-328	10	53	administering	administer	VERB
dpc-328	10	54	it	it	PRON
dpc-328	10	55	as	as	ADP
dpc-328	10	56	a	a	DET
dpc-328	10	57	“	"	PUNCT
dpc-328	10	58	wonder	wonder	NOUN
dpc-328	10	59	”	"	PUNCT
dpc-328	10	60	drug	drug	NOUN
dpc-328	10	61	for	for	ADP
dpc-328	10	62	skin	skin	NOUN
dpc-328	10	63	lightening	lightening	NOUN
dpc-328	10	64	and	and	CCONJ
dpc-328	10	65	treatment	treatment	NOUN
dpc-328	10	66	of	of	ADP
dpc-328	10	67	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	10	68	,	,	PUNCT
dpc-328	10	69	especially	especially	ADV
dpc-328	10	70	in	in	ADP
dpc-328	10	71	ethnic	ethnic	ADJ
dpc-328	10	72	populations	population	NOUN
dpc-328	10	73	with	with	ADP
dpc-328	10	74	darker	dark	ADJ
dpc-328	10	75	skin	skin	NOUN
dpc-328	10	76	tones	tone	NOUN
dpc-328	10	77	.	.	PUNCT
dpc-328	11	1	this	this	DET
dpc-328	11	2	phenomenon	phenomenon	NOUN
dpc-328	11	3	has	have	AUX
dpc-328	11	4	seen	see	VERB
dpc-328	11	5	a	a	DET
dpc-328	11	6	recent	recent	ADJ
dpc-328	11	7	surge	surge	NOUN
dpc-328	11	8	owing	owe	VERB
dpc-328	11	9	to	to	ADP
dpc-328	11	10	aggressive	aggressive	ADJ
dpc-328	11	11	marketing	marketing	NOUN
dpc-328	11	12	and	and	CCONJ
dpc-328	11	13	capitalization	capitalization	NOUN
dpc-328	11	14	of	of	ADP
dpc-328	11	15	pharma	pharma	NOUN
dpc-328	11	16	-	-	PUNCT
dpc-328	11	17	cosmeceutical	cosmeceutical	ADJ
dpc-328	11	18	companies	company	NOUN
dpc-328	11	19	.	.	PUNCT
dpc-328	12	1	however	however	ADV
dpc-328	12	2	,	,	PUNCT
dpc-328	12	3	the	the	DET
dpc-328	12	4	unbridled	unbridled	ADJ
dpc-328	12	5	and	and	CCONJ
dpc-328	12	6	prodigal	prodigal	ADJ
dpc-328	12	7	use	use	NOUN
dpc-328	12	8	of	of	ADP
dpc-328	12	9	it	it	PRON
dpc-328	12	10	,	,	PUNCT
dpc-328	12	11	especially	especially	ADV
dpc-328	12	12	as	as	ADP
dpc-328	12	13	a	a	DET
dpc-328	12	14	parenteral	parenteral	ADJ
dpc-328	12	15	formulation	formulation	NOUN
dpc-328	12	16	,	,	PUNCT
dpc-328	12	17	seems	seem	VERB
dpc-328	12	18	unjustified	unjustified	ADJ
dpc-328	12	19	,	,	PUNCT
dpc-328	12	20	given	give	VERB
dpc-328	12	21	the	the	DET
dpc-328	12	22	lacunae	lacunae	NOUN
dpc-328	12	23	in	in	ADP
dpc-328	12	24	our	our	PRON
dpc-328	12	25	knowledge	knowledge	NOUN
dpc-328	12	26	about	about	ADP
dpc-328	12	27	its	its	PRON
dpc-328	12	28	antimelanogenic	antimelanogenic	ADJ
dpc-328	12	29	potential	potential	NOUN
dpc-328	12	30	,	,	PUNCT
dpc-328	12	31	limited	limited	ADJ
dpc-328	12	32	clinical	clinical	ADJ
dpc-328	12	33	evidence	evidence	NOUN
dpc-328	12	34	favoring	favor	VERB
dpc-328	12	35	its	its	PRON
dpc-328	12	36	role	role	NOUN
dpc-328	12	37	in	in	ADP
dpc-328	12	38	skin	skin	NOUN
dpc-328	12	39	lightening	lightening	NOUN
dpc-328	12	40	,	,	PUNCT
dpc-328	12	41	and	and	CCONJ
dpc-328	12	42	the	the	DET
dpc-328	12	43	statutory	statutory	ADJ
dpc-328	12	44	ban	ban	NOUN
dpc-328	12	45	/	/	SYM
dpc-328	12	46	advisory	advisory	NOUN
dpc-328	12	47	issued	issue	VERB
dpc-328	12	48	by	by	ADP
dpc-328	12	49	certain	certain	ADJ
dpc-328	12	50	federal	federal	ADJ
dpc-328	12	51	agencies	agency	NOUN
dpc-328	12	52	.	.	PUNCT
dpc-328	13	1	even	even	ADV
dpc-328	13	2	though	though	SCONJ
dpc-328	13	3	parenteral	parenteral	ADJ
dpc-328	13	4	glutathione	glutathione	NOUN
dpc-328	13	5	is	be	AUX
dpc-328	13	6	approved	approve	VERB
dpc-328	13	7	only	only	ADV
dpc-328	13	8	for	for	ADP
dpc-328	13	9	severe	severe	ADJ
dpc-328	13	10	liver	liver	NOUN
dpc-328	13	11	disorders	disorder	NOUN
dpc-328	13	12	and	and	CCONJ
dpc-328	13	13	for	for	ADP
dpc-328	13	14	prevention	prevention	NOUN
dpc-328	13	15	of	of	ADP
dpc-328	13	16	chemotherapy	chemotherapy	NOUN
dpc-328	13	17	associated	associate	VERB
dpc-328	13	18	neurotoxicity	neurotoxicity	NOUN
dpc-328	13	19	,	,	PUNCT
dpc-328	13	20	the	the	DET
dpc-328	13	21	lack	lack	NOUN
dpc-328	13	22	of	of	ADP
dpc-328	13	23	statutory	statutory	ADJ
dpc-328	13	24	laws	law	NOUN
dpc-328	13	25	governing	govern	VERB
dpc-328	13	26	the	the	DET
dpc-328	13	27	use	use	NOUN
dpc-328	13	28	of	of	ADP
dpc-328	13	29	systemic	systemic	ADJ
dpc-328	13	30	glutathione	glutathione	NOUN
dpc-328	13	31	in	in	ADP
dpc-328	13	32	most	most	ADJ
dpc-328	13	33	countries	country	NOUN
dpc-328	13	34	has	have	AUX
dpc-328	13	35	contributed	contribute	VERB
dpc-328	13	36	to	to	ADP
dpc-328	13	37	its	its	PRON
dpc-328	13	38	unchecked	unchecked	ADJ
dpc-328	13	39	use	use	NOUN
dpc-328	13	40	for	for	ADP
dpc-328	13	41	skin	skin	NOUN
dpc-328	13	42	lightening	lightening	NOUN
dpc-328	13	43	.	.	PUNCT
dpc-328	14	1	the	the	DET
dpc-328	14	2	current	current	ADJ
dpc-328	14	3	clinical	clinical	ADJ
dpc-328	14	4	evidence	evidence	NOUN
dpc-328	14	5	of	of	ADP
dpc-328	14	6	intravenous	intravenous	ADJ
dpc-328	14	7	glutathione	glutathione	NOUN
dpc-328	14	8	for	for	ADP
dpc-328	14	9	skin	skin	NOUN
dpc-328	14	10	lightening	lightening	NOUN
dpc-328	14	11	is	be	AUX
dpc-328	14	12	limited	limit	VERB
dpc-328	14	13	to	to	ADP
dpc-328	14	14	a	a	DET
dpc-328	14	15	single	single	ADJ
dpc-328	14	16	study	study	NOUN
dpc-328	14	17	with	with	ADP
dpc-328	14	18	a	a	DET
dpc-328	14	19	dubious	dubious	ADJ
dpc-328	14	20	study	study	NOUN
dpc-328	14	21	design	design	NOUN
dpc-328	14	22	and	and	CCONJ
dpc-328	14	23	apparently	apparently	ADV
dpc-328	14	24	flawed	flaw	VERB
dpc-328	14	25	analysis	analysis	NOUN
dpc-328	14	26	of	of	ADP
dpc-328	14	27	results	result	NOUN
dpc-328	14	28	,	,	PUNCT
dpc-328	14	29	casting	cast	VERB
dpc-328	14	30	doubt	doubt	NOUN
dpc-328	14	31	on	on	ADP
dpc-328	14	32	the	the	DET
dpc-328	14	33	drug	drug	NOUN
dpc-328	14	34	’s	’s	PART
dpc-328	14	35	efficacy	efficacy	NOUN
dpc-328	14	36	and	and	CCONJ
dpc-328	14	37	reported	report	VERB
dpc-328	14	38	adverse	adverse	ADJ
dpc-328	14	39	effects	effect	NOUN
dpc-328	14	40	.	.	PUNCT
dpc-328	15	1	two	two	NUM
dpc-328	15	2	studies	study	NOUN
dpc-328	15	3	evaluating	evaluate	VERB
dpc-328	15	4	oral	oral	ADJ
dpc-328	15	5	/	/	SYM
dpc-328	15	6	sublingual	sublingual	ADJ
dpc-328	15	7	administration	administration	NOUN
dpc-328	15	8	and	and	CCONJ
dpc-328	15	9	one	one	NUM
dpc-328	15	10	trial	trial	NOUN
dpc-328	15	11	involving	involve	VERB
dpc-328	15	12	the	the	DET
dpc-328	15	13	use	use	NOUN
dpc-328	15	14	of	of	ADP
dpc-328	15	15	topical	topical	ADJ
dpc-328	15	16	glutathione	glutathione	NOUN
dpc-328	15	17	reported	report	VERB
dpc-328	15	18	good	good	ADJ
dpc-328	15	19	safety	safety	NOUN
dpc-328	15	20	profile	profile	NOUN
dpc-328	15	21	and	and	CCONJ
dpc-328	15	22	appreciable	appreciable	ADJ
dpc-328	15	23	but	but	CCONJ
dpc-328	15	24	reversible	reversible	ADJ
dpc-328	15	25	results	result	NOUN
dpc-328	15	26	on	on	ADP
dpc-328	15	27	skin	skin	NOUN
dpc-328	15	28	tone	tone	NOUN
dpc-328	15	29	.	.	PUNCT
dpc-328	16	1	in	in	ADP
dpc-328	16	2	this	this	DET
dpc-328	16	3	article	article	NOUN
dpc-328	16	4	,	,	PUNCT
dpc-328	16	5	we	we	PRON
dpc-328	16	6	shall	shall	AUX
dpc-328	16	7	review	review	VERB
dpc-328	16	8	and	and	CCONJ
dpc-328	16	9	discuss	discuss	VERB
dpc-328	16	10	the	the	DET
dpc-328	16	11	current	current	ADJ
dpc-328	16	12	status	status	NOUN
dpc-328	16	13	of	of	ADP
dpc-328	16	14	glutathione	glutathione	NOUN
dpc-328	16	15	as	as	ADP
dpc-328	16	16	a	a	DET
dpc-328	16	17	skin	skin	NOUN
dpc-328	16	18	lightening	lighten	VERB
dpc-328	16	19	agent	agent	NOUN
dpc-328	16	20	and	and	CCONJ
dpc-328	16	21	address	address	VERB
dpc-328	16	22	the	the	DET
dpc-328	16	23	sundry	sundry	ADJ
dpc-328	16	24	unanswered	unanswered	ADJ
dpc-328	16	25	queries	query	NOUN
dpc-328	16	26	regarding	regard	VERB
dpc-328	16	27	the	the	DET
dpc-328	16	28	dosage	dosage	NOUN
dpc-328	16	29	,	,	PUNCT
dpc-328	16	30	duration	duration	NOUN
dpc-328	16	31	of	of	ADP
dpc-328	16	32	use	use	NOUN
dpc-328	16	33	and	and	CCONJ
dpc-328	16	34	longevity	longevity	NOUN
dpc-328	16	35	of	of	ADP
dpc-328	16	36	accrued	accrue	VERB
dpc-328	16	37	effects	effect	NOUN
dpc-328	16	38	based	base	VERB
dpc-328	16	39	on	on	ADP
dpc-328	16	40	clinical	clinical	ADJ
dpc-328	16	41	evidence	evidence	NOUN
dpc-328	16	42	and	and	CCONJ
dpc-328	16	43	recent	recent	ADJ
dpc-328	16	44	insights	insight	NOUN
dpc-328	16	45	into	into	ADP
dpc-328	16	46	its	its	PRON
dpc-328	16	47	antimelanogenic	antimelanogenic	ADJ
dpc-328	16	48	mechanism	mechanism	NOUN
dpc-328	16	49	.	.	PUNCT
dpc-328	17	1	abstract	abstract	ADJ
dpc-328	17	2	mailto:sidharth.sonthalia@gmail.com	mailto:sidharth.sonthalia@gmail.com	PROPN
dpc-328	17	3	16	16	NUM
dpc-328	18	1	review	review	NOUN
dpc-328	18	2	|	|	ADV
dpc-328	18	3	dermatol	dermatol	ADJ
dpc-328	18	4	pract	pract	PROPN
dpc-328	18	5	concept	concept	NOUN
dpc-328	18	6	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	18	7	hailed	hail	VERB
dpc-328	18	8	for	for	ADP
dpc-328	18	9	generations	generation	NOUN
dpc-328	18	10	as	as	ADP
dpc-328	18	11	a	a	DET
dpc-328	18	12	“	"	PUNCT
dpc-328	18	13	magical	magical	ADJ
dpc-328	18	14	skin	skin	NOUN
dpc-328	18	15	whitening	whitening	NOUN
dpc-328	18	16	”	"	PUNCT
dpc-328	18	17	molecule	molecule	NOUN
dpc-328	18	18	in	in	ADP
dpc-328	18	19	countries	country	NOUN
dpc-328	18	20	like	like	ADP
dpc-328	18	21	the	the	DET
dpc-328	18	22	republic	republic	NOUN
dpc-328	18	23	of	of	ADP
dpc-328	18	24	philippines	philippine	NOUN
dpc-328	18	25	,	,	PUNCT
dpc-328	18	26	glutathione	glutathione	NOUN
dpc-328	18	27	has	have	AUX
dpc-328	18	28	seen	see	VERB
dpc-328	18	29	a	a	DET
dpc-328	18	30	rapid	rapid	ADJ
dpc-328	18	31	spread	spread	NOUN
dpc-328	18	32	in	in	ADP
dpc-328	18	33	its	its	PRON
dpc-328	18	34	popularity	popularity	NOUN
dpc-328	18	35	across	across	ADP
dpc-328	18	36	the	the	DET
dpc-328	18	37	globe	globe	NOUN
dpc-328	18	38	in	in	ADP
dpc-328	18	39	a	a	DET
dpc-328	18	40	short	short	ADJ
dpc-328	18	41	duration	duration	NOUN
dpc-328	18	42	of	of	ADP
dpc-328	18	43	time	time	NOUN
dpc-328	18	44	.	.	PUNCT
dpc-328	19	1	this	this	PRON
dpc-328	19	2	has	have	AUX
dpc-328	19	3	been	be	AUX
dpc-328	19	4	the	the	DET
dpc-328	19	5	outcome	outcome	NOUN
dpc-328	19	6	of	of	ADP
dpc-328	19	7	ardent	ardent	ADJ
dpc-328	19	8	manufacturer	manufacturer	NOUN
dpc-328	19	9	supported	support	VERB
dpc-328	19	10	media	medium	NOUN
dpc-328	19	11	campaigns	campaign	NOUN
dpc-328	19	12	about	about	ADP
dpc-328	19	13	the	the	DET
dpc-328	19	14	almost	almost	ADV
dpc-328	19	15	preposterous	preposterous	ADJ
dpc-328	19	16	effects	effect	NOUN
dpc-328	19	17	of	of	ADP
dpc-328	19	18	this	this	DET
dpc-328	19	19	molecule	molecule	NOUN
dpc-328	19	20	as	as	ADP
dpc-328	19	21	a	a	DET
dpc-328	19	22	wonder	wonder	NOUN
dpc-328	19	23	drug	drug	NOUN
dpc-328	19	24	for	for	ADP
dpc-328	19	25	not	not	PART
dpc-328	19	26	only	only	ADJ
dpc-328	19	27	disorders	disorder	NOUN
dpc-328	19	28	of	of	ADP
dpc-328	19	29	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	19	30	such	such	ADJ
dpc-328	19	31	as	as	ADP
dpc-328	19	32	melasma	melasma	NOUN
dpc-328	19	33	,	,	PUNCT
dpc-328	19	34	but	but	CCONJ
dpc-328	19	35	also	also	ADV
dpc-328	19	36	for	for	ADP
dpc-328	19	37	general	general	ADJ
dpc-328	19	38	“	"	PUNCT
dpc-328	19	39	skin	skin	NOUN
dpc-328	19	40	whitening	whitening	NOUN
dpc-328	19	41	.	.	PUNCT
dpc-328	19	42	”	"	PUNCT
dpc-328	20	1	this	this	DET
dpc-328	20	2	article	article	NOUN
dpc-328	20	3	is	be	AUX
dpc-328	20	4	meant	mean	VERB
dpc-328	20	5	to	to	PART
dpc-328	20	6	update	update	VERB
dpc-328	20	7	healthcare	healthcare	NOUN
dpc-328	20	8	professionals	professional	NOUN
dpc-328	20	9	about	about	ADP
dpc-328	20	10	the	the	DET
dpc-328	20	11	current	current	ADJ
dpc-328	20	12	status	status	NOUN
dpc-328	20	13	of	of	ADP
dpc-328	20	14	efficacy	efficacy	NOUN
dpc-328	20	15	,	,	PUNCT
dpc-328	20	16	safety	safety	NOUN
dpc-328	20	17	,	,	PUNCT
dpc-328	20	18	and	and	CCONJ
dpc-328	20	19	evidence	evidence	NOUN
dpc-328	20	20	of	of	ADP
dpc-328	20	21	different	different	ADJ
dpc-328	20	22	formulations	formulation	NOUN
dpc-328	20	23	of	of	ADP
dpc-328	20	24	glutathione	glutathione	NOUN
dpc-328	20	25	for	for	ADP
dpc-328	20	26	skin	skin	NOUN
dpc-328	20	27	tone	tone	NOUN
dpc-328	20	28	lightening	lightening	NOUN
dpc-328	20	29	.	.	PUNCT
dpc-328	21	1	for	for	ADP
dpc-328	21	2	more	more	ADV
dpc-328	21	3	detailed	detailed	ADJ
dpc-328	21	4	background	background	NOUN
dpc-328	21	5	information	information	NOUN
dpc-328	21	6	regarding	regard	VERB
dpc-328	21	7	the	the	DET
dpc-328	21	8	basic	basic	ADJ
dpc-328	21	9	and	and	CCONJ
dpc-328	21	10	applied	apply	VERB
dpc-328	21	11	physiology	physiology	NOUN
dpc-328	21	12	of	of	ADP
dpc-328	21	13	glutathione	glutathione	NOUN
dpc-328	21	14	,	,	PUNCT
dpc-328	21	15	readers	reader	NOUN
dpc-328	21	16	may	may	AUX
dpc-328	21	17	refer	refer	VERB
dpc-328	21	18	to	to	ADP
dpc-328	21	19	a	a	DET
dpc-328	21	20	previously	previously	ADV
dpc-328	21	21	published	publish	VERB
dpc-328	21	22	exhaustive	exhaustive	ADJ
dpc-328	21	23	article	article	NOUN
dpc-328	21	24	on	on	ADP
dpc-328	21	25	this	this	DET
dpc-328	21	26	aspect	aspect	NOUN
dpc-328	21	27	[	[	X
dpc-328	21	28	6	6	NUM
dpc-328	21	29	]	]	PUNCT
dpc-328	21	30	.	.	PUNCT
dpc-328	22	1	it	it	PRON
dpc-328	22	2	is	be	AUX
dpc-328	22	3	important	important	ADJ
dpc-328	22	4	to	to	PART
dpc-328	22	5	know	know	VERB
dpc-328	22	6	that	that	SCONJ
dpc-328	22	7	glutathione	glutathione	NOUN
dpc-328	22	8	exists	exist	VERB
dpc-328	22	9	in	in	ADP
dpc-328	22	10	a	a	DET
dpc-328	22	11	reduced	reduced	ADJ
dpc-328	22	12	form	form	NOUN
dpc-328	22	13	(	(	PUNCT
dpc-328	22	14	gsh	gsh	PROPN
dpc-328	22	15	)	)	PUNCT
dpc-328	22	16	and	and	CCONJ
dpc-328	22	17	an	an	DET
dpc-328	22	18	oxidized	oxidized	ADJ
dpc-328	22	19	form	form	NOUN
dpc-328	22	20	(	(	PUNCT
dpc-328	22	21	gssg	gssg	VERB
dpc-328	22	22	)	)	PUNCT
dpc-328	22	23	.	.	PUNCT
dpc-328	23	1	the	the	DET
dpc-328	23	2	reduced	reduced	ADJ
dpc-328	23	3	form	form	NOUN
dpc-328	23	4	,	,	PUNCT
dpc-328	23	5	gsh	gsh	PROPN
dpc-328	23	6	,	,	PUNCT
dpc-328	23	7	seems	seem	VERB
dpc-328	23	8	to	to	PART
dpc-328	23	9	be	be	AUX
dpc-328	23	10	instrumental	instrumental	ADJ
dpc-328	23	11	in	in	ADP
dpc-328	23	12	the	the	DET
dpc-328	23	13	depigmenting	depigmente	VERB
dpc-328	23	14	properties	property	NOUN
dpc-328	23	15	of	of	ADP
dpc-328	23	16	this	this	DET
dpc-328	23	17	unique	unique	ADJ
dpc-328	23	18	molecule	molecule	NOUN
dpc-328	23	19	.	.	PUNCT
dpc-328	24	1	apart	apart	ADV
dpc-328	24	2	from	from	ADP
dpc-328	24	3	these	these	DET
dpc-328	24	4	two	two	NUM
dpc-328	24	5	major	major	ADJ
dpc-328	24	6	forms	form	NOUN
dpc-328	24	7	,	,	PUNCT
dpc-328	24	8	gsh	gsh	PROPN
dpc-328	24	9	may	may	AUX
dpc-328	24	10	be	be	AUX
dpc-328	24	11	esterified	esterify	VERB
dpc-328	24	12	to	to	PART
dpc-328	24	13	form	form	VERB
dpc-328	24	14	glutathione	glutathione	NOUN
dpc-328	24	15	esters	ester	NOUN
dpc-328	24	16	[	[	X
dpc-328	24	17	7	7	NUM
dpc-328	24	18	]	]	PUNCT
dpc-328	24	19	.	.	PUNCT
dpc-328	25	1	an	an	DET
dpc-328	25	2	evidence	evidence	NOUN
dpc-328	25	3	-	-	PUNCT
dpc-328	25	4	update	update	NOUN
dpc-328	25	5	on	on	ADP
dpc-328	25	6	glutathione	glutathione	NOUN
dpc-328	25	7	as	as	ADP
dpc-328	25	8	a	a	DET
dpc-328	25	9	skin	skin	NOUN
dpc-328	25	10	-	-	PUNCT
dpc-328	25	11	lightening	lighten	VERB
dpc-328	25	12	agent	agent	NOUN
dpc-328	25	13	at	at	ADP
dpc-328	25	14	the	the	DET
dpc-328	25	15	time	time	NOUN
dpc-328	25	16	of	of	ADP
dpc-328	25	17	authoring	author	VERB
dpc-328	25	18	this	this	DET
dpc-328	25	19	article	article	NOUN
dpc-328	25	20	,	,	PUNCT
dpc-328	25	21	there	there	PRON
dpc-328	25	22	were	be	VERB
dpc-328	25	23	only	only	ADV
dpc-328	25	24	four	four	NUM
dpc-328	25	25	published	publish	VERB
dpc-328	25	26	studies	study	NOUN
dpc-328	25	27	that	that	PRON
dpc-328	25	28	evaluated	evaluate	VERB
dpc-328	25	29	the	the	DET
dpc-328	25	30	efficacy	efficacy	NOUN
dpc-328	25	31	of	of	ADP
dpc-328	25	32	oral	oral	ADJ
dpc-328	25	33	,	,	PUNCT
dpc-328	25	34	topical	topical	ADJ
dpc-328	25	35	,	,	PUNCT
dpc-328	25	36	and	and	CCONJ
dpc-328	25	37	parenteral	parenteral	ADJ
dpc-328	25	38	glutathione	glutathione	NOUN
dpc-328	25	39	as	as	ADP
dpc-328	25	40	a	a	DET
dpc-328	25	41	skin	skin	NOUN
dpc-328	25	42	-	-	PUNCT
dpc-328	25	43	whitening	whiten	VERB
dpc-328	25	44	agent	agent	NOUN
dpc-328	25	45	(	(	PUNCT
dpc-328	25	46	table	table	NOUN
dpc-328	25	47	 	 	SPACE
dpc-328	25	48	1	1	NUM
dpc-328	25	49	)	)	PUNCT
dpc-328	26	1	[	[	X
dpc-328	26	2	10	10	NUM
dpc-328	26	3	-	-	SYM
dpc-328	26	4	13	13	NUM
dpc-328	26	5	]	]	PUNCT
dpc-328	26	6	.	.	PUNCT
dpc-328	27	1	the	the	DET
dpc-328	27	2	two	two	NUM
dpc-328	27	3	trials	trial	NOUN
dpc-328	27	4	on	on	ADP
dpc-328	27	5	oral	oral	ADJ
dpc-328	27	6	gsh	gsh	PROPN
dpc-328	27	7	,	,	PUNCT
dpc-328	27	8	conducted	conduct	VERB
dpc-328	27	9	in	in	ADP
dpc-328	27	10	thai	thai	ADJ
dpc-328	27	11	population	population	NOUN
dpc-328	27	12	by	by	ADP
dpc-328	27	13	arjinpathana	arjinpathana	NOUN
dpc-328	27	14	and	and	CCONJ
dpc-328	27	15	asawanonda	asawanonda	NOUN
dpc-328	27	16	,	,	PUNCT
dpc-328	27	17	and	and	CCONJ
dpc-328	27	18	in	in	ADP
dpc-328	27	19	filipino	filipino	ADJ
dpc-328	27	20	women	woman	NOUN
dpc-328	27	21	by	by	ADP
dpc-328	27	22	handog	handog	PROPN
dpc-328	27	23	et	et	PROPN
dpc-328	27	24	al	al	PROPN
dpc-328	27	25	.	.	PROPN
dpc-328	27	26	involved	involve	VERB
dpc-328	27	27	administering	administer	VERB
dpc-328	27	28	500	500	NUM
dpc-328	27	29	mg	mg	NUM
dpc-328	27	30	/	/	SYM
dpc-328	27	31	day	day	NOUN
dpc-328	27	32	of	of	ADP
dpc-328	27	33	gsh	gsh	NOUN
dpc-328	27	34	in	in	ADP
dpc-328	27	35	two	two	NUM
dpc-328	27	36	divided	divide	VERB
dpc-328	27	37	doses	dose	NOUN
dpc-328	27	38	to	to	ADP
dpc-328	27	39	the	the	DET
dpc-328	27	40	study	study	NOUN
dpc-328	27	41	population	population	NOUN
dpc-328	27	42	,	,	PUNCT
dpc-328	27	43	the	the	DET
dpc-328	27	44	difference	difference	NOUN
dpc-328	27	45	being	be	AUX
dpc-328	27	46	the	the	DET
dpc-328	27	47	use	use	NOUN
dpc-328	27	48	of	of	ADP
dpc-328	27	49	a	a	DET
dpc-328	27	50	buccal	buccal	ADJ
dpc-328	27	51	lozenge	lozenge	NOUN
dpc-328	27	52	(	(	PUNCT
dpc-328	27	53	instead	instead	ADV
dpc-328	27	54	of	of	ADP
dpc-328	27	55	oral	oral	ADJ
dpc-328	27	56	capsules	capsule	NOUN
dpc-328	27	57	)	)	PUNCT
dpc-328	27	58	in	in	ADP
dpc-328	27	59	the	the	DET
dpc-328	27	60	latter	latter	ADJ
dpc-328	27	61	study	study	NOUN
dpc-328	27	62	to	to	PART
dpc-328	27	63	enhance	enhance	VERB
dpc-328	27	64	systemic	systemic	ADJ
dpc-328	27	65	absorption	absorption	NOUN
dpc-328	27	66	of	of	ADP
dpc-328	27	67	glutathione	glutathione	NOUN
dpc-328	27	68	[	[	X
dpc-328	27	69	10,11	10,11	NOUN
dpc-328	27	70	]	]	PUNCT
dpc-328	27	71	.	.	PUNCT
dpc-328	28	1	the	the	DET
dpc-328	28	2	primary	primary	ADJ
dpc-328	28	3	efficacy	efficacy	NOUN
dpc-328	28	4	outcome	outcome	NOUN
dpc-328	28	5	in	in	ADP
dpc-328	28	6	both	both	CCONJ
dpc-328	28	7	the	the	DET
dpc-328	28	8	trials	trial	NOUN
dpc-328	28	9	was	be	AUX
dpc-328	28	10	to	to	PART
dpc-328	28	11	evaluate	evaluate	VERB
dpc-328	28	12	the	the	DET
dpc-328	28	13	preand	preand	NOUN
dpc-328	28	14	post	post	ADJ
dpc-328	28	15	-	-	ADJ
dpc-328	28	16	treatment	treatment	ADJ
dpc-328	28	17	melanin	melanin	NOUN
dpc-328	28	18	indices	index	NOUN
dpc-328	28	19	.	.	PUNCT
dpc-328	29	1	both	both	DET
dpc-328	29	2	trials	trial	NOUN
dpc-328	29	3	employed	employ	VERB
dpc-328	29	4	a	a	DET
dpc-328	29	5	mexameter	mexameter	NOUN
dpc-328	29	6	mx	mx	PROPN
dpc-328	29	7	18	18	NUM
dpc-328	29	8	(	(	PUNCT
dpc-328	29	9	courage+khazaka	courage+khazaka	PROPN
dpc-328	29	10	electronic	electronic	ADJ
dpc-328	29	11	gmbh	gmbh	NOUN
dpc-328	29	12	,	,	PUNCT
dpc-328	29	13	cologne	cologne	NOUN
dpc-328	29	14	,	,	PUNCT
dpc-328	29	15	germany	germany	PROPN
dpc-328	29	16	)	)	PUNCT
dpc-328	29	17	introduction	introduction	NOUN
dpc-328	29	18	the	the	DET
dpc-328	29	19	preoccupation	preoccupation	NOUN
dpc-328	29	20	with	with	ADP
dpc-328	29	21	exploration	exploration	NOUN
dpc-328	29	22	of	of	ADP
dpc-328	29	23	treatment	treatment	NOUN
dpc-328	29	24	options	option	NOUN
dpc-328	29	25	that	that	PRON
dpc-328	29	26	may	may	AUX
dpc-328	29	27	help	help	VERB
dpc-328	29	28	attain	attain	VERB
dpc-328	29	29	a	a	DET
dpc-328	29	30	lighter	light	ADJ
dpc-328	29	31	skin	skin	NOUN
dpc-328	29	32	tone	tone	NOUN
dpc-328	29	33	or	or	CCONJ
dpc-328	29	34	fairer	fair	ADJ
dpc-328	29	35	complexion	complexion	NOUN
dpc-328	29	36	has	have	AUX
dpc-328	29	37	been	be	AUX
dpc-328	29	38	an	an	DET
dpc-328	29	39	ongoing	ongoing	ADJ
dpc-328	29	40	phenomenon	phenomenon	NOUN
dpc-328	29	41	in	in	ADP
dpc-328	29	42	people	people	NOUN
dpc-328	29	43	with	with	ADP
dpc-328	29	44	skin	skin	NOUN
dpc-328	29	45	of	of	ADP
dpc-328	29	46	color	color	NOUN
dpc-328	29	47	(	(	PUNCT
dpc-328	29	48	soc	soc	NOUN
dpc-328	29	49	)	)	PUNCT
dpc-328	29	50	.	.	PUNCT
dpc-328	30	1	the	the	DET
dpc-328	30	2	direct	direct	ADJ
dpc-328	30	3	implication	implication	NOUN
dpc-328	30	4	of	of	ADP
dpc-328	30	5	this	this	DET
dpc-328	30	6	craze	craze	NOUN
dpc-328	30	7	is	be	AUX
dpc-328	30	8	the	the	DET
dpc-328	30	9	exploitation	exploitation	NOUN
dpc-328	30	10	of	of	ADP
dpc-328	30	11	topical	topical	ADJ
dpc-328	30	12	agents	agent	NOUN
dpc-328	30	13	originally	originally	ADV
dpc-328	30	14	developed	develop	VERB
dpc-328	30	15	for	for	ADP
dpc-328	30	16	treatment	treatment	NOUN
dpc-328	30	17	of	of	ADP
dpc-328	30	18	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	30	19	,	,	PUNCT
dpc-328	30	20	such	such	ADJ
dpc-328	30	21	as	as	ADP
dpc-328	30	22	skin	skin	NOUN
dpc-328	30	23	lightening	lighten	VERB
dpc-328	30	24	therapies	therapy	NOUN
dpc-328	30	25	.	.	PUNCT
dpc-328	31	1	topicals	topical	NOUN
dpc-328	31	2	containing	contain	VERB
dpc-328	31	3	hydroquinone	hydroquinone	NOUN
dpc-328	31	4	,	,	PUNCT
dpc-328	31	5	alpha	alpha	NOUN
dpc-328	31	6	and	and	CCONJ
dpc-328	31	7	beta	beta	ADJ
dpc-328	31	8	hydroxy	hydroxy	NOUN
dpc-328	31	9	acids	acid	NOUN
dpc-328	31	10	,	,	PUNCT
dpc-328	31	11	tretinoin	tretinoin	NOUN
dpc-328	31	12	,	,	PUNCT
dpc-328	31	13	mequinol	mequinol	NOUN
dpc-328	31	14	,	,	PUNCT
dpc-328	31	15	arbutin	arbutin	NOUN
dpc-328	31	16	,	,	PUNCT
dpc-328	31	17	vitamin	vitamin	NOUN
dpc-328	31	18	c	c	NOUN
dpc-328	31	19	,	,	PUNCT
dpc-328	31	20	soy	soy	NOUN
dpc-328	31	21	extracts	extract	NOUN
dpc-328	31	22	and	and	CCONJ
dpc-328	31	23	concoctions	concoction	NOUN
dpc-328	31	24	of	of	ADP
dpc-328	31	25	multiple	multiple	ADJ
dpc-328	31	26	ingredients	ingredient	NOUN
dpc-328	31	27	,	,	PUNCT
dpc-328	31	28	including	include	VERB
dpc-328	31	29	newer	new	ADJ
dpc-328	31	30	cosmeceuticals	cosmeceutical	NOUN
dpc-328	31	31	,	,	PUNCT
dpc-328	31	32	are	be	AUX
dpc-328	31	33	now	now	ADV
dpc-328	31	34	in	in	ADP
dpc-328	31	35	vogue	vogue	NOUN
dpc-328	31	36	for	for	ADP
dpc-328	31	37	treatment	treatment	NOUN
dpc-328	31	38	of	of	ADP
dpc-328	31	39	facial	facial	ADJ
dpc-328	31	40	melanoses	melanose	NOUN
dpc-328	31	41	especially	especially	ADV
dpc-328	31	42	melasma	melasma	NOUN
dpc-328	31	43	[	[	X
dpc-328	31	44	1	1	NUM
dpc-328	31	45	]	]	PUNCT
dpc-328	31	46	and	and	CCONJ
dpc-328	31	47	for	for	ADP
dpc-328	31	48	general	general	ADJ
dpc-328	31	49	skin	skin	NOUN
dpc-328	31	50	lightening	lightening	NOUN
dpc-328	31	51	,	,	PUNCT
dpc-328	31	52	at	at	ADP
dpc-328	31	53	least	least	ADJ
dpc-328	31	54	of	of	ADP
dpc-328	31	55	the	the	DET
dpc-328	31	56	face	face	NOUN
dpc-328	31	57	,	,	PUNCT
dpc-328	31	58	neck	neck	NOUN
dpc-328	31	59	and	and	CCONJ
dpc-328	31	60	other	other	ADJ
dpc-328	31	61	exposed	expose	VERB
dpc-328	31	62	parts	part	NOUN
dpc-328	31	63	.	.	PUNCT
dpc-328	32	1	the	the	DET
dpc-328	32	2	local	local	ADJ
dpc-328	32	3	adverse	adverse	ADJ
dpc-328	32	4	effects	effect	NOUN
dpc-328	32	5	of	of	ADP
dpc-328	32	6	these	these	DET
dpc-328	32	7	agents	agent	NOUN
dpc-328	32	8	[	[	X
dpc-328	32	9	1	1	X
dpc-328	32	10	]	]	PUNCT
dpc-328	32	11	and	and	CCONJ
dpc-328	32	12	the	the	DET
dpc-328	32	13	quantity	quantity	NOUN
dpc-328	32	14	required	require	VERB
dpc-328	32	15	for	for	ADP
dpc-328	32	16	large	large	ADJ
dpc-328	32	17	surface	surface	NOUN
dpc-328	32	18	area	area	NOUN
dpc-328	32	19	application	application	NOUN
dpc-328	32	20	constitute	constitute	VERB
dpc-328	32	21	major	major	ADJ
dpc-328	32	22	limitations	limitation	NOUN
dpc-328	32	23	of	of	ADP
dpc-328	32	24	this	this	DET
dpc-328	32	25	approach	approach	NOUN
dpc-328	32	26	.	.	PUNCT
dpc-328	33	1	understandably	understandably	ADV
dpc-328	33	2	,	,	PUNCT
dpc-328	33	3	the	the	DET
dpc-328	33	4	effect	effect	NOUN
dpc-328	33	5	of	of	ADP
dpc-328	33	6	such	such	ADJ
dpc-328	33	7	locally	locally	ADV
dpc-328	33	8	applied	apply	VERB
dpc-328	33	9	topicals	topical	NOUN
dpc-328	33	10	remains	remain	VERB
dpc-328	33	11	limited	limited	ADJ
dpc-328	33	12	to	to	ADP
dpc-328	33	13	the	the	DET
dpc-328	33	14	application	application	NOUN
dpc-328	33	15	site	site	NOUN
dpc-328	33	16	alone	alone	ADV
dpc-328	33	17	without	without	ADP
dpc-328	33	18	any	any	DET
dpc-328	33	19	notable	notable	ADJ
dpc-328	33	20	systemic	systemic	ADJ
dpc-328	33	21	skin	skin	NOUN
dpc-328	33	22	lightening	lighten	VERB
dpc-328	33	23	effect	effect	NOUN
dpc-328	33	24	.	.	PUNCT
dpc-328	34	1	the	the	DET
dpc-328	34	2	quest	quest	NOUN
dpc-328	34	3	for	for	ADP
dpc-328	34	4	a	a	DET
dpc-328	34	5	systemic	systemic	ADJ
dpc-328	34	6	skin	skin	NOUN
dpc-328	34	7	-	-	PUNCT
dpc-328	34	8	whitening	whiten	VERB
dpc-328	34	9	agent	agent	NOUN
dpc-328	34	10	ensues	ensue	NOUN
dpc-328	34	11	.	.	PUNCT
dpc-328	35	1	oral	oral	ADJ
dpc-328	35	2	antioxidants	antioxidant	NOUN
dpc-328	35	3	,	,	PUNCT
dpc-328	35	4	such	such	ADJ
dpc-328	35	5	as	as	ADP
dpc-328	35	6	vitamin	vitamin	NOUN
dpc-328	35	7	c	c	NOUN
dpc-328	35	8	,	,	PUNCT
dpc-328	35	9	vitamin	vitamin	NOUN
dpc-328	35	10	e	e	NOUN
dpc-328	35	11	,	,	PUNCT
dpc-328	35	12	tranexamic	tranexamic	ADJ
dpc-328	35	13	acid	acid	NOUN
dpc-328	35	14	,	,	PUNCT
dpc-328	35	15	flavonoids	flavonoid	NOUN
dpc-328	35	16	,	,	PUNCT
dpc-328	35	17	and	and	CCONJ
dpc-328	35	18	various	various	ADJ
dpc-328	35	19	botanical	botanical	ADJ
dpc-328	35	20	extracts	extract	NOUN
dpc-328	35	21	have	have	AUX
dpc-328	35	22	been	be	AUX
dpc-328	35	23	tried	try	VERB
dpc-328	35	24	in	in	ADP
dpc-328	35	25	melasma	melasma	NOUN
dpc-328	35	26	and	and	CCONJ
dpc-328	35	27	disorders	disorder	NOUN
dpc-328	35	28	of	of	ADP
dpc-328	35	29	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	35	30	,	,	PUNCT
dpc-328	35	31	but	but	CCONJ
dpc-328	35	32	none	none	NOUN
dpc-328	35	33	has	have	AUX
dpc-328	35	34	proven	prove	VERB
dpc-328	35	35	to	to	PART
dpc-328	35	36	provide	provide	VERB
dpc-328	35	37	an	an	DET
dpc-328	35	38	overall	overall	ADJ
dpc-328	35	39	skin	skin	NOUN
dpc-328	35	40	lightening	lighten	VERB
dpc-328	35	41	effect	effect	NOUN
dpc-328	36	1	[	[	X
dpc-328	36	2	1,2	1,2	NUM
dpc-328	36	3	]	]	PUNCT
dpc-328	36	4	.	.	PUNCT
dpc-328	37	1	glutathione	glutathione	NOUN
dpc-328	37	2	,	,	PUNCT
dpc-328	37	3	being	be	AUX
dpc-328	37	4	a	a	DET
dpc-328	37	5	strong	strong	ADJ
dpc-328	37	6	antioxidant	antioxidant	NOUN
dpc-328	37	7	with	with	ADP
dpc-328	37	8	additional	additional	ADJ
dpc-328	37	9	anti	anti	ADJ
dpc-328	37	10	-	-	ADJ
dpc-328	37	11	melanogenic	melanogenic	ADJ
dpc-328	37	12	properties	property	NOUN
dpc-328	37	13	,	,	PUNCT
dpc-328	37	14	has	have	AUX
dpc-328	37	15	recently	recently	ADV
dpc-328	37	16	become	become	VERB
dpc-328	37	17	the	the	DET
dpc-328	37	18	most	most	ADV
dpc-328	37	19	popular	popular	ADJ
dpc-328	37	20	“	"	PUNCT
dpc-328	37	21	systemic	systemic	ADJ
dpc-328	37	22	skin	skin	NOUN
dpc-328	37	23	lightening	lighten	VERB
dpc-328	37	24	molecule	molecule	NOUN
dpc-328	37	25	.	.	PUNCT
dpc-328	37	26	”	"	PUNCT
dpc-328	38	1	the	the	DET
dpc-328	38	2	most	most	ADV
dpc-328	38	3	“	"	PUNCT
dpc-328	38	4	popular	popular	ADJ
dpc-328	38	5	”	"	PUNCT
dpc-328	38	6	and	and	CCONJ
dpc-328	38	7	controversial	controversial	ADJ
dpc-328	38	8	route	route	NOUN
dpc-328	38	9	of	of	ADP
dpc-328	38	10	administration	administration	NOUN
dpc-328	38	11	of	of	ADP
dpc-328	38	12	glutathione	glutathione	NOUN
dpc-328	38	13	for	for	ADP
dpc-328	38	14	skin	skin	NOUN
dpc-328	38	15	lightening	lightening	NOUN
dpc-328	38	16	has	have	AUX
dpc-328	38	17	been	be	AUX
dpc-328	38	18	intravenous	intravenous	ADJ
dpc-328	38	19	(	(	PUNCT
dpc-328	38	20	iv	iv	NUM
dpc-328	38	21	)	)	PUNCT
dpc-328	38	22	.	.	PUNCT
dpc-328	39	1	glutathione	glutathione	NOUN
dpc-328	39	2	(	(	PUNCT
dpc-328	39	3	gsh	gsh	PROPN
dpc-328	39	4	)	)	PUNCT
dpc-328	39	5	,	,	PUNCT
dpc-328	39	6	a	a	DET
dpc-328	39	7	low	low	ADJ
dpc-328	39	8	molecular	molecular	ADJ
dpc-328	39	9	weight	weight	NOUN
dpc-328	39	10	thiol	thiol	NOUN
dpc-328	39	11	-	-	PUNCT
dpc-328	39	12	tripeptide	tripeptide	NOUN
dpc-328	39	13	is	be	AUX
dpc-328	39	14	central	central	ADJ
dpc-328	39	15	to	to	ADP
dpc-328	39	16	the	the	DET
dpc-328	39	17	maintenance	maintenance	NOUN
dpc-328	39	18	of	of	ADP
dpc-328	39	19	intracellular	intracellular	ADJ
dpc-328	39	20	redox	redox	ADJ
dpc-328	39	21	balance	balance	NOUN
dpc-328	39	22	[	[	X
dpc-328	39	23	3	3	NUM
dpc-328	39	24	]	]	PUNCT
dpc-328	39	25	.	.	PUNCT
dpc-328	40	1	currently	currently	ADV
dpc-328	40	2	,	,	PUNCT
dpc-328	40	3	to	to	ADP
dpc-328	40	4	the	the	DET
dpc-328	40	5	best	good	ADJ
dpc-328	40	6	of	of	ADP
dpc-328	40	7	our	our	PRON
dpc-328	40	8	knowledge	knowledge	NOUN
dpc-328	40	9	,	,	PUNCT
dpc-328	40	10	iv	iv	NUM
dpc-328	40	11	gsh	gsh	NOUN
dpc-328	40	12	has	have	AUX
dpc-328	40	13	been	be	AUX
dpc-328	40	14	approved	approve	VERB
dpc-328	40	15	by	by	ADP
dpc-328	40	16	different	different	ADJ
dpc-328	40	17	statutory	statutory	ADJ
dpc-328	40	18	drug	drug	NOUN
dpc-328	40	19	regulatory	regulatory	ADJ
dpc-328	40	20	authorities	authority	NOUN
dpc-328	40	21	for	for	ADP
dpc-328	40	22	specific	specific	ADJ
dpc-328	40	23	systemic	systemic	ADJ
dpc-328	40	24	disorders	disorder	NOUN
dpc-328	40	25	.	.	PUNCT
dpc-328	41	1	the	the	DET
dpc-328	41	2	indications	indication	NOUN
dpc-328	41	3	approved	approve	VERB
dpc-328	41	4	by	by	ADP
dpc-328	41	5	the	the	DET
dpc-328	41	6	central	central	ADJ
dpc-328	41	7	drugs	drug	NOUN
dpc-328	41	8	standard	standard	PROPN
dpc-328	41	9	control	control	PROPN
dpc-328	41	10	organization	organization	PROPN
dpc-328	41	11	(	(	PUNCT
dpc-328	41	12	cdsco	cdsco	PROPN
dpc-328	41	13	)	)	PUNCT
dpc-328	41	14	in	in	ADP
dpc-328	41	15	india	india	PROPN
dpc-328	41	16	are	be	AUX
dpc-328	41	17	:	:	PUNCT
dpc-328	41	18	1	1	X
dpc-328	41	19	)	)	PUNCT
dpc-328	41	20	alcoholic	alcoholic	ADJ
dpc-328	41	21	fatty	fatty	NOUN
dpc-328	41	22	liver	liver	NOUN
dpc-328	41	23	,	,	PUNCT
dpc-328	41	24	2	2	X
dpc-328	41	25	)	)	PUNCT
dpc-328	41	26	alcoholic	alcoholic	ADJ
dpc-328	41	27	liver	liver	NOUN
dpc-328	41	28	fibrosis	fibrosis	NOUN
dpc-328	41	29	,	,	PUNCT
dpc-328	41	30	3	3	X
dpc-328	41	31	)	)	PUNCT
dpc-328	41	32	alcoholic	alcoholic	ADJ
dpc-328	41	33	liver	liver	NOUN
dpc-328	41	34	cirrhosis	cirrhosis	NOUN
dpc-328	41	35	,	,	PUNCT
dpc-328	41	36	and	and	CCONJ
dpc-328	42	1	4	4	X
dpc-328	42	2	)	)	PUNCT
dpc-328	42	3	alcoholic	alcoholic	ADJ
dpc-328	42	4	hepatitis	hepatitis	NOUN
dpc-328	43	1	[	[	X
dpc-328	43	2	4	4	NUM
dpc-328	43	3	]	]	PUNCT
dpc-328	43	4	.	.	PUNCT
dpc-328	44	1	the	the	DET
dpc-328	44	2	philippines	philippine	NOUN
dpc-328	44	3	food	food	NOUN
dpc-328	44	4	and	and	CCONJ
dpc-328	44	5	drug	drug	PROPN
dpc-328	44	6	administration	administration	PROPN
dpc-328	44	7	(	(	PUNCT
dpc-328	44	8	fda	fda	PROPN
dpc-328	44	9	)	)	PUNCT
dpc-328	44	10	has	have	AUX
dpc-328	44	11	approved	approve	VERB
dpc-328	44	12	its	its	PRON
dpc-328	44	13	use	use	NOUN
dpc-328	44	14	as	as	ADP
dpc-328	44	15	an	an	DET
dpc-328	44	16	adjunctive	adjunctive	ADJ
dpc-328	44	17	treatment	treatment	NOUN
dpc-328	44	18	to	to	PART
dpc-328	44	19	reduce	reduce	VERB
dpc-328	44	20	neurotoxicity	neurotoxicity	NOUN
dpc-328	44	21	associated	associate	VERB
dpc-328	44	22	with	with	ADP
dpc-328	44	23	cisplatin	cisplatin	NOUN
dpc-328	44	24	chemotherapy	chemotherapy	NOUN
dpc-328	45	1	[	[	X
dpc-328	45	2	5	5	NUM
dpc-328	45	3	]	]	PUNCT
dpc-328	45	4	.	.	PUNCT
dpc-328	46	1	in	in	ADP
dpc-328	46	2	addition	addition	NOUN
dpc-328	46	3	to	to	ADP
dpc-328	46	4	it	it	PRON
dpc-328	46	5	being	be	AUX
dpc-328	46	6	one	one	NUM
dpc-328	46	7	of	of	ADP
dpc-328	46	8	the	the	DET
dpc-328	46	9	richest	rich	ADJ
dpc-328	46	10	antioxidants	antioxidant	NOUN
dpc-328	46	11	,	,	PUNCT
dpc-328	46	12	it	it	PRON
dpc-328	46	13	is	be	AUX
dpc-328	46	14	being	be	AUX
dpc-328	46	15	promoted	promote	VERB
dpc-328	46	16	as	as	ADP
dpc-328	46	17	a	a	DET
dpc-328	46	18	skin	skin	NOUN
dpc-328	46	19	-	-	PUNCT
dpc-328	46	20	lightening	lighten	VERB
dpc-328	46	21	agent	agent	NOUN
dpc-328	46	22	,	,	PUNCT
dpc-328	46	23	following	follow	VERB
dpc-328	46	24	the	the	DET
dpc-328	46	25	discovery	discovery	NOUN
dpc-328	46	26	of	of	ADP
dpc-328	46	27	its	its	PRON
dpc-328	46	28	antimelanogenic	antimelanogenic	ADJ
dpc-328	46	29	properties	property	NOUN
dpc-328	46	30	[	[	X
dpc-328	46	31	7	7	NUM
dpc-328	46	32	]	]	PUNCT
dpc-328	46	33	.	.	PUNCT
dpc-328	47	1	amongst	amongst	ADP
dpc-328	47	2	the	the	DET
dpc-328	47	3	many	many	ADJ
dpc-328	47	4	mechanisms	mechanism	NOUN
dpc-328	47	5	postulated	postulate	VERB
dpc-328	47	6	to	to	PART
dpc-328	47	7	contribute	contribute	VERB
dpc-328	47	8	to	to	ADP
dpc-328	47	9	its	its	PRON
dpc-328	47	10	antimelanogenic	antimelanogenic	ADJ
dpc-328	47	11	properties	property	NOUN
dpc-328	47	12	(	(	PUNCT
dpc-328	47	13	figure	figure	NOUN
dpc-328	47	14	1	1	NUM
dpc-328	47	15	)	)	PUNCT
dpc-328	47	16	,	,	PUNCT
dpc-328	47	17	inhibition	inhibition	NOUN
dpc-328	47	18	of	of	ADP
dpc-328	47	19	tyrosinase	tyrosinase	ADJ
dpc-328	47	20	enzyme	enzyme	NOUN
dpc-328	47	21	,	,	PUNCT
dpc-328	47	22	skewing	skew	VERB
dpc-328	47	23	of	of	ADP
dpc-328	47	24	melanogenesis	melanogenesis	NOUN
dpc-328	47	25	from	from	ADP
dpc-328	47	26	the	the	DET
dpc-328	47	27	darker	dark	ADJ
dpc-328	47	28	eumelanin	eumelanin	NOUN
dpc-328	47	29	to	to	ADP
dpc-328	47	30	the	the	DET
dpc-328	47	31	lighter	light	ADJ
dpc-328	47	32	phaeomelanin	phaeomelanin	NOUN
dpc-328	47	33	,	,	PUNCT
dpc-328	47	34	and	and	CCONJ
dpc-328	47	35	scavenging	scavenge	VERB
dpc-328	47	36	of	of	ADP
dpc-328	47	37	free	free	ADJ
dpc-328	47	38	radicals	radical	NOUN
dpc-328	47	39	seem	seem	VERB
dpc-328	47	40	to	to	PART
dpc-328	47	41	be	be	AUX
dpc-328	47	42	the	the	DET
dpc-328	47	43	most	most	ADV
dpc-328	47	44	important	important	ADJ
dpc-328	47	45	[	[	X
dpc-328	47	46	8	8	NUM
dpc-328	47	47	]	]	PUNCT
dpc-328	47	48	.	.	PUNCT
dpc-328	48	1	unfortunately	unfortunately	ADV
dpc-328	48	2	,	,	PUNCT
dpc-328	48	3	there	there	PRON
dpc-328	48	4	is	be	VERB
dpc-328	48	5	a	a	DET
dpc-328	48	6	clear	clear	ADJ
dpc-328	48	7	contradiction	contradiction	NOUN
dpc-328	48	8	between	between	ADP
dpc-328	48	9	the	the	DET
dpc-328	48	10	exact	exact	ADJ
dpc-328	48	11	evidence	evidence	NOUN
dpc-328	48	12	supporting	support	VERB
dpc-328	48	13	its	its	PRON
dpc-328	48	14	efficacy	efficacy	NOUN
dpc-328	48	15	and	and	CCONJ
dpc-328	48	16	safety	safety	NOUN
dpc-328	48	17	,	,	PUNCT
dpc-328	48	18	and	and	CCONJ
dpc-328	48	19	the	the	DET
dpc-328	48	20	hype	hype	NOUN
dpc-328	48	21	around	around	ADP
dpc-328	48	22	its	its	PRON
dpc-328	48	23	depigmentary	depigmentary	ADJ
dpc-328	48	24	properties	property	NOUN
dpc-328	48	25	,	,	PUNCT
dpc-328	48	26	with	with	ADP
dpc-328	48	27	pharma	pharma	NOUN
dpc-328	48	28	-	-	PUNCT
dpc-328	48	29	cosmeceuticals	cosmeceutical	NOUN
dpc-328	48	30	inundating	inundate	VERB
dpc-328	48	31	dermatology	dermatology	NOUN
dpc-328	48	32	therapeutics	therapeutic	NOUN
dpc-328	48	33	with	with	ADP
dpc-328	48	34	glutathione	glutathione	NOUN
dpc-328	48	35	tablets	tablet	NOUN
dpc-328	48	36	,	,	PUNCT
dpc-328	48	37	capsules	capsule	NOUN
dpc-328	48	38	,	,	PUNCT
dpc-328	48	39	topical	topical	ADJ
dpc-328	48	40	preparations	preparation	NOUN
dpc-328	48	41	and	and	CCONJ
dpc-328	48	42	parenteral	parenteral	ADJ
dpc-328	48	43	preparations	preparation	NOUN
dpc-328	48	44	across	across	ADP
dpc-328	48	45	the	the	DET
dpc-328	48	46	globe	globe	NOUN
dpc-328	49	1	[	[	X
dpc-328	49	2	9	9	NUM
dpc-328	49	3	]	]	PUNCT
dpc-328	49	4	.	.	PUNCT
dpc-328	50	1	•	•	NOUN
dpc-328	50	2	inhibition	inhibition	NOUN
dpc-328	50	3	of	of	ADP
dpc-328	50	4	tyrosinase	tyrosinase	NOUN
dpc-328	50	5	(	(	PUNCT
dpc-328	50	6	the	the	DET
dpc-328	50	7	key	key	ADJ
dpc-328	50	8	enzyme	enzyme	NOUN
dpc-328	50	9	of	of	ADP
dpc-328	50	10	melanogenesis	melanogenesis	NOUN
dpc-328	50	11	):	):	PUNCT
dpc-328	50	12	–	–	PUNCT
dpc-328	50	13	direct	direct	ADJ
dpc-328	50	14	inhibition	inhibition	NOUN
dpc-328	50	15	:	:	PUNCT
dpc-328	50	16	thiol	thiol	ADJ
dpc-328	50	17	group	group	NOUN
dpc-328	50	18	binding	bind	VERB
dpc-328	50	19	with	with	ADP
dpc-328	50	20	the	the	DET
dpc-328	50	21	copper	copper	NOUN
dpc-328	50	22	-	-	PUNCT
dpc-328	50	23	containing	contain	VERB
dpc-328	50	24	active	active	ADJ
dpc-328	50	25	site	site	NOUN
dpc-328	50	26	of	of	ADP
dpc-328	50	27	the	the	DET
dpc-328	50	28	enzyme	enzyme	NOUN
dpc-328	50	29	–	–	PUNCT
dpc-328	50	30	indirect	indirect	ADJ
dpc-328	50	31	inactivation	inactivation	NOUN
dpc-328	50	32	:	:	PUNCT
dpc-328	50	33	exerted	exert	VERB
dpc-328	50	34	via	via	ADP
dpc-328	50	35	the	the	DET
dpc-328	50	36	antioxidant	antioxidant	ADJ
dpc-328	50	37	effect	effect	NOUN
dpc-328	50	38	of	of	ADP
dpc-328	50	39	glutathione	glutathione	NOUN
dpc-328	50	40	that	that	PRON
dpc-328	50	41	leads	lead	VERB
dpc-328	50	42	to	to	ADP
dpc-328	50	43	quenching	quenching	NOUN
dpc-328	50	44	of	of	ADP
dpc-328	50	45	free	free	ADJ
dpc-328	50	46	radicals	radical	NOUN
dpc-328	50	47	and	and	CCONJ
dpc-328	50	48	peroxides	peroxides	NOUN
dpc-328	50	49	•	•	NOUN
dpc-328	50	50	switching	switch	VERB
dpc-328	50	51	production	production	NOUN
dpc-328	50	52	of	of	ADP
dpc-328	50	53	eumelanin	eumelanin	NOUN
dpc-328	50	54	to	to	ADP
dpc-328	50	55	phaeomelanin	phaeomelanin	NOUN
dpc-328	50	56	•	•	NOUN
dpc-328	50	57	modulation	modulation	NOUN
dpc-328	50	58	of	of	ADP
dpc-328	50	59	the	the	DET
dpc-328	50	60	depigmenting	depigmente	VERB
dpc-328	50	61	properties	property	NOUN
dpc-328	50	62	of	of	ADP
dpc-328	50	63	other	other	ADJ
dpc-328	50	64	antimelanogenic	antimelanogenic	ADJ
dpc-328	50	65	principles	principle	NOUN
dpc-328	50	66	figure	figure	VERB
dpc-328	50	67	1	1	NUM
dpc-328	50	68	.	.	PUNCT
dpc-328	50	69	mechanisms	mechanism	NOUN
dpc-328	50	70	postulated	postulate	VERB
dpc-328	50	71	to	to	PART
dpc-328	50	72	be	be	AUX
dpc-328	50	73	responsible	responsible	ADJ
dpc-328	50	74	for	for	ADP
dpc-328	50	75	the	the	DET
dpc-328	50	76	skin	skin	NOUN
dpc-328	50	77	lightening	lighten	VERB
dpc-328	50	78	effect	effect	NOUN
dpc-328	50	79	of	of	ADP
dpc-328	50	80	glutathione	glutathione	NOUN
dpc-328	50	81	.	.	PUNCT
dpc-328	51	1	[	[	X
dpc-328	51	2	copyright	copyright	NOUN
dpc-328	51	3	:	:	PUNCT
dpc-328	51	4	©	©	PROPN
dpc-328	51	5	2018	2018	NUM
dpc-328	51	6	sonthalia	sonthalia	PROPN
dpc-328	51	7	et	et	PROPN
dpc-328	51	8	al	al	PROPN
dpc-328	51	9	.	.	PROPN
dpc-328	51	10	]	]	PUNCT
dpc-328	52	1	review	review	NOUN
dpc-328	52	2	|	|	ADV
dpc-328	52	3	dermatol	dermatol	ADJ
dpc-328	52	4	pract	pract	NOUN
dpc-328	52	5	concept	concept	NOUN
dpc-328	52	6	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	52	7	17	17	NUM
dpc-328	52	8	tion	tion	NOUN
dpc-328	52	9	in	in	ADP
dpc-328	52	10	melanin	melanin	NOUN
dpc-328	52	11	index	index	NOUN
dpc-328	52	12	at	at	ADP
dpc-328	52	13	both	both	CCONJ
dpc-328	52	14	sun	sun	NOUN
dpc-328	52	15	-	-	PUNCT
dpc-328	52	16	exposed	expose	VERB
dpc-328	52	17	and	and	CCONJ
dpc-328	52	18	sun	sun	NOUN
dpc-328	52	19	-	-	PUNCT
dpc-328	52	20	protected	protect	VERB
dpc-328	52	21	sites	site	NOUN
dpc-328	52	22	in	in	ADP
dpc-328	52	23	all	all	DET
dpc-328	52	24	the	the	DET
dpc-328	52	25	subjects	subject	NOUN
dpc-328	52	26	and	and	CCONJ
dpc-328	52	27	moderate	moderate	ADJ
dpc-328	52	28	skin	skin	NOUN
dpc-328	52	29	lightening	lightening	NOUN
dpc-328	52	30	observed	observe	VERB
dpc-328	52	31	by	by	ADP
dpc-328	52	32	90	90	NUM
dpc-328	52	33	%	%	NOUN
dpc-328	52	34	of	of	ADP
dpc-328	52	35	the	the	DET
dpc-328	52	36	subjects	subject	NOUN
dpc-328	52	37	on	on	ADP
dpc-328	52	38	global	global	ADJ
dpc-328	52	39	evaluation	evaluation	NOUN
dpc-328	52	40	[	[	X
dpc-328	52	41	11	11	NUM
dpc-328	52	42	]	]	PUNCT
dpc-328	52	43	.	.	PUNCT
dpc-328	53	1	the	the	DET
dpc-328	53	2	tolerance	tolerance	NOUN
dpc-328	53	3	to	to	PART
dpc-328	53	4	gsh	gsh	PROPN
dpc-328	53	5	was	be	AUX
dpc-328	53	6	excellent	excellent	ADJ
dpc-328	53	7	in	in	ADP
dpc-328	53	8	both	both	CCONJ
dpc-328	53	9	the	the	DET
dpc-328	53	10	studies	study	NOUN
dpc-328	53	11	.	.	PUNCT
dpc-328	54	1	the	the	DET
dpc-328	54	2	singular	singular	NOUN
dpc-328	54	3	randomized	randomize	VERB
dpc-328	54	4	,	,	PUNCT
dpc-328	54	5	double	double	ADJ
dpc-328	54	6	-	-	PUNCT
dpc-328	54	7	blind	blind	ADJ
dpc-328	54	8	,	,	PUNCT
dpc-328	54	9	placebo	placebo	NOUN
dpc-328	54	10	-	-	PUNCT
dpc-328	54	11	controlled	control	VERB
dpc-328	54	12	clinical	clinical	ADJ
dpc-328	54	13	trial	trial	NOUN
dpc-328	54	14	by	by	ADP
dpc-328	54	15	watanabe	watanabe	PROPN
dpc-328	54	16	et	et	PROPN
dpc-328	54	17	al	al	PROPN
dpc-328	54	18	.	.	PROPN
dpc-328	54	19	,	,	PUNCT
dpc-328	54	20	conducted	conduct	VERB
dpc-328	54	21	in	in	ADP
dpc-328	54	22	30	30	NUM
dpc-328	54	23	healthy	healthy	ADJ
dpc-328	54	24	filipino	filipino	ADJ
dpc-328	54	25	women	woman	NOUN
dpc-328	54	26	aged	age	VERB
dpc-328	54	27	30	30	NUM
dpc-328	54	28	-	-	SYM
dpc-328	54	29	50	50	NUM
dpc-328	54	30	years	year	NOUN
dpc-328	54	31	has	have	AUX
dpc-328	54	32	provided	provide	VERB
dpc-328	54	33	virginal	virginal	ADJ
dpc-328	54	34	evidence	evidence	NOUN
dpc-328	54	35	favoring	favor	VERB
dpc-328	54	36	efficacy	efficacy	NOUN
dpc-328	54	37	of	of	ADP
dpc-328	54	38	topical	topical	ADJ
dpc-328	54	39	gssg	gssg	ADJ
dpc-328	54	40	2	2	NUM
dpc-328	54	41	%	%	NOUN
dpc-328	54	42	lotion	lotion	NOUN
dpc-328	54	43	(	(	PUNCT
dpc-328	54	44	applied	apply	VERB
dpc-328	54	45	twice	twice	ADV
dpc-328	54	46	daily	daily	ADV
dpc-328	54	47	for	for	ADP
dpc-328	54	48	10	10	NUM
dpc-328	54	49	weeks	week	NOUN
dpc-328	54	50	)	)	PUNCT
dpc-328	54	51	in	in	ADP
dpc-328	54	52	producing	produce	VERB
dpc-328	54	53	temporary	temporary	ADJ
dpc-328	54	54	skin	skin	NOUN
dpc-328	54	55	whitening	whiten	VERB
dpc-328	54	56	[	[	X
dpc-328	54	57	12	12	NUM
dpc-328	54	58	]	]	PUNCT
dpc-328	54	59	.	.	PUNCT
dpc-328	55	1	the	the	DET
dpc-328	55	2	results	result	NOUN
dpc-328	55	3	of	of	ADP
dpc-328	55	4	this	this	DET
dpc-328	55	5	split	split	ADJ
dpc-328	55	6	-	-	PUNCT
dpc-328	55	7	face	face	NOUN
dpc-328	55	8	,	,	PUNCT
dpc-328	55	9	protocol	protocol	NOUN
dpc-328	55	10	-	-	PUNCT
dpc-328	55	11	based	base	VERB
dpc-328	55	12	study	study	NOUN
dpc-328	55	13	revealed	reveal	VERB
dpc-328	55	14	statistically	statistically	ADV
dpc-328	55	15	to	to	PART
dpc-328	55	16	evaluate	evaluate	VERB
dpc-328	55	17	the	the	DET
dpc-328	55	18	primary	primary	ADJ
dpc-328	55	19	efficacy	efficacy	NOUN
dpc-328	55	20	outcome	outcome	NOUN
dpc-328	55	21	.	.	PUNCT
dpc-328	56	1	the	the	DET
dpc-328	56	2	randomized	randomized	ADJ
dpc-328	56	3	,	,	PUNCT
dpc-328	56	4	double	double	ADJ
dpc-328	56	5	-	-	PUNCT
dpc-328	56	6	blind	blind	ADJ
dpc-328	56	7	,	,	PUNCT
dpc-328	56	8	two	two	NUM
dpc-328	56	9	-	-	PUNCT
dpc-328	56	10	arm	arm	NOUN
dpc-328	56	11	,	,	PUNCT
dpc-328	56	12	placebo	placebo	NOUN
dpc-328	56	13	-	-	PUNCT
dpc-328	56	14	controlled	control	VERB
dpc-328	56	15	study	study	NOUN
dpc-328	56	16	conducted	conduct	VERB
dpc-328	56	17	by	by	ADP
dpc-328	56	18	arjinpathana	arjinpathana	NOUN
dpc-328	56	19	and	and	CCONJ
dpc-328	56	20	asawanonda	asawanonda	NOUN
dpc-328	56	21	in	in	ADP
dpc-328	56	22	60	60	NUM
dpc-328	56	23	healthy	healthy	ADJ
dpc-328	56	24	medical	medical	ADJ
dpc-328	56	25	students	student	NOUN
dpc-328	56	26	showed	show	VERB
dpc-328	56	27	a	a	DET
dpc-328	56	28	consistent	consistent	ADJ
dpc-328	56	29	reduction	reduction	NOUN
dpc-328	56	30	in	in	ADP
dpc-328	56	31	the	the	DET
dpc-328	56	32	melanin	melanin	NOUN
dpc-328	56	33	indices	index	NOUN
dpc-328	56	34	at	at	ADP
dpc-328	56	35	all	all	DET
dpc-328	56	36	the	the	DET
dpc-328	56	37	six	six	NUM
dpc-328	56	38	sites	site	NOUN
dpc-328	56	39	evaluated	evaluate	VERB
dpc-328	56	40	in	in	ADP
dpc-328	56	41	the	the	DET
dpc-328	56	42	gsh	gsh	PROPN
dpc-328	56	43	group	group	NOUN
dpc-328	56	44	subjects	subject	NOUN
dpc-328	56	45	,	,	PUNCT
dpc-328	56	46	with	with	ADP
dpc-328	56	47	a	a	DET
dpc-328	56	48	statistically	statistically	ADV
dpc-328	56	49	significant	significant	ADJ
dpc-328	56	50	reduction	reduction	NOUN
dpc-328	56	51	over	over	ADP
dpc-328	56	52	placebo	placebo	NOUN
dpc-328	56	53	at	at	ADP
dpc-328	56	54	two	two	NUM
dpc-328	56	55	sites	site	NOUN
dpc-328	56	56	[	[	X
dpc-328	56	57	10	10	NUM
dpc-328	56	58	]	]	PUNCT
dpc-328	56	59	.	.	PUNCT
dpc-328	57	1	the	the	DET
dpc-328	57	2	open	open	ADJ
dpc-328	57	3	-	-	PUNCT
dpc-328	57	4	label	label	NOUN
dpc-328	57	5	,	,	PUNCT
dpc-328	57	6	single	single	ADJ
dpc-328	57	7	-	-	PUNCT
dpc-328	57	8	arm	arm	NOUN
dpc-328	57	9	pilot	pilot	NOUN
dpc-328	57	10	study	study	NOUN
dpc-328	57	11	conducted	conduct	VERB
dpc-328	57	12	by	by	ADP
dpc-328	57	13	handog	handog	PROPN
dpc-328	57	14	et	et	PROPN
dpc-328	57	15	al	al	PROPN
dpc-328	57	16	.	.	PUNCT
dpc-328	58	1	in	in	ADP
dpc-328	58	2	30	30	NUM
dpc-328	58	3	healthy	healthy	ADJ
dpc-328	58	4	filipino	filipino	ADJ
dpc-328	58	5	women	woman	NOUN
dpc-328	58	6	(	(	PUNCT
dpc-328	58	7	aged	aged	ADJ
dpc-328	58	8	22	22	NUM
dpc-328	58	9	-	-	SYM
dpc-328	58	10	42	42	NUM
dpc-328	58	11	years	year	NOUN
dpc-328	58	12	)	)	PUNCT
dpc-328	58	13	with	with	ADP
dpc-328	58	14	fitzpatrick	fitzpatrick	PROPN
dpc-328	58	15	skin	skin	NOUN
dpc-328	58	16	types	type	NOUN
dpc-328	58	17	iv	iv	ADP
dpc-328	58	18	or	or	CCONJ
dpc-328	58	19	v	v	NOUN
dpc-328	58	20	,	,	PUNCT
dpc-328	58	21	using	use	VERB
dpc-328	58	22	buccal	buccal	ADJ
dpc-328	58	23	lozenges	lozenge	NOUN
dpc-328	58	24	instead	instead	ADV
dpc-328	58	25	of	of	ADP
dpc-328	58	26	capsules	capsule	NOUN
dpc-328	58	27	of	of	ADP
dpc-328	58	28	gsh	gsh	PROPN
dpc-328	58	29	,	,	PUNCT
dpc-328	58	30	reported	report	VERB
dpc-328	58	31	significant	significant	ADJ
dpc-328	58	32	reductable	reductable	ADJ
dpc-328	58	33	1	1	NUM
dpc-328	58	34	.	.	PUNCT
dpc-328	58	35	evidence	evidence	NOUN
dpc-328	58	36	of	of	ADP
dpc-328	58	37	glutathione	glutathione	NOUN
dpc-328	58	38	as	as	ADP
dpc-328	58	39	a	a	DET
dpc-328	58	40	skin	skin	NOUN
dpc-328	58	41	lightening	lighten	VERB
dpc-328	58	42	agent	agent	NOUN
dpc-328	58	43	:	:	PUNCT
dpc-328	58	44	current	current	ADJ
dpc-328	58	45	summary	summary	NOUN
dpc-328	58	46	of	of	ADP
dpc-328	58	47	studies	study	NOUN
dpc-328	58	48	conducted	conduct	VERB
dpc-328	58	49	to	to	ADP
dpc-328	58	50	date	date	NOUN
dpc-328	58	51	glutathione	glutathione	NOUN
dpc-328	58	52	formulation	formulation	NOUN
dpc-328	58	53	topical	topical	NOUN
dpc-328	58	54	(	(	PUNCT
dpc-328	58	55	gssg	gssg	ADJ
dpc-328	58	56	cream	cream	NOUN
dpc-328	58	57	)	)	PUNCT
dpc-328	58	58	oral	oral	NOUN
dpc-328	58	59	(	(	PUNCT
dpc-328	58	60	capsules	capsule	NOUN
dpc-328	58	61	)	)	PUNCT
dpc-328	58	62	oral	oral	ADJ
dpc-328	58	63	/	/	SYM
dpc-328	58	64	buccal	buccal	ADJ
dpc-328	58	65	lozenges	lozenge	NOUN
dpc-328	58	66	intravenous	intravenous	ADJ
dpc-328	58	67	authors	author	NOUN
dpc-328	58	68	watanabe	watanabe	PROPN
dpc-328	58	69	et	et	PROPN
dpc-328	58	70	al	al	PROPN
dpc-328	58	71	.	.	PUNCT
dpc-328	59	1	[	[	X
dpc-328	59	2	12	12	NUM
dpc-328	59	3	]	]	PUNCT
dpc-328	59	4	arjinpathana	arjinpathana	NOUN
dpc-328	59	5	&	&	CCONJ
dpc-328	59	6	asawanonda	asawanonda	PROPN
dpc-328	59	7	[	[	X
dpc-328	59	8	10	10	NUM
dpc-328	59	9	]	]	X
dpc-328	59	10	handog	handog	NOUN
dpc-328	59	11	et	et	PROPN
dpc-328	59	12	al	al	PROPN
dpc-328	59	13	.	.	PUNCT
dpc-328	60	1	[	[	X
dpc-328	60	2	11	11	NUM
dpc-328	60	3	]	]	SYM
dpc-328	60	4	zubair	zubair	PROPN
dpc-328	60	5	et	et	PROPN
dpc-328	60	6	al	al	PROPN
dpc-328	60	7	.	.	PUNCT
dpc-328	61	1	[	[	X
dpc-328	61	2	15	15	NUM
dpc-328	61	3	]	]	PUNCT
dpc-328	61	4	study	study	NOUN
dpc-328	61	5	subjects	subject	NOUN
dpc-328	61	6	•	•	NOUN
dpc-328	61	7	30	30	NUM
dpc-328	61	8	healthy	healthy	ADJ
dpc-328	61	9	filipino	filipino	ADJ
dpc-328	61	10	women	woman	NOUN
dpc-328	61	11	•	•	NOUN
dpc-328	61	12	ages	age	NOUN
dpc-328	61	13	:	:	PUNCT
dpc-328	61	14	30	30	NUM
dpc-328	61	15	-	-	SYM
dpc-328	61	16	50	50	NUM
dpc-328	61	17	years	year	NOUN
dpc-328	61	18	•	•	ADP
dpc-328	61	19	60	60	NUM
dpc-328	61	20	healthy	healthy	ADJ
dpc-328	61	21	medical	medical	ADJ
dpc-328	61	22	students	student	NOUN
dpc-328	61	23	•	•	NOUN
dpc-328	61	24	ages	age	NOUN
dpc-328	61	25	:	:	PUNCT
dpc-328	61	26	19	19	NUM
dpc-328	61	27	-	-	SYM
dpc-328	61	28	22	22	NUM
dpc-328	61	29	years	year	NOUN
dpc-328	61	30	•	•	NOUN
dpc-328	61	31	30	30	NUM
dpc-328	61	32	healthy	healthy	ADJ
dpc-328	61	33	women	woman	NOUN
dpc-328	61	34	•	•	NOUN
dpc-328	61	35	ages	age	NOUN
dpc-328	61	36	:	:	PUNCT
dpc-328	61	37	22–42	22–42	NUM
dpc-328	61	38	years	year	NOUN
dpc-328	61	39	•	•	PROPN
dpc-328	61	40	fitzpatrick	fitzpatrick	PROPN
dpc-328	61	41	skin	skin	NOUN
dpc-328	61	42	types	type	NOUN
dpc-328	61	43	iv	iv	ADP
dpc-328	61	44	or	or	CCONJ
dpc-328	61	45	v	v	NUM
dpc-328	61	46	•	•	NUM
dpc-328	61	47	50	50	NUM
dpc-328	61	48	healthy	healthy	ADJ
dpc-328	61	49	pakistani	pakistani	ADJ
dpc-328	61	50	women	woman	NOUN
dpc-328	61	51	•	•	NOUN
dpc-328	61	52	ages	age	NOUN
dpc-328	61	53	:	:	PUNCT
dpc-328	61	54	25	25	NUM
dpc-328	61	55	-	-	SYM
dpc-328	61	56	47	47	NUM
dpc-328	61	57	years	year	NOUN
dpc-328	61	58	•	•	ADP
dpc-328	61	59	skin	skin	NOUN
dpc-328	61	60	type	type	NOUN
dpc-328	61	61	not	not	PART
dpc-328	61	62	mentioned	mention	VERB
dpc-328	61	63	study	study	NOUN
dpc-328	61	64	design	design	NOUN
dpc-328	61	65	randomized	randomize	VERB
dpc-328	61	66	,	,	PUNCT
dpc-328	61	67	doubleblind	doubleblind	PROPN
dpc-328	61	68	,	,	PUNCT
dpc-328	61	69	placebocontrolled	placebocontrolle	VERB
dpc-328	61	70	,	,	PUNCT
dpc-328	61	71	split	split	ADJ
dpc-328	61	72	-	-	PUNCT
dpc-328	61	73	face	face	NOUN
dpc-328	61	74	study	study	NOUN
dpc-328	61	75	randomized	randomize	VERB
dpc-328	61	76	,	,	PUNCT
dpc-328	61	77	doubleblind	doubleblind	NOUN
dpc-328	61	78	,	,	PUNCT
dpc-328	61	79	placebo	placebo	NOUN
dpc-328	61	80	controlled	control	VERB
dpc-328	61	81	study	study	NOUN
dpc-328	61	82	open	open	ADJ
dpc-328	61	83	-	-	PUNCT
dpc-328	61	84	label	label	NOUN
dpc-328	61	85	,	,	PUNCT
dpc-328	61	86	singlearm	singlearm	PROPN
dpc-328	61	87	,	,	PUNCT
dpc-328	61	88	pilot	pilot	NOUN
dpc-328	61	89	study	study	NOUN
dpc-328	62	1	open	open	ADJ
dpc-328	62	2	-	-	PUNCT
dpc-328	62	3	label	label	NOUN
dpc-328	62	4	,	,	PUNCT
dpc-328	62	5	placebocontrolled	placebocontrolle	VERB
dpc-328	62	6	study	study	NOUN
dpc-328	62	7	methodology	methodology	NOUN
dpc-328	62	8	split	split	NOUN
dpc-328	62	9	-	-	PUNCT
dpc-328	62	10	face	face	NOUN
dpc-328	62	11	study	study	NOUN
dpc-328	62	12	;	;	PUNCT
dpc-328	62	13	application	application	NOUN
dpc-328	62	14	of	of	ADP
dpc-328	62	15	2	2	NUM
dpc-328	62	16	%	%	NOUN
dpc-328	62	17	(	(	PUNCT
dpc-328	62	18	w	w	NOUN
dpc-328	62	19	/	/	SYM
dpc-328	62	20	w	w	NOUN
dpc-328	62	21	)	)	PUNCT
dpc-328	62	22	gssg	gssg	ADJ
dpc-328	62	23	lotion	lotion	NOUN
dpc-328	62	24	and	and	CCONJ
dpc-328	62	25	placebo	placebo	NOUN
dpc-328	62	26	lotion	lotion	NOUN
dpc-328	62	27	,	,	PUNCT
dpc-328	62	28	twice	twice	ADV
dpc-328	62	29	daily	daily	ADV
dpc-328	62	30	for	for	ADP
dpc-328	62	31	10	10	NUM
dpc-328	62	32	weeks	week	NOUN
dpc-328	62	33	oral	oral	ADJ
dpc-328	62	34	glutathione	glutathione	NOUN
dpc-328	62	35	(	(	PUNCT
dpc-328	62	36	500	500	NUM
dpc-328	62	37	mg	mg	NUM
dpc-328	62	38	)	)	PUNCT
dpc-328	62	39	or	or	CCONJ
dpc-328	62	40	placebo	placebo	NOUN
dpc-328	62	41	capsules	capsule	NOUN
dpc-328	62	42	daily	daily	ADV
dpc-328	62	43	,	,	PUNCT
dpc-328	62	44	in	in	ADP
dpc-328	62	45	2	2	NUM
dpc-328	62	46	divided	divide	VERB
dpc-328	62	47	doses	dose	NOUN
dpc-328	62	48	on	on	ADP
dpc-328	62	49	an	an	DET
dpc-328	62	50	empty	empty	ADJ
dpc-328	62	51	stomach	stomach	NOUN
dpc-328	62	52	for	for	ADP
dpc-328	62	53	4	4	NUM
dpc-328	62	54	weeks	week	NOUN
dpc-328	62	55	one	one	NUM
dpc-328	62	56	buccal	buccal	ADJ
dpc-328	62	57	lozenge	lozenge	NOUN
dpc-328	62	58	(	(	PUNCT
dpc-328	62	59	500	500	NUM
dpc-328	62	60	mg	mg	NOUN
dpc-328	62	61	)	)	PUNCT
dpc-328	62	62	per	per	ADP
dpc-328	62	63	day	day	NOUN
dpc-328	62	64	,	,	PUNCT
dpc-328	62	65	for	for	ADP
dpc-328	62	66	8	8	NUM
dpc-328	62	67	weeks	week	NOUN
dpc-328	62	68	.	.	PUNCT
dpc-328	63	1	injection	injection	NOUN
dpc-328	63	2	glutathione	glutathione	NOUN
dpc-328	63	3	1200	1200	NUM
dpc-328	63	4	mg	mg	ADP
dpc-328	63	5	or	or	CCONJ
dpc-328	63	6	normal	normal	ADJ
dpc-328	63	7	saline	saline	NOUN
dpc-328	63	8	(	(	PUNCT
dpc-328	63	9	placebo	placebo	NOUN
dpc-328	63	10	)	)	PUNCT
dpc-328	63	11	injected	inject	VERB
dpc-328	63	12	over	over	ADP
dpc-328	63	13	30	30	NUM
dpc-328	63	14	minutes	minute	NOUN
dpc-328	63	15	frequency	frequency	NOUN
dpc-328	63	16	of	of	ADP
dpc-328	63	17	evaluation	evaluation	NOUN
dpc-328	63	18	baseline	baseline	NOUN
dpc-328	63	19	;	;	PUNCT
dpc-328	63	20	weekly	weekly	ADJ
dpc-328	63	21	for	for	ADP
dpc-328	63	22	10	10	NUM
dpc-328	63	23	weeks	week	NOUN
dpc-328	63	24	baseline	baseline	NOUN
dpc-328	63	25	;	;	PUNCT
dpc-328	63	26	and	and	CCONJ
dpc-328	63	27	at	at	ADP
dpc-328	63	28	4	4	NUM
dpc-328	63	29	weeks	week	NOUN
dpc-328	63	30	baseline	baseline	NOUN
dpc-328	63	31	,	,	PUNCT
dpc-328	63	32	twice	twice	ADV
dpc-328	63	33	weekly	weekly	ADJ
dpc-328	63	34	for	for	ADP
dpc-328	63	35	8	8	NUM
dpc-328	63	36	weeks	week	NOUN
dpc-328	63	37	baseline	baseline	NOUN
dpc-328	63	38	,	,	PUNCT
dpc-328	63	39	twice	twice	ADV
dpc-328	63	40	weekly	weekly	ADJ
dpc-328	63	41	for	for	ADP
dpc-328	63	42	8	8	NUM
dpc-328	63	43	weeks	week	NOUN
dpc-328	63	44	primary	primary	ADJ
dpc-328	63	45	outcome	outcome	NOUN
dpc-328	63	46	melanin	melanin	NOUN
dpc-328	63	47	index	index	NOUN
dpc-328	63	48	—	—	PUNCT
dpc-328	63	49	by	by	ADP
dpc-328	63	50	mexameter	mexameter	NOUN
dpc-328	63	51	mx18	mx18	PROPN
dpc-328	63	52	melanin	melanin	NOUN
dpc-328	63	53	index	index	NOUN
dpc-328	63	54	—	—	PUNCT
dpc-328	63	55	by	by	ADP
dpc-328	63	56	mexameter	mexameter	X
dpc-328	63	57	melanin	melanin	PROPN
dpc-328	63	58	index	index	NOUN
dpc-328	63	59	—	—	PUNCT
dpc-328	63	60	by	by	ADP
dpc-328	63	61	mexameter	mexameter	PROPN
dpc-328	63	62	visual	visual	PROPN
dpc-328	63	63	taylor	taylor	PROPN
dpc-328	63	64	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	63	65	scale	scale	NOUN
dpc-328	63	66	subjective	subjective	ADJ
dpc-328	63	67	parameters	parameter	NOUN
dpc-328	63	68	global	global	ADJ
dpc-328	63	69	evaluation	evaluation	NOUN
dpc-328	63	70	on	on	ADP
dpc-328	63	71	a	a	DET
dpc-328	63	72	7	7	NUM
dpc-328	63	73	-	-	PUNCT
dpc-328	63	74	point	point	NOUN
dpc-328	63	75	rating	rating	NOUN
dpc-328	63	76	scale	scale	NOUN
dpc-328	63	77	global	global	ADJ
dpc-328	63	78	evaluation	evaluation	NOUN
dpc-328	63	79	s	s	NOUN
dpc-328	63	80	on	on	ADP
dpc-328	63	81	a	a	DET
dpc-328	63	82	4	4	NUM
dpc-328	63	83	-	-	PUNCT
dpc-328	63	84	point	point	NOUN
dpc-328	63	85	rating	rating	NOUN
dpc-328	63	86	scale	scale	NOUN
dpc-328	63	87	global	global	ADJ
dpc-328	63	88	evaluation	evaluation	NOUN
dpc-328	63	89	on	on	ADP
dpc-328	63	90	a	a	DET
dpc-328	63	91	5	5	NUM
dpc-328	63	92	-	-	PUNCT
dpc-328	63	93	point	point	NOUN
dpc-328	63	94	rating	rating	NOUN
dpc-328	63	95	scale	scale	NOUN
dpc-328	63	96	none	none	NOUN
dpc-328	63	97	results	result	VERB
dpc-328	63	98	melanin	melanin	NOUN
dpc-328	63	99	index	index	NOUN
dpc-328	63	100	•	•	NOUN
dpc-328	63	101	melanin	melanin	NOUN
dpc-328	63	102	index	index	NOUN
dpc-328	63	103	reduction	reduction	NOUN
dpc-328	63	104	significant	significant	ADJ
dpc-328	63	105	in	in	ADP
dpc-328	63	106	gssg	gssg	ADJ
dpc-328	63	107	group	group	NOUN
dpc-328	63	108	vs.	vs.	ADP
dpc-328	63	109	placebo	placebo	NOUN
dpc-328	63	110	•	•	ADP
dpc-328	63	111	other	other	ADJ
dpc-328	63	112	parameters	parameter	NOUN
dpc-328	63	113	such	such	ADJ
dpc-328	63	114	as	as	ADP
dpc-328	63	115	skin	skin	NOUN
dpc-328	63	116	moisture	moisture	NOUN
dpc-328	63	117	,	,	PUNCT
dpc-328	63	118	curvature	curvature	NOUN
dpc-328	63	119	index	index	NOUN
dpc-328	63	120	,	,	PUNCT
dpc-328	63	121	keratin	keratin	NOUN
dpc-328	63	122	index	index	NOUN
dpc-328	63	123	also	also	ADV
dpc-328	63	124	improved	improve	VERB
dpc-328	63	125	in	in	ADP
dpc-328	63	126	the	the	DET
dpc-328	63	127	gssg	gssg	ADJ
dpc-328	63	128	group	group	NOUN
dpc-328	63	129	melanin	melanin	NOUN
dpc-328	63	130	index	index	NOUN
dpc-328	63	131	•	•	NOUN
dpc-328	63	132	melanin	melanin	NOUN
dpc-328	63	133	index	index	NOUN
dpc-328	63	134	reduction	reduction	NOUN
dpc-328	63	135	significant	significant	ADJ
dpc-328	63	136	at	at	ADP
dpc-328	63	137	all	all	DET
dpc-328	63	138	six	six	NUM
dpc-328	63	139	sites	site	NOUN
dpc-328	63	140	in	in	ADP
dpc-328	63	141	oral	oral	ADJ
dpc-328	63	142	gsh	gsh	PROPN
dpc-328	63	143	group	group	NOUN
dpc-328	63	144	vs.	vs.	ADP
dpc-328	63	145	placebo	placebo	NOUN
dpc-328	63	146	melanin	melanin	NOUN
dpc-328	63	147	index	index	NOUN
dpc-328	63	148	•	•	NOUN
dpc-328	63	149	melanin	melanin	NOUN
dpc-328	63	150	index	index	NOUN
dpc-328	63	151	reduction	reduction	NOUN
dpc-328	63	152	significant	significant	ADJ
dpc-328	63	153	at	at	ADP
dpc-328	63	154	all	all	DET
dpc-328	63	155	sites	site	NOUN
dpc-328	63	156	in	in	ADP
dpc-328	63	157	buccal	buccal	ADJ
dpc-328	63	158	gsh	gsh	PROPN
dpc-328	63	159	group	group	NOUN
dpc-328	63	160	vs.	vs.	ADP
dpc-328	63	161	placebo	placebo	NOUN
dpc-328	63	162	•	•	ADP
dpc-328	63	163	global	global	ADJ
dpc-328	63	164	assessment	assessment	NOUN
dpc-328	63	165	:	:	PUNCT
dpc-328	63	166	27	27	NUM
dpc-328	63	167	subjects	subject	NOUN
dpc-328	63	168	(	(	PUNCT
dpc-328	63	169	90	90	NUM
dpc-328	63	170	%	%	NOUN
dpc-328	63	171	)	)	PUNCT
dpc-328	63	172	noted	note	VERB
dpc-328	63	173	moderate	moderate	ADJ
dpc-328	63	174	skin	skin	NOUN
dpc-328	63	175	lightening	lighten	VERB
dpc-328	63	176	taylor	taylor	PROPN
dpc-328	63	177	scale	scale	NOUN
dpc-328	63	178	•	•	NUM
dpc-328	64	1	improvement	improvement	NOUN
dpc-328	65	1	(	(	PUNCT
dpc-328	65	2	iv	iv	X
dpc-328	65	3	gsh	gsh	NOUN
dpc-328	65	4	vs	vs	ADP
dpc-328	65	5	placebo	placebo	NOUN
dpc-328	65	6	):	):	PUNCT
dpc-328	65	7	completion	completion	NOUN
dpc-328	65	8	of	of	ADP
dpc-328	65	9	12	12	NUM
dpc-328	65	10	injections—37.5	injections—37.5	NOUN
dpc-328	65	11	%	%	NOUN
dpc-328	65	12	vs.	vs.	ADP
dpc-328	65	13	18.7	18.7	NUM
dpc-328	65	14	%	%	NOUN
dpc-328	65	15	•	•	ADP
dpc-328	65	16	after	after	ADP
dpc-328	65	17	2	2	NUM
dpc-328	65	18	months	month	NOUN
dpc-328	65	19	:	:	PUNCT
dpc-328	65	20	18.7	18.7	NUM
dpc-328	65	21	%	%	NOUN
dpc-328	65	22	vs.	vs.	ADP
dpc-328	65	23	12.5	12.5	NUM
dpc-328	65	24	%	%	NOUN
dpc-328	65	25	•	•	ADP
dpc-328	65	26	after	after	ADP
dpc-328	65	27	4	4	NUM
dpc-328	65	28	months	month	NOUN
dpc-328	65	29	:	:	PUNCT
dpc-328	65	30	18.7	18.7	NUM
dpc-328	65	31	%	%	NOUN
dpc-328	65	32	vs	vs	ADP
dpc-328	65	33	,	,	PUNCT
dpc-328	65	34	0	0	NUM
dpc-328	65	35	%	%	NOUN
dpc-328	65	36	•	•	NOUN
dpc-328	65	37	after	after	ADP
dpc-328	65	38	6	6	NUM
dpc-328	65	39	months	month	NOUN
dpc-328	65	40	:	:	PUNCT
dpc-328	65	41	6.2	6.2	NUM
dpc-328	65	42	%	%	NOUN
dpc-328	65	43	vs.	vs.	ADP
dpc-328	65	44	0	0	NUM
dpc-328	65	45	%	%	NOUN
dpc-328	65	46	tolerance	tolerance	NOUN
dpc-328	65	47	&	&	CCONJ
dpc-328	65	48	safety	safety	NOUN
dpc-328	65	49	•	•	ADV
dpc-328	65	50	very	very	ADV
dpc-328	65	51	well	well	ADV
dpc-328	65	52	tolerated	tolerate	VERB
dpc-328	65	53	•	•	NOUN
dpc-328	65	54	no	no	DET
dpc-328	65	55	significant	significant	ADJ
dpc-328	65	56	adverse	adverse	ADJ
dpc-328	65	57	effects	effect	NOUN
dpc-328	65	58	in	in	ADP
dpc-328	65	59	either	either	DET
dpc-328	65	60	group	group	NOUN
dpc-328	65	61	•	•	ADV
dpc-328	65	62	very	very	ADV
dpc-328	65	63	well	well	ADV
dpc-328	65	64	tolerated	tolerate	VERB
dpc-328	65	65	•	•	NOUN
dpc-328	65	66	no	no	DET
dpc-328	65	67	significant	significant	ADJ
dpc-328	65	68	adverse	adverse	ADJ
dpc-328	65	69	effects	effect	NOUN
dpc-328	65	70	in	in	ADP
dpc-328	65	71	either	either	DET
dpc-328	65	72	group	group	NOUN
dpc-328	65	73	•	•	ADV
dpc-328	65	74	very	very	ADV
dpc-328	65	75	well	well	ADV
dpc-328	65	76	tolerated	tolerate	VERB
dpc-328	65	77	•	•	NOUN
dpc-328	65	78	no	no	DET
dpc-328	65	79	significant	significant	ADJ
dpc-328	65	80	adverse	adverse	ADJ
dpc-328	65	81	effects	effect	NOUN
dpc-328	65	82	in	in	ADP
dpc-328	65	83	either	either	DET
dpc-328	65	84	group	group	NOUN
dpc-328	65	85	•	•	ADP
dpc-328	65	86	adverse	adverse	ADJ
dpc-328	65	87	effects	effect	NOUN
dpc-328	65	88	in	in	ADP
dpc-328	65	89	all	all	DET
dpc-328	65	90	gsh	gsh	NOUN
dpc-328	65	91	treated	treat	VERB
dpc-328	65	92	patients	patient	NOUN
dpc-328	65	93	•	•	ADV
dpc-328	65	94	serious	serious	ADJ
dpc-328	65	95	—	—	PUNCT
dpc-328	65	96	liver	liver	NOUN
dpc-328	65	97	dysfunction	dysfunction	NOUN
dpc-328	65	98	in	in	ADP
dpc-328	65	99	32	32	NUM
dpc-328	65	100	%	%	NOUN
dpc-328	65	101	(	(	PUNCT
dpc-328	65	102	8)	8)	NUM
dpc-328	65	103	patients	patient	NOUN
dpc-328	65	104	and	and	CCONJ
dpc-328	65	105	anaphylactic	anaphylactic	ADJ
dpc-328	65	106	shock	shock	NOUN
dpc-328	65	107	in	in	ADP
dpc-328	65	108	1	1	NUM
dpc-328	65	109	patient	patient	NOUN
dpc-328	65	110	.	.	PUNCT
dpc-328	66	1	(	(	PUNCT
dpc-328	66	2	continued	continue	VERB
dpc-328	66	3	next	next	ADJ
dpc-328	66	4	page	page	NOUN
dpc-328	66	5	)	)	PUNCT
dpc-328	66	6	18	18	NUM
dpc-328	66	7	review	review	NOUN
dpc-328	66	8	|	|	ADV
dpc-328	66	9	dermatol	dermatol	ADJ
dpc-328	66	10	pract	pract	PROPN
dpc-328	66	11	concept	concept	NOUN
dpc-328	66	12	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	66	13	taylor	taylor	PROPN
dpc-328	66	14	scale	scale	NOUN
dpc-328	66	15	for	for	ADP
dpc-328	66	16	preand	preand	NOUN
dpc-328	66	17	post	post	ADJ
dpc-328	66	18	-	-	ADJ
dpc-328	66	19	treatment	treatment	ADJ
dpc-328	66	20	evaluation	evaluation	NOUN
dpc-328	66	21	of	of	ADP
dpc-328	66	22	change	change	NOUN
dpc-328	66	23	in	in	ADP
dpc-328	66	24	skin	skin	NOUN
dpc-328	66	25	hue	hue	NOUN
dpc-328	66	26	and	and	CCONJ
dpc-328	66	27	tone	tone	NOUN
dpc-328	66	28	and	and	CCONJ
dpc-328	66	29	lack	lack	NOUN
dpc-328	66	30	of	of	ADP
dpc-328	66	31	mention	mention	NOUN
dpc-328	66	32	of	of	ADP
dpc-328	66	33	statistical	statistical	ADJ
dpc-328	66	34	tests	test	NOUN
dpc-328	66	35	applied	apply	VERB
dpc-328	66	36	.	.	PUNCT
dpc-328	67	1	the	the	DET
dpc-328	67	2	taylor	taylor	PROPN
dpc-328	67	3	scale	scale	NOUN
dpc-328	67	4	is	be	AUX
dpc-328	67	5	an	an	DET
dpc-328	67	6	unreliable	unreliable	ADJ
dpc-328	67	7	tool	tool	NOUN
dpc-328	67	8	for	for	ADP
dpc-328	67	9	observing	observe	VERB
dpc-328	67	10	subtle	subtle	ADJ
dpc-328	67	11	changes	change	NOUN
dpc-328	67	12	in	in	ADP
dpc-328	67	13	skin	skin	NOUN
dpc-328	67	14	pigmentation	pigmentation	NOUN
dpc-328	67	15	with	with	ADP
dpc-328	67	16	a	a	DET
dpc-328	67	17	very	very	ADV
dpc-328	67	18	high	high	ADJ
dpc-328	67	19	interinvestigator	interinvestigator	NOUN
dpc-328	67	20	variability	variability	NOUN
dpc-328	67	21	in	in	ADP
dpc-328	67	22	its	its	PRON
dpc-328	67	23	interpretation	interpretation	NOUN
dpc-328	67	24	[	[	X
dpc-328	67	25	16	16	NUM
dpc-328	67	26	]	]	PUNCT
dpc-328	67	27	.	.	PUNCT
dpc-328	68	1	results	result	NOUN
dpc-328	68	2	based	base	VERB
dpc-328	68	3	on	on	ADP
dpc-328	68	4	taylor	taylor	PROPN
dpc-328	68	5	scale	scale	NOUN
dpc-328	68	6	,	,	PUNCT
dpc-328	68	7	rather	rather	ADV
dpc-328	68	8	than	than	ADP
dpc-328	68	9	a	a	DET
dpc-328	68	10	reliable	reliable	ADJ
dpc-328	68	11	objective	objective	ADJ
dpc-328	68	12	parameter	parameter	NOUN
dpc-328	68	13	like	like	ADP
dpc-328	68	14	the	the	DET
dpc-328	68	15	melanin	melanin	NOUN
dpc-328	68	16	index	index	NOUN
dpc-328	68	17	using	use	VERB
dpc-328	68	18	a	a	DET
dpc-328	68	19	mexameter	mexameter	NOUN
dpc-328	68	20	mx-18	mx-18	NOUN
dpc-328	68	21	,	,	PUNCT
dpc-328	68	22	at	at	ADP
dpc-328	68	23	best	good	ADJ
dpc-328	68	24	,	,	PUNCT
dpc-328	68	25	are	be	AUX
dpc-328	68	26	speculative	speculative	ADJ
dpc-328	68	27	.	.	PUNCT
dpc-328	69	1	further	far	ADV
dpc-328	69	2	,	,	PUNCT
dpc-328	69	3	the	the	DET
dpc-328	69	4	major	major	ADJ
dpc-328	69	5	adverse	adverse	ADJ
dpc-328	69	6	effect	effect	NOUN
dpc-328	69	7	reported	report	VERB
dpc-328	69	8	in	in	ADP
dpc-328	69	9	the	the	DET
dpc-328	69	10	iv	iv	NUM
dpc-328	69	11	gsh	gsh	PROPN
dpc-328	69	12	treated	treat	VERB
dpc-328	69	13	group	group	NOUN
dpc-328	69	14	was	be	AUX
dpc-328	69	15	liver	liver	ADJ
dpc-328	69	16	dysfunction	dysfunction	NOUN
dpc-328	69	17	,	,	PUNCT
dpc-328	69	18	which	which	PRON
dpc-328	69	19	was	be	AUX
dpc-328	69	20	neither	neither	CCONJ
dpc-328	69	21	qualified	qualified	ADJ
dpc-328	69	22	nor	nor	CCONJ
dpc-328	69	23	quantified	quantify	VERB
dpc-328	69	24	.	.	PUNCT
dpc-328	70	1	development	development	NOUN
dpc-328	70	2	of	of	ADP
dpc-328	70	3	liver	liver	ADJ
dpc-328	70	4	dysfunction	dysfunction	NOUN
dpc-328	70	5	in	in	ADP
dpc-328	70	6	healthy	healthy	ADJ
dpc-328	70	7	individuals	individual	NOUN
dpc-328	70	8	receiving	receive	VERB
dpc-328	70	9	iv	iv	NUM
dpc-328	70	10	gsh	gsh	NOUN
dpc-328	70	11	is	be	AUX
dpc-328	70	12	surprising	surprising	ADJ
dpc-328	70	13	,	,	PUNCT
dpc-328	70	14	since	since	SCONJ
dpc-328	70	15	the	the	DET
dpc-328	70	16	medication	medication	NOUN
dpc-328	70	17	is	be	AUX
dpc-328	70	18	approved	approve	VERB
dpc-328	70	19	by	by	ADP
dpc-328	70	20	the	the	DET
dpc-328	70	21	cdsco	cdsco	NOUN
dpc-328	70	22	for	for	ADP
dpc-328	70	23	the	the	DET
dpc-328	70	24	treatment	treatment	NOUN
dpc-328	70	25	of	of	ADP
dpc-328	70	26	various	various	ADJ
dpc-328	70	27	liver	liver	NOUN
dpc-328	70	28	disorders	disorder	NOUN
dpc-328	70	29	mentioned	mention	VERB
dpc-328	70	30	earlier	early	ADV
dpc-328	70	31	[	[	X
dpc-328	70	32	4	4	NUM
dpc-328	70	33	]	]	PUNCT
dpc-328	70	34	.	.	PUNCT
dpc-328	71	1	the	the	DET
dpc-328	71	2	researchers	researcher	NOUN
dpc-328	71	3	also	also	ADV
dpc-328	71	4	did	do	AUX
dpc-328	71	5	not	not	PART
dpc-328	71	6	evaluate	evaluate	VERB
dpc-328	71	7	baseline	baseline	NOUN
dpc-328	71	8	or	or	CCONJ
dpc-328	71	9	post	post	ADJ
dpc-328	71	10	-	-	ADJ
dpc-328	71	11	treatment	treatment	ADJ
dpc-328	71	12	renal	renal	ADJ
dpc-328	71	13	nor	nor	CCONJ
dpc-328	71	14	thyroid	thyroid	NOUN
dpc-328	71	15	function	function	NOUN
dpc-328	71	16	of	of	ADP
dpc-328	71	17	the	the	DET
dpc-328	71	18	subjects	subject	NOUN
dpc-328	71	19	,	,	PUNCT
dpc-328	71	20	both	both	PRON
dpc-328	71	21	of	of	ADP
dpc-328	71	22	which	which	PRON
dpc-328	71	23	were	be	AUX
dpc-328	71	24	reported	report	VERB
dpc-328	71	25	to	to	PART
dpc-328	71	26	be	be	AUX
dpc-328	71	27	adversely	adversely	ADV
dpc-328	71	28	affected	affect	VERB
dpc-328	71	29	by	by	ADP
dpc-328	71	30	iv	iv	NOUN
dpc-328	71	31	glutathione	glutathione	NOUN
dpc-328	71	32	in	in	ADP
dpc-328	71	33	the	the	DET
dpc-328	71	34	position	position	NOUN
dpc-328	71	35	paper	paper	NOUN
dpc-328	71	36	by	by	ADP
dpc-328	71	37	the	the	DET
dpc-328	71	38	fda	fda	PROPN
dpc-328	71	39	,	,	PUNCT
dpc-328	71	40	department	department	PROPN
dpc-328	71	41	of	of	ADP
dpc-328	71	42	health	health	PROPN
dpc-328	71	43	,	,	PUNCT
dpc-328	71	44	republic	republic	NOUN
dpc-328	71	45	of	of	ADP
dpc-328	71	46	the	the	DET
dpc-328	71	47	philippines	philippine	NOUN
dpc-328	72	1	[	[	X
dpc-328	72	2	5	5	NUM
dpc-328	72	3	]	]	PUNCT
dpc-328	72	4	.	.	PUNCT
dpc-328	73	1	the	the	DET
dpc-328	73	2	controversy	controversy	NOUN
dpc-328	73	3	surrounding	surround	VERB
dpc-328	73	4	absorption	absorption	NOUN
dpc-328	73	5	of	of	ADP
dpc-328	73	6	oral	oral	ADJ
dpc-328	73	7	glutathione	glutathione	NOUN
dpc-328	73	8	and	and	CCONJ
dpc-328	73	9	adverse	adverse	ADJ
dpc-328	73	10	effects	effect	NOUN
dpc-328	73	11	of	of	ADP
dpc-328	73	12	iv	iv	NUM
dpc-328	73	13	glutathione	glutathione	NOUN
dpc-328	73	14	and	and	CCONJ
dpc-328	73	15	statutory	statutory	ADJ
dpc-328	73	16	status	status	NOUN
dpc-328	73	17	glutathione	glutathione	NOUN
dpc-328	73	18	-	-	PUNCT
dpc-328	73	19	based	base	VERB
dpc-328	73	20	oral	oral	ADJ
dpc-328	73	21	dietary	dietary	ADJ
dpc-328	73	22	supplements	supplement	NOUN
dpc-328	73	23	have	have	AUX
dpc-328	73	24	been	be	AUX
dpc-328	73	25	accorded	accord	VERB
dpc-328	73	26	the	the	DET
dpc-328	73	27	status	status	NOUN
dpc-328	73	28	of	of	ADP
dpc-328	73	29	“	"	PUNCT
dpc-328	73	30	generally	generally	ADV
dpc-328	73	31	recognized	recognize	VERB
dpc-328	73	32	as	as	ADP
dpc-328	73	33	safe	safe	ADJ
dpc-328	73	34	(	(	PUNCT
dpc-328	73	35	gras	gras	PROPN
dpc-328	73	36	)	)	PUNCT
dpc-328	73	37	”	"	PUNCT
dpc-328	73	38	consistent	consistent	ADJ
dpc-328	73	39	with	with	ADP
dpc-328	73	40	section	section	NOUN
dpc-328	73	41	201(s	201(s	PROPN
dpc-328	73	42	)	)	PUNCT
dpc-328	73	43	of	of	ADP
dpc-328	73	44	the	the	DET
dpc-328	73	45	federal	federal	ADJ
dpc-328	73	46	food	food	NOUN
dpc-328	73	47	,	,	PUNCT
dpc-328	73	48	drug	drug	NOUN
dpc-328	73	49	,	,	PUNCT
dpc-328	73	50	and	and	CCONJ
dpc-328	73	51	cosmetic	cosmetic	ADJ
dpc-328	73	52	act	act	NOUN
dpc-328	73	53	of	of	ADP
dpc-328	73	54	the	the	DET
dpc-328	73	55	united	united	PROPN
dpc-328	73	56	states	states	PROPN
dpc-328	73	57	food	food	PROPN
dpc-328	73	58	and	and	CCONJ
dpc-328	73	59	drug	drug	PROPN
dpc-328	73	60	administration	administration	NOUN
dpc-328	73	61	(	(	PUNCT
dpc-328	73	62	us	us	PROPN
dpc-328	73	63	-	-	PUNCT
dpc-328	73	64	fda	fda	PROPN
dpc-328	73	65	)	)	PUNCT
dpc-328	74	1	[	[	X
dpc-328	74	2	16	16	NUM
dpc-328	74	3	]	]	PUNCT
dpc-328	74	4	.	.	PUNCT
dpc-328	75	1	there	there	PRON
dpc-328	75	2	is	be	VERB
dpc-328	75	3	no	no	DET
dpc-328	75	4	restriction	restriction	NOUN
dpc-328	75	5	on	on	ADP
dpc-328	75	6	its	its	PRON
dpc-328	75	7	significant	significant	ADJ
dpc-328	75	8	reduction	reduction	NOUN
dpc-328	75	9	of	of	ADP
dpc-328	75	10	skin	skin	NOUN
dpc-328	75	11	melanin	melanin	NOUN
dpc-328	75	12	index	index	NOUN
dpc-328	75	13	with	with	ADP
dpc-328	75	14	glutathione	glutathione	NOUN
dpc-328	75	15	compared	compare	VERB
dpc-328	75	16	to	to	ADP
dpc-328	75	17	placebo	placebo	NOUN
dpc-328	75	18	,	,	PUNCT
dpc-328	75	19	with	with	ADP
dpc-328	75	20	no	no	DET
dpc-328	75	21	adverse	adverse	ADJ
dpc-328	75	22	drug	drug	NOUN
dpc-328	75	23	effects	effect	NOUN
dpc-328	75	24	.	.	PUNCT
dpc-328	76	1	however	however	ADV
dpc-328	76	2	,	,	PUNCT
dpc-328	76	3	the	the	DET
dpc-328	76	4	results	result	NOUN
dpc-328	76	5	of	of	ADP
dpc-328	76	6	these	these	DET
dpc-328	76	7	studies	study	NOUN
dpc-328	76	8	need	need	VERB
dpc-328	76	9	to	to	PART
dpc-328	76	10	be	be	AUX
dpc-328	76	11	interpreted	interpret	VERB
dpc-328	76	12	with	with	ADP
dpc-328	76	13	caution	caution	NOUN
dpc-328	76	14	owing	owe	VERB
dpc-328	76	15	to	to	ADP
dpc-328	76	16	certain	certain	ADJ
dpc-328	76	17	limitations	limitation	NOUN
dpc-328	76	18	in	in	ADP
dpc-328	76	19	their	their	PRON
dpc-328	76	20	study	study	NOUN
dpc-328	76	21	design	design	NOUN
dpc-328	76	22	.	.	PUNCT
dpc-328	77	1	the	the	DET
dpc-328	77	2	major	major	ADJ
dpc-328	77	3	limitations	limitation	NOUN
dpc-328	77	4	of	of	ADP
dpc-328	77	5	these	these	DET
dpc-328	77	6	studies	study	NOUN
dpc-328	77	7	included	include	VERB
dpc-328	77	8	:	:	PUNCT
dpc-328	77	9	small	small	ADJ
dpc-328	77	10	sample	sample	NOUN
dpc-328	77	11	size	size	NOUN
dpc-328	77	12	,	,	PUNCT
dpc-328	77	13	cohort	cohort	NOUN
dpc-328	77	14	consisting	consist	VERB
dpc-328	77	15	of	of	ADP
dpc-328	77	16	healthy	healthy	ADJ
dpc-328	77	17	volunteers	volunteer	NOUN
dpc-328	77	18	,	,	PUNCT
dpc-328	77	19	extremely	extremely	ADV
dpc-328	77	20	short	short	ADJ
dpc-328	77	21	study	study	NOUN
dpc-328	77	22	period	period	NOUN
dpc-328	77	23	with	with	ADP
dpc-328	77	24	an	an	DET
dpc-328	77	25	even	even	ADV
dpc-328	77	26	shorter	short	ADJ
dpc-328	77	27	follow	follow	NOUN
dpc-328	77	28	-	-	PUNCT
dpc-328	77	29	up	up	NOUN
dpc-328	77	30	,	,	PUNCT
dpc-328	77	31	and	and	CCONJ
dpc-328	77	32	lack	lack	NOUN
dpc-328	77	33	of	of	ADP
dpc-328	77	34	measurement	measurement	NOUN
dpc-328	77	35	of	of	ADP
dpc-328	77	36	blood	blood	NOUN
dpc-328	77	37	levels	level	NOUN
dpc-328	77	38	of	of	ADP
dpc-328	77	39	glutathione	glutathione	NOUN
dpc-328	77	40	[	[	X
dpc-328	77	41	10	10	NUM
dpc-328	77	42	-	-	SYM
dpc-328	77	43	12	12	NUM
dpc-328	77	44	]	]	PUNCT
dpc-328	77	45	.	.	PUNCT
dpc-328	78	1	details	detail	NOUN
dpc-328	78	2	of	of	ADP
dpc-328	78	3	the	the	DET
dpc-328	78	4	inclusion	inclusion	NOUN
dpc-328	78	5	criteria	criterion	NOUN
dpc-328	78	6	,	,	PUNCT
dpc-328	78	7	methodology	methodology	NOUN
dpc-328	78	8	,	,	PUNCT
dpc-328	78	9	results	result	NOUN
dpc-328	78	10	and	and	CCONJ
dpc-328	78	11	specific	specific	ADJ
dpc-328	78	12	limitations	limitation	NOUN
dpc-328	78	13	of	of	ADP
dpc-328	78	14	these	these	DET
dpc-328	78	15	studies	study	NOUN
dpc-328	78	16	have	have	AUX
dpc-328	78	17	been	be	AUX
dpc-328	78	18	comprehensively	comprehensively	ADV
dpc-328	78	19	catalogued	catalogue	VERB
dpc-328	78	20	in	in	ADP
dpc-328	78	21	table	table	NOUN
dpc-328	78	22	1	1	NUM
dpc-328	78	23	.	.	PUNCT
dpc-328	79	1	despite	despite	SCONJ
dpc-328	79	2	the	the	DET
dpc-328	79	3	rampant	rampant	ADJ
dpc-328	79	4	use	use	NOUN
dpc-328	79	5	of	of	ADP
dpc-328	79	6	intravenous	intravenous	ADJ
dpc-328	79	7	(	(	PUNCT
dpc-328	79	8	iv	iv	X
dpc-328	79	9	)	)	PUNCT
dpc-328	79	10	glutathione	glutathione	NOUN
dpc-328	79	11	injections	injection	NOUN
dpc-328	79	12	for	for	ADP
dpc-328	79	13	skin	skin	NOUN
dpc-328	79	14	lightening	lighten	VERB
dpc-328	79	15	in	in	ADP
dpc-328	79	16	certain	certain	ADJ
dpc-328	79	17	countries	country	NOUN
dpc-328	79	18	,	,	PUNCT
dpc-328	79	19	evidence	evidence	NOUN
dpc-328	79	20	favoring	favor	VERB
dpc-328	79	21	such	such	DET
dpc-328	79	22	a	a	DET
dpc-328	79	23	practice	practice	NOUN
dpc-328	79	24	remains	remain	VERB
dpc-328	79	25	elusive	elusive	ADJ
dpc-328	79	26	.	.	PUNCT
dpc-328	80	1	for	for	ADP
dpc-328	80	2	years	year	NOUN
dpc-328	80	3	,	,	PUNCT
dpc-328	80	4	the	the	DET
dpc-328	80	5	strong	strong	ADJ
dpc-328	80	6	lobby	lobby	NOUN
dpc-328	80	7	of	of	ADP
dpc-328	80	8	proponents	proponent	NOUN
dpc-328	80	9	of	of	ADP
dpc-328	80	10	iv	iv	NUM
dpc-328	80	11	glutathione	glutathione	NOUN
dpc-328	80	12	for	for	ADP
dpc-328	80	13	skin	skin	NOUN
dpc-328	80	14	lightening	lightening	NOUN
dpc-328	80	15	,	,	PUNCT
dpc-328	80	16	including	include	VERB
dpc-328	80	17	manufacturers	manufacturer	NOUN
dpc-328	80	18	,	,	PUNCT
dpc-328	80	19	distributors	distributor	NOUN
dpc-328	80	20	,	,	PUNCT
dpc-328	80	21	many	many	ADJ
dpc-328	80	22	skin	skin	NOUN
dpc-328	80	23	clinics	clinic	NOUN
dpc-328	80	24	,	,	PUNCT
dpc-328	80	25	and	and	CCONJ
dpc-328	80	26	med	med	ADJ
dpc-328	80	27	spas	spa	NOUN
dpc-328	80	28	,	,	PUNCT
dpc-328	80	29	have	have	AUX
dpc-328	80	30	been	be	AUX
dpc-328	80	31	recommending	recommend	VERB
dpc-328	80	32	arbitrary	arbitrary	ADJ
dpc-328	80	33	dosage	dosage	NOUN
dpc-328	80	34	schedules	schedule	NOUN
dpc-328	80	35	,	,	PUNCT
dpc-328	80	36	despite	despite	SCONJ
dpc-328	80	37	complete	complete	ADJ
dpc-328	80	38	lack	lack	NOUN
dpc-328	80	39	of	of	ADP
dpc-328	80	40	evidence	evidence	NOUN
dpc-328	80	41	[	[	X
dpc-328	80	42	13,14	13,14	NUM
dpc-328	80	43	]	]	PUNCT
dpc-328	80	44	.	.	PUNCT
dpc-328	81	1	it	it	PRON
dpc-328	81	2	is	be	AUX
dpc-328	81	3	only	only	ADV
dpc-328	81	4	recently	recently	ADV
dpc-328	81	5	,	,	PUNCT
dpc-328	81	6	that	that	SCONJ
dpc-328	81	7	zubair	zubair	PROPN
dpc-328	81	8	et	et	PROPN
dpc-328	81	9	al	al	PROPN
dpc-328	81	10	.	.	PROPN
dpc-328	81	11	studied	study	VERB
dpc-328	81	12	the	the	DET
dpc-328	81	13	efficacy	efficacy	NOUN
dpc-328	81	14	and	and	CCONJ
dpc-328	81	15	safety	safety	NOUN
dpc-328	81	16	of	of	ADP
dpc-328	81	17	iv	iv	NUM
dpc-328	81	18	gsh	gsh	NOUN
dpc-328	81	19	for	for	ADP
dpc-328	81	20	skin	skin	NOUN
dpc-328	81	21	tone	tone	NOUN
dpc-328	81	22	lightening	lighten	VERB
dpc-328	81	23	in	in	ADP
dpc-328	81	24	25	25	NUM
dpc-328	81	25	patients	patient	NOUN
dpc-328	81	26	of	of	ADP
dpc-328	81	27	pakistani	pakistani	ADJ
dpc-328	81	28	origin	origin	NOUN
dpc-328	81	29	in	in	ADP
dpc-328	81	30	a	a	DET
dpc-328	81	31	placebo	placebo	NOUN
dpc-328	81	32	-	-	PUNCT
dpc-328	81	33	controlled	control	VERB
dpc-328	81	34	trial	trial	NOUN
dpc-328	81	35	(	(	PUNCT
dpc-328	81	36	1,200	1,200	NUM
dpc-328	81	37	mg	mg	NOUN
dpc-328	81	38	given	give	VERB
dpc-328	81	39	iv	iv	NUM
dpc-328	81	40	twice	twice	DET
dpc-328	81	41	a	a	DET
dpc-328	81	42	week	week	NOUN
dpc-328	81	43	for	for	ADP
dpc-328	81	44	6	6	NUM
dpc-328	81	45	weeks	week	NOUN
dpc-328	81	46	in	in	ADP
dpc-328	81	47	the	the	DET
dpc-328	81	48	treatment	treatment	NOUN
dpc-328	81	49	group	group	NOUN
dpc-328	81	50	versus	versus	ADP
dpc-328	81	51	normal	normal	ADJ
dpc-328	81	52	saline	saline	NOUN
dpc-328	81	53	in	in	ADP
dpc-328	81	54	control	control	NOUN
dpc-328	81	55	group	group	NOUN
dpc-328	81	56	)	)	PUNCT
dpc-328	82	1	[	[	X
dpc-328	82	2	15	15	NUM
dpc-328	82	3	]	]	PUNCT
dpc-328	82	4	.	.	PUNCT
dpc-328	83	1	although	although	SCONJ
dpc-328	83	2	the	the	DET
dpc-328	83	3	results	result	NOUN
dpc-328	83	4	from	from	ADP
dpc-328	83	5	this	this	DET
dpc-328	83	6	singular	singular	ADJ
dpc-328	83	7	trial	trial	NOUN
dpc-328	83	8	did	do	AUX
dpc-328	83	9	not	not	PART
dpc-328	83	10	favor	favor	VERB
dpc-328	83	11	iv	iv	NOUN
dpc-328	83	12	glutathione	glutathione	NOUN
dpc-328	83	13	as	as	ADP
dpc-328	83	14	an	an	DET
dpc-328	83	15	effective	effective	ADJ
dpc-328	83	16	or	or	CCONJ
dpc-328	83	17	lasting	lasting	ADJ
dpc-328	83	18	treatment	treatment	NOUN
dpc-328	83	19	for	for	ADP
dpc-328	83	20	skin	skin	NOUN
dpc-328	83	21	tone	tone	NOUN
dpc-328	83	22	lightening	lightening	NOUN
dpc-328	83	23	,	,	PUNCT
dpc-328	83	24	the	the	DET
dpc-328	83	25	inherent	inherent	ADJ
dpc-328	83	26	flaws	flaw	NOUN
dpc-328	83	27	of	of	ADP
dpc-328	83	28	the	the	DET
dpc-328	83	29	study	study	NOUN
dpc-328	83	30	design	design	NOUN
dpc-328	83	31	mandate	mandate	NOUN
dpc-328	83	32	cautious	cautious	ADJ
dpc-328	83	33	analysis	analysis	NOUN
dpc-328	83	34	.	.	PUNCT
dpc-328	84	1	the	the	DET
dpc-328	84	2	small	small	ADJ
dpc-328	84	3	sample	sample	NOUN
dpc-328	84	4	size	size	NOUN
dpc-328	84	5	(	(	PUNCT
dpc-328	84	6	n=25	n=25	ADV
dpc-328	84	7	in	in	ADP
dpc-328	84	8	each	each	DET
dpc-328	84	9	group	group	NOUN
dpc-328	84	10	)	)	PUNCT
dpc-328	84	11	,	,	PUNCT
dpc-328	84	12	complicated	complicate	VERB
dpc-328	84	13	with	with	ADP
dpc-328	84	14	a	a	DET
dpc-328	84	15	high	high	ADJ
dpc-328	84	16	dropout	dropout	NOUN
dpc-328	84	17	rate	rate	NOUN
dpc-328	84	18	from	from	ADP
dpc-328	84	19	the	the	DET
dpc-328	84	20	treatment	treatment	NOUN
dpc-328	84	21	group	group	NOUN
dpc-328	84	22	(	(	PUNCT
dpc-328	84	23	9	9	NUM
dpc-328	84	24	out	out	ADP
dpc-328	84	25	of	of	ADP
dpc-328	84	26	25	25	NUM
dpc-328	84	27	)	)	PUNCT
dpc-328	84	28	in	in	ADP
dpc-328	84	29	this	this	DET
dpc-328	84	30	trial	trial	NOUN
dpc-328	84	31	exhorts	exhort	VERB
dpc-328	84	32	a	a	DET
dpc-328	84	33	cautious	cautious	ADJ
dpc-328	84	34	interpretation	interpretation	NOUN
dpc-328	84	35	of	of	ADP
dpc-328	84	36	the	the	DET
dpc-328	84	37	results	result	NOUN
dpc-328	84	38	.	.	PUNCT
dpc-328	85	1	the	the	DET
dpc-328	85	2	methodology	methodology	NOUN
dpc-328	85	3	was	be	AUX
dpc-328	85	4	flawed	flawed	ADJ
dpc-328	85	5	due	due	ADP
dpc-328	85	6	to	to	ADP
dpc-328	85	7	the	the	DET
dpc-328	85	8	employment	employment	NOUN
dpc-328	85	9	of	of	ADP
dpc-328	85	10	a	a	DET
dpc-328	85	11	highly	highly	ADV
dpc-328	85	12	subjective	subjective	ADJ
dpc-328	85	13	visual	visual	ADJ
dpc-328	85	14	glutathione	glutathione	NOUN
dpc-328	85	15	formulation	formulation	NOUN
dpc-328	85	16	topical	topical	NOUN
dpc-328	85	17	(	(	PUNCT
dpc-328	85	18	gssg	gssg	ADJ
dpc-328	85	19	cream	cream	NOUN
dpc-328	85	20	)	)	PUNCT
dpc-328	85	21	oral	oral	NOUN
dpc-328	85	22	(	(	PUNCT
dpc-328	85	23	capsules	capsule	NOUN
dpc-328	85	24	)	)	PUNCT
dpc-328	85	25	oral	oral	ADJ
dpc-328	85	26	/	/	SYM
dpc-328	85	27	buccal	buccal	ADJ
dpc-328	85	28	lozenges	lozenge	NOUN
dpc-328	85	29	intravenous	intravenous	ADJ
dpc-328	85	30	follow	follow	NOUN
dpc-328	85	31	-	-	PUNCT
dpc-328	85	32	up	up	NOUN
dpc-328	85	33	after	after	ADP
dpc-328	85	34	completion	completion	NOUN
dpc-328	85	35	of	of	ADP
dpc-328	85	36	study	study	NOUN
dpc-328	85	37	none	none	NOUN
dpc-328	85	38	none	none	NOUN
dpc-328	85	39	none	none	NOUN
dpc-328	85	40	done	do	VERB
dpc-328	85	41	on	on	ADP
dpc-328	85	42	3	3	NUM
dpc-328	85	43	occasions—2nd	occasions—2nd	NOUN
dpc-328	85	44	,	,	PUNCT
dpc-328	85	45	4th	4th	ADJ
dpc-328	85	46	,	,	PUNCT
dpc-328	85	47	6th	6th	ADJ
dpc-328	85	48	month	month	NOUN
dpc-328	85	49	after	after	ADP
dpc-328	85	50	treatment	treatment	NOUN
dpc-328	85	51	completion	completion	NOUN
dpc-328	85	52	study	study	NOUN
dpc-328	85	53	limitations	limitation	NOUN
dpc-328	85	54	•	•	VERB
dpc-328	85	55	small	small	ADJ
dpc-328	85	56	sample	sample	NOUN
dpc-328	85	57	size	size	NOUN
dpc-328	85	58	•	•	ADP
dpc-328	85	59	short	short	ADJ
dpc-328	85	60	duration	duration	NOUN
dpc-328	85	61	of	of	ADP
dpc-328	85	62	study	study	NOUN
dpc-328	85	63	•	•	NOUN
dpc-328	85	64	subjects	subject	NOUN
dpc-328	85	65	:	:	PUNCT
dpc-328	85	66	healthy	healthy	ADJ
dpc-328	85	67	filipino	filipino	ADJ
dpc-328	85	68	women	woman	NOUN
dpc-328	85	69	•	•	VERB
dpc-328	86	1	no	no	DET
dpc-328	86	2	post	post	ADJ
dpc-328	86	3	-	-	ADJ
dpc-328	86	4	study	study	ADJ
dpc-328	86	5	follow	follow	VERB
dpc-328	86	6	up	up	ADP
dpc-328	86	7	•	•	ADJ
dpc-328	86	8	small	small	ADJ
dpc-328	86	9	sample	sample	NOUN
dpc-328	86	10	size	size	NOUN
dpc-328	86	11	•	•	ADP
dpc-328	86	12	short	short	ADJ
dpc-328	86	13	duration	duration	NOUN
dpc-328	86	14	of	of	ADP
dpc-328	86	15	study	study	NOUN
dpc-328	86	16	•	•	NOUN
dpc-328	86	17	subjects	subject	NOUN
dpc-328	86	18	:	:	PUNCT
dpc-328	86	19	healthy	healthy	ADJ
dpc-328	86	20	young	young	ADJ
dpc-328	86	21	adults	adult	NOUN
dpc-328	86	22	•	•	ADP
dpc-328	86	23	no	no	DET
dpc-328	86	24	post	post	ADJ
dpc-328	86	25	-	-	ADJ
dpc-328	86	26	study	study	ADJ
dpc-328	86	27	follow	follow	VERB
dpc-328	86	28	up	up	ADP
dpc-328	86	29	•	•	NOUN
dpc-328	86	30	serum	serum	PROPN
dpc-328	86	31	gsh	gsh	PROPN
dpc-328	86	32	levels	level	NOUN
dpc-328	86	33	not	not	PART
dpc-328	86	34	measured	measure	VERB
dpc-328	86	35	•	•	NUM
dpc-328	86	36	small	small	ADJ
dpc-328	86	37	sample	sample	NOUN
dpc-328	86	38	size	size	NOUN
dpc-328	86	39	•	•	ADP
dpc-328	86	40	short	short	ADJ
dpc-328	86	41	duration	duration	NOUN
dpc-328	86	42	of	of	ADP
dpc-328	86	43	study	study	NOUN
dpc-328	86	44	•	•	NOUN
dpc-328	86	45	subjects	subject	NOUN
dpc-328	86	46	:	:	PUNCT
dpc-328	86	47	healthy	healthy	ADJ
dpc-328	86	48	women	woman	NOUN
dpc-328	86	49	•	•	VERB
dpc-328	86	50	no	no	DET
dpc-328	86	51	post	post	ADJ
dpc-328	86	52	-	-	ADJ
dpc-328	86	53	study	study	ADJ
dpc-328	86	54	follow	follow	VERB
dpc-328	86	55	up	up	ADP
dpc-328	86	56	•	•	NOUN
dpc-328	86	57	serum	serum	PROPN
dpc-328	86	58	gsh	gsh	PROPN
dpc-328	86	59	levels	level	NOUN
dpc-328	86	60	not	not	PART
dpc-328	86	61	measured	measure	VERB
dpc-328	86	62	.	.	PUNCT
dpc-328	87	1	•	•	NUM
dpc-328	87	2	small	small	ADJ
dpc-328	87	3	sample	sample	NOUN
dpc-328	87	4	size	size	NOUN
dpc-328	87	5	•	•	ADP
dpc-328	87	6	poor	poor	ADJ
dpc-328	87	7	study	study	NOUN
dpc-328	87	8	design	design	NOUN
dpc-328	87	9	•	•	NOUN
dpc-328	87	10	no	no	DET
dpc-328	87	11	mention	mention	NOUN
dpc-328	87	12	of	of	ADP
dpc-328	87	13	statistical	statistical	ADJ
dpc-328	87	14	analysis	analysis	NOUN
dpc-328	87	15	•	•	NOUN
dpc-328	87	16	only	only	ADV
dpc-328	87	17	two	two	NUM
dpc-328	87	18	sites	site	NOUN
dpc-328	87	19	evaluated	evaluate	VERB
dpc-328	87	20	•	•	ADP
dpc-328	87	21	unreliable	unreliable	ADJ
dpc-328	87	22	method	method	NOUN
dpc-328	87	23	of	of	ADP
dpc-328	87	24	efficacy	efficacy	NOUN
dpc-328	87	25	evaluation	evaluation	NOUN
dpc-328	87	26	•	•	ADP
dpc-328	87	27	no	no	DET
dpc-328	87	28	information	information	NOUN
dpc-328	87	29	on	on	ADP
dpc-328	87	30	baseline	baseline	PROPN
dpc-328	87	31	bio	bio	ADJ
dpc-328	87	32	-	-	ADJ
dpc-328	87	33	chemical	chemical	ADJ
dpc-328	87	34	parameters	parameter	NOUN
dpc-328	87	35	•	•	VERB
dpc-328	87	36	no	no	DET
dpc-328	87	37	details	detail	NOUN
dpc-328	87	38	on	on	ADP
dpc-328	87	39	hepatic	hepatic	ADJ
dpc-328	87	40	adverse	adverse	ADJ
dpc-328	87	41	effects	effect	NOUN
dpc-328	87	42	,	,	PUNCT
dpc-328	87	43	nature	nature	NOUN
dpc-328	87	44	,	,	PUNCT
dpc-328	87	45	severity	severity	NOUN
dpc-328	87	46	and	and	CCONJ
dpc-328	87	47	recovery	recovery	NOUN
dpc-328	87	48	•	•	ADP
dpc-328	87	49	serum	serum	PROPN
dpc-328	87	50	gsh	gsh	PROPN
dpc-328	87	51	levels	level	NOUN
dpc-328	87	52	not	not	PART
dpc-328	87	53	measured	measure	VERB
dpc-328	87	54	*	*	PUNCT
dpc-328	87	55	modified	modify	VERB
dpc-328	87	56	from	from	ADP
dpc-328	87	57	table	table	NOUN
dpc-328	87	58	1	1	NUM
dpc-328	87	59	published	publish	VERB
dpc-328	87	60	in	in	ADP
dpc-328	87	61	:	:	PUNCT
dpc-328	87	62	sonthalia	sonthalia	PROPN
dpc-328	87	63	s	s	PART
dpc-328	87	64	,	,	PUNCT
dpc-328	87	65	daulatabad	daulatabad	ADJ
dpc-328	87	66	d	d	PROPN
dpc-328	87	67	,	,	PUNCT
dpc-328	87	68	sarkar	sarkar	PROPN
dpc-328	87	69	r.	r.	PROPN
dpc-328	87	70	glutathione	glutathione	PROPN
dpc-328	87	71	as	as	ADP
dpc-328	87	72	a	a	DET
dpc-328	87	73	skin	skin	NOUN
dpc-328	87	74	whitening	whiten	VERB
dpc-328	87	75	agent	agent	NOUN
dpc-328	87	76	:	:	PUNCT
dpc-328	87	77	facts	fact	NOUN
dpc-328	87	78	,	,	PUNCT
dpc-328	87	79	myths	myth	NOUN
dpc-328	87	80	,	,	PUNCT
dpc-328	87	81	evidence	evidence	NOUN
dpc-328	87	82	and	and	CCONJ
dpc-328	87	83	controversies	controversy	NOUN
dpc-328	87	84	.	.	PUNCT
dpc-328	88	1	indian	indian	PROPN
dpc-328	88	2	j	j	PROPN
dpc-328	88	3	dermatol	dermatol	PROPN
dpc-328	88	4	venereol	venereol	ADJ
dpc-328	88	5	leprol	leprol	NOUN
dpc-328	88	6	.	.	PUNCT
dpc-328	89	1	2016;82:262	2016;82:262	X
dpc-328	89	2	.	.	PUNCT
dpc-328	89	3	table	table	NOUN
dpc-328	89	4	1	1	NUM
dpc-328	89	5	.	.	PUNCT
dpc-328	89	6	evidence	evidence	NOUN
dpc-328	89	7	of	of	ADP
dpc-328	89	8	glutathione	glutathione	NOUN
dpc-328	89	9	as	as	ADP
dpc-328	89	10	a	a	DET
dpc-328	89	11	skin	skin	NOUN
dpc-328	89	12	lightening	lighten	VERB
dpc-328	89	13	agent	agent	NOUN
dpc-328	89	14	:	:	PUNCT
dpc-328	89	15	current	current	ADJ
dpc-328	89	16	summary	summary	NOUN
dpc-328	89	17	of	of	ADP
dpc-328	89	18	studies	study	NOUN
dpc-328	89	19	conducted	conduct	VERB
dpc-328	89	20	to	to	ADP
dpc-328	89	21	date	date	NOUN
dpc-328	89	22	(	(	PUNCT
dpc-328	89	23	continued	continued	ADJ
dpc-328	89	24	)	)	PUNCT
dpc-328	89	25	review	review	NOUN
dpc-328	89	26	|	|	ADV
dpc-328	89	27	dermatol	dermatol	ADJ
dpc-328	89	28	pract	pract	NOUN
dpc-328	89	29	concept	concept	NOUN
dpc-328	89	30	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	89	31	19	19	NUM
dpc-328	89	32	gsh	gsh	NOUN
dpc-328	89	33	for	for	ADP
dpc-328	89	34	skin	skin	NOUN
dpc-328	89	35	lightening	lightening	NOUN
dpc-328	90	1	,	,	PUNCT
dpc-328	90	2	the	the	DET
dpc-328	90	3	extremely	extremely	ADV
dpc-328	90	4	high	high	ADJ
dpc-328	90	5	cost	cost	NOUN
dpc-328	90	6	of	of	ADP
dpc-328	90	7	injection	injection	NOUN
dpc-328	90	8	vials	vial	NOUN
dpc-328	90	9	constitutes	constitute	VERB
dpc-328	90	10	another	another	DET
dpc-328	90	11	compelling	compelling	ADJ
dpc-328	90	12	deterrent	deterrent	NOUN
dpc-328	90	13	to	to	ADP
dpc-328	90	14	its	its	PRON
dpc-328	90	15	use	use	NOUN
dpc-328	90	16	.	.	PUNCT
dpc-328	91	1	the	the	DET
dpc-328	91	2	important	important	ADJ
dpc-328	91	3	limitations	limitation	NOUN
dpc-328	91	4	of	of	ADP
dpc-328	91	5	iv	iv	NUM
dpc-328	91	6	gsh	gsh	PROPN
dpc-328	91	7	have	have	AUX
dpc-328	91	8	been	be	AUX
dpc-328	91	9	enumerated	enumerate	VERB
dpc-328	91	10	in	in	ADP
dpc-328	91	11	figure	figure	NOUN
dpc-328	91	12	4	4	NUM
dpc-328	91	13	.	.	PUNCT
dpc-328	92	1	the	the	DET
dpc-328	92	2	pharmacological	pharmacological	ADJ
dpc-328	92	3	game	game	NOUN
dpc-328	92	4	changer	changer	NOUN
dpc-328	92	5	:	:	PUNCT
dpc-328	92	6	recent	recent	ADJ
dpc-328	92	7	insights	insight	NOUN
dpc-328	92	8	from	from	ADP
dpc-328	92	9	research	research	NOUN
dpc-328	92	10	on	on	ADP
dpc-328	92	11	the	the	DET
dpc-328	92	12	effect	effect	NOUN
dpc-328	92	13	of	of	ADP
dpc-328	92	14	gsh	gsh	PROPN
dpc-328	92	15	versus	versus	ADP
dpc-328	92	16	esterified	esterify	VERB
dpc-328	92	17	gsh	gsh	NOUN
dpc-328	92	18	in	in	ADP
dpc-328	92	19	tyrosinase	tyrosinase	NOUN
dpc-328	92	20	inhibition	inhibition	VERB
dpc-328	92	21	a	a	DET
dpc-328	92	22	reasonable	reasonable	ADJ
dpc-328	92	23	intracellular	intracellular	ADJ
dpc-328	92	24	concentration	concentration	NOUN
dpc-328	92	25	of	of	ADP
dpc-328	92	26	gsh	gsh	PROPN
dpc-328	92	27	and	and	CCONJ
dpc-328	92	28	its	its	PRON
dpc-328	92	29	unimpeded	unimpeded	ADJ
dpc-328	92	30	transportation	transportation	NOUN
dpc-328	92	31	into	into	ADP
dpc-328	92	32	the	the	DET
dpc-328	92	33	melanosomes	melanosome	NOUN
dpc-328	92	34	are	be	AUX
dpc-328	92	35	essenavailability	essenavailability	NOUN
dpc-328	92	36	in	in	ADP
dpc-328	92	37	this	this	DET
dpc-328	92	38	form	form	NOUN
dpc-328	92	39	in	in	ADP
dpc-328	92	40	the	the	DET
dpc-328	92	41	us	us	PROPN
dpc-328	92	42	,	,	PUNCT
dpc-328	92	43	philippines	philippine	NOUN
dpc-328	92	44	and	and	CCONJ
dpc-328	92	45	japan	japan	PROPN
dpc-328	92	46	.	.	PUNCT
dpc-328	93	1	oral	oral	ADJ
dpc-328	93	2	gsh	gsh	PROPN
dpc-328	93	3	is	be	AUX
dpc-328	93	4	also	also	ADV
dpc-328	93	5	easily	easily	ADV
dpc-328	93	6	available	available	ADJ
dpc-328	93	7	over	over	ADP
dpc-328	93	8	-	-	PUNCT
dpc-328	93	9	the	the	DET
dpc-328	93	10	-	-	PUNCT
dpc-328	93	11	counter	counter	NOUN
dpc-328	93	12	(	(	PUNCT
dpc-328	93	13	otc	otc	PROPN
dpc-328	93	14	)	)	PUNCT
dpc-328	93	15	in	in	ADP
dpc-328	93	16	india	india	PROPN
dpc-328	93	17	and	and	CCONJ
dpc-328	93	18	many	many	ADJ
dpc-328	93	19	other	other	ADJ
dpc-328	93	20	asian	asian	ADJ
dpc-328	93	21	countries	country	NOUN
dpc-328	93	22	.	.	PUNCT
dpc-328	94	1	since	since	SCONJ
dpc-328	94	2	oral	oral	ADJ
dpc-328	94	3	gsh	gsh	PROPN
dpc-328	94	4	is	be	AUX
dpc-328	94	5	known	know	VERB
dpc-328	94	6	to	to	PART
dpc-328	94	7	have	have	VERB
dpc-328	94	8	a	a	DET
dpc-328	94	9	low	low	ADJ
dpc-328	94	10	bioavailability	bioavailability	NOUN
dpc-328	94	11	in	in	ADP
dpc-328	94	12	humans	human	NOUN
dpc-328	94	13	[	[	X
dpc-328	94	14	9	9	NUM
dpc-328	94	15	]	]	PUNCT
dpc-328	94	16	,	,	PUNCT
dpc-328	94	17	manufacturers	manufacturer	NOUN
dpc-328	94	18	of	of	ADP
dpc-328	94	19	iv	iv	NUM
dpc-328	94	20	injections	injection	NOUN
dpc-328	94	21	of	of	ADP
dpc-328	94	22	gsh	gsh	NOUN
dpc-328	94	23	“	"	PUNCT
dpc-328	94	24	recommend	recommend	VERB
dpc-328	94	25	”	"	PUNCT
dpc-328	94	26	this	this	DET
dpc-328	94	27	route	route	NOUN
dpc-328	94	28	of	of	ADP
dpc-328	94	29	administration	administration	NOUN
dpc-328	94	30	to	to	PART
dpc-328	94	31	achieve	achieve	VERB
dpc-328	94	32	desired	desire	VERB
dpc-328	94	33	therapeutic	therapeutic	ADJ
dpc-328	94	34	levels	level	NOUN
dpc-328	94	35	in	in	ADP
dpc-328	94	36	the	the	DET
dpc-328	94	37	blood	blood	NOUN
dpc-328	94	38	and	and	CCONJ
dpc-328	94	39	skin	skin	NOUN
dpc-328	94	40	rapidly	rapidly	ADV
dpc-328	94	41	to	to	PART
dpc-328	94	42	produce	produce	VERB
dpc-328	94	43	“	"	PUNCT
dpc-328	94	44	instant	instant	ADJ
dpc-328	94	45	”	"	PUNCT
dpc-328	94	46	skin	skin	NOUN
dpc-328	94	47	whitening	whitening	NOUN
dpc-328	94	48	results	result	NOUN
dpc-328	94	49	.	.	PUNCT
dpc-328	95	1	however	however	ADV
dpc-328	95	2	,	,	PUNCT
dpc-328	95	3	as	as	SCONJ
dpc-328	95	4	emphasized	emphasize	VERB
dpc-328	95	5	above	above	ADV
dpc-328	95	6	,	,	PUNCT
dpc-328	95	7	the	the	DET
dpc-328	95	8	literature	literature	NOUN
dpc-328	95	9	evaluating	evaluate	VERB
dpc-328	95	10	the	the	DET
dpc-328	95	11	efficacy	efficacy	NOUN
dpc-328	95	12	of	of	ADP
dpc-328	95	13	iv	iv	NUM
dpc-328	95	14	gsh	gsh	PROPN
dpc-328	95	15	is	be	AUX
dpc-328	95	16	still	still	ADV
dpc-328	95	17	lacking	lack	VERB
dpc-328	95	18	.	.	PUNCT
dpc-328	96	1	furthermore	furthermore	ADV
dpc-328	96	2	,	,	PUNCT
dpc-328	96	3	the	the	DET
dpc-328	96	4	duration	duration	NOUN
dpc-328	96	5	of	of	ADP
dpc-328	96	6	therapy	therapy	NOUN
dpc-328	96	7	and	and	CCONJ
dpc-328	96	8	long	long	ADJ
dpc-328	96	9	-	-	PUNCT
dpc-328	96	10	term	term	NOUN
dpc-328	96	11	efficacy	efficacy	NOUN
dpc-328	96	12	is	be	AUX
dpc-328	96	13	yet	yet	ADV
dpc-328	96	14	to	to	PART
dpc-328	96	15	be	be	AUX
dpc-328	96	16	established	establish	VERB
dpc-328	96	17	.	.	PUNCT
dpc-328	97	1	despite	despite	SCONJ
dpc-328	97	2	the	the	DET
dpc-328	97	3	lack	lack	NOUN
dpc-328	97	4	of	of	ADP
dpc-328	97	5	evidence	evidence	NOUN
dpc-328	97	6	,	,	PUNCT
dpc-328	97	7	manufacturers	manufacturer	NOUN
dpc-328	97	8	of	of	ADP
dpc-328	97	9	iv	iv	NUM
dpc-328	97	10	gsh	gsh	PROPN
dpc-328	97	11	have	have	AUX
dpc-328	97	12	been	be	AUX
dpc-328	97	13	“	"	PUNCT
dpc-328	97	14	recommending	recommend	VERB
dpc-328	97	15	”	"	PUNCT
dpc-328	97	16	a	a	DET
dpc-328	97	17	dose	dose	NOUN
dpc-328	97	18	of	of	ADP
dpc-328	97	19	600	600	NUM
dpc-328	97	20	-	-	SYM
dpc-328	97	21	1200	1200	NUM
dpc-328	97	22	mg	mg	NOUN
dpc-328	97	23	,	,	PUNCT
dpc-328	97	24	to	to	PART
dpc-328	97	25	be	be	AUX
dpc-328	97	26	injected	inject	VERB
dpc-328	97	27	weekly	weekly	ADJ
dpc-328	97	28	or	or	CCONJ
dpc-328	97	29	twice	twice	DET
dpc-328	97	30	a	a	DET
dpc-328	97	31	week	week	NOUN
dpc-328	97	32	,	,	PUNCT
dpc-328	97	33	with	with	ADP
dpc-328	97	34	no	no	DET
dpc-328	97	35	specified	specify	VERB
dpc-328	97	36	net	net	ADJ
dpc-328	97	37	duration	duration	NOUN
dpc-328	97	38	of	of	ADP
dpc-328	97	39	the	the	DET
dpc-328	97	40	therapy	therapy	NOUN
dpc-328	97	41	[	[	X
dpc-328	97	42	8	8	NUM
dpc-328	97	43	]	]	PUNCT
dpc-328	97	44	.	.	PUNCT
dpc-328	98	1	although	although	SCONJ
dpc-328	98	2	the	the	DET
dpc-328	98	3	overall	overall	ADJ
dpc-328	98	4	safety	safety	NOUN
dpc-328	98	5	of	of	ADP
dpc-328	98	6	iv	iv	X
dpc-328	98	7	gsh	gsh	PROPN
dpc-328	98	8	,	,	PUNCT
dpc-328	98	9	extrapolated	extrapolate	VERB
dpc-328	98	10	from	from	ADP
dpc-328	98	11	studies	study	NOUN
dpc-328	98	12	evaluating	evaluate	VERB
dpc-328	98	13	its	its	PRON
dpc-328	98	14	use	use	NOUN
dpc-328	98	15	for	for	ADP
dpc-328	98	16	male	male	ADJ
dpc-328	98	17	infertility	infertility	NOUN
dpc-328	98	18	and	and	CCONJ
dpc-328	98	19	liver	liver	NOUN
dpc-328	98	20	disorders	disorder	NOUN
dpc-328	98	21	seems	seem	VERB
dpc-328	98	22	to	to	PART
dpc-328	98	23	be	be	AUX
dpc-328	98	24	convincing	convincing	ADJ
dpc-328	98	25	[	[	X
dpc-328	98	26	18,19	18,19	NUM
dpc-328	98	27	]	]	X
dpc-328	98	28	,	,	PUNCT
dpc-328	98	29	several	several	ADJ
dpc-328	98	30	adverse	adverse	ADJ
dpc-328	98	31	effects	effect	NOUN
dpc-328	98	32	of	of	ADP
dpc-328	98	33	iv	iv	NUM
dpc-328	98	34	gsh	gsh	NOUN
dpc-328	98	35	have	have	AUX
dpc-328	98	36	been	be	AUX
dpc-328	98	37	documented	document	VERB
dpc-328	98	38	in	in	ADP
dpc-328	98	39	the	the	DET
dpc-328	98	40	philippines	philippine	NOUN
dpc-328	98	41	(	(	PUNCT
dpc-328	98	42	figure	figure	NOUN
dpc-328	98	43	 	 	SPACE
dpc-328	98	44	2	2	NUM
dpc-328	98	45	)	)	PUNCT
dpc-328	98	46	,	,	PUNCT
dpc-328	98	47	detailed	detail	VERB
dpc-328	98	48	in	in	ADP
dpc-328	98	49	the	the	DET
dpc-328	98	50	position	position	NOUN
dpc-328	98	51	paper	paper	NOUN
dpc-328	98	52	by	by	ADP
dpc-328	98	53	the	the	DET
dpc-328	98	54	fda	fda	PROPN
dpc-328	98	55	,	,	PUNCT
dpc-328	98	56	department	department	PROPN
dpc-328	98	57	of	of	ADP
dpc-328	98	58	health	health	PROPN
dpc-328	98	59	,	,	PUNCT
dpc-328	98	60	republic	republic	NOUN
dpc-328	98	61	of	of	ADP
dpc-328	98	62	the	the	DET
dpc-328	98	63	philippines	philippine	NOUN
dpc-328	98	64	[	[	X
dpc-328	98	65	5	5	NUM
dpc-328	98	66	]	]	PUNCT
dpc-328	98	67	with	with	ADP
dpc-328	98	68	a	a	DET
dpc-328	98	69	warning	warning	NOUN
dpc-328	98	70	for	for	ADP
dpc-328	98	71	the	the	DET
dpc-328	98	72	public	public	NOUN
dpc-328	98	73	on	on	ADP
dpc-328	98	74	the	the	DET
dpc-328	98	75	subject	subject	NOUN
dpc-328	98	76	of	of	ADP
dpc-328	98	77	the	the	DET
dpc-328	98	78	safety	safety	NOUN
dpc-328	98	79	of	of	ADP
dpc-328	98	80	the	the	DET
dpc-328	98	81	off	off	ADP
dpc-328	98	82	-	-	PUNCT
dpc-328	98	83	label	label	NOUN
dpc-328	98	84	use	use	NOUN
dpc-328	98	85	of	of	ADP
dpc-328	98	86	glutathione	glutathione	NOUN
dpc-328	98	87	solution	solution	NOUN
dpc-328	98	88	for	for	ADP
dpc-328	98	89	injection	injection	NOUN
dpc-328	98	90	(	(	PUNCT
dpc-328	98	91	figure	figure	NOUN
dpc-328	98	92	3	3	NUM
dpc-328	98	93	)	)	PUNCT
dpc-328	98	94	.	.	PUNCT
dpc-328	99	1	the	the	DET
dpc-328	99	2	reported	report	VERB
dpc-328	99	3	adverse	adverse	ADJ
dpc-328	99	4	effects	effect	NOUN
dpc-328	99	5	include	include	VERB
dpc-328	99	6	adverse	adverse	ADJ
dpc-328	99	7	cutaneous	cutaneous	ADJ
dpc-328	99	8	eruptions	eruption	NOUN
dpc-328	99	9	including	include	VERB
dpc-328	99	10	potentially	potentially	ADV
dpc-328	99	11	fatal	fatal	ADJ
dpc-328	99	12	stevens	stevens	PROPN
dpc-328	99	13	-	-	PUNCT
dpc-328	99	14	johnson	johnson	PROPN
dpc-328	99	15	syndrome	syndrome	PROPN
dpc-328	99	16	(	(	PUNCT
dpc-328	99	17	sjs	sjs	PROPN
dpc-328	99	18	)	)	PUNCT
dpc-328	99	19	and	and	CCONJ
dpc-328	99	20	toxic	toxic	ADJ
dpc-328	99	21	epidermal	epidermal	ADJ
dpc-328	99	22	necrolysis	necrolysis	NOUN
dpc-328	99	23	(	(	PUNCT
dpc-328	99	24	ten	ten	NUM
dpc-328	99	25	)	)	PUNCT
dpc-328	99	26	,	,	PUNCT
dpc-328	99	27	severe	severe	ADJ
dpc-328	99	28	abdominal	abdominal	ADJ
dpc-328	99	29	pain	pain	NOUN
dpc-328	99	30	,	,	PUNCT
dpc-328	99	31	thyroid	thyroid	NOUN
dpc-328	99	32	dysfunction	dysfunction	NOUN
dpc-328	99	33	,	,	PUNCT
dpc-328	99	34	renal	renal	ADJ
dpc-328	99	35	dysfunction	dysfunction	NOUN
dpc-328	99	36	,	,	PUNCT
dpc-328	99	37	and	and	CCONJ
dpc-328	99	38	lethal	lethal	ADJ
dpc-328	99	39	complications	complication	NOUN
dpc-328	99	40	such	such	ADJ
dpc-328	99	41	as	as	ADP
dpc-328	99	42	air	air	NOUN
dpc-328	99	43	embolism	embolism	NOUN
dpc-328	99	44	,	,	PUNCT
dpc-328	99	45	or	or	CCONJ
dpc-328	99	46	potentially	potentially	ADV
dpc-328	99	47	fatal	fatal	ADJ
dpc-328	99	48	sepsis	sepsis	NOUN
dpc-328	99	49	due	due	ADP
dpc-328	99	50	to	to	ADP
dpc-328	99	51	incorrect/	incorrect/	PROPN
dpc-328	99	52	unsterile	unsterile	NOUN
dpc-328	99	53	method	method	NOUN
dpc-328	99	54	of	of	ADP
dpc-328	99	55	iv	iv	NUM
dpc-328	99	56	administration	administration	NOUN
dpc-328	99	57	and	and	CCONJ
dpc-328	99	58	use	use	NOUN
dpc-328	99	59	of	of	ADP
dpc-328	99	60	counterfeit	counterfeit	ADJ
dpc-328	99	61	gsh	gsh	NOUN
dpc-328	100	1	[	[	X
dpc-328	100	2	5,9	5,9	NUM
dpc-328	100	3	]	]	PUNCT
dpc-328	100	4	.	.	PUNCT
dpc-328	101	1	apart	apart	ADV
dpc-328	101	2	from	from	ADP
dpc-328	101	3	the	the	DET
dpc-328	101	4	lack	lack	NOUN
dpc-328	101	5	of	of	ADP
dpc-328	101	6	evidence	evidence	NOUN
dpc-328	101	7	favoring	favor	VERB
dpc-328	101	8	iv	iv	ADP
dpc-328	101	9	1	1	NUM
dpc-328	101	10	.	.	PUNCT
dpc-328	102	1	cutaneous	cutaneous	ADJ
dpc-328	102	2	—	—	PUNCT
dpc-328	102	3	ranging	range	VERB
dpc-328	102	4	from	from	ADP
dpc-328	102	5	skin	skin	NOUN
dpc-328	102	6	rashes	rash	NOUN
dpc-328	102	7	to	to	ADP
dpc-328	102	8	serious	serious	ADJ
dpc-328	102	9	and	and	CCONJ
dpc-328	102	10	potentially	potentially	ADV
dpc-328	102	11	fatal	fatal	ADJ
dpc-328	102	12	stevens	stevens	PROPN
dpc-328	102	13	-	-	PUNCT
dpc-328	102	14	johnson	johnson	PROPN
dpc-328	102	15	syndrome	syndrome	PROPN
dpc-328	102	16	(	(	PUNCT
dpc-328	102	17	sjs	sjs	PROPN
dpc-328	102	18	)	)	PUNCT
dpc-328	102	19	and	and	CCONJ
dpc-328	102	20	toxic	toxic	ADJ
dpc-328	102	21	epidermal	epidermal	ADJ
dpc-328	102	22	necrolysis	necrolysis	NOUN
dpc-328	102	23	(	(	PUNCT
dpc-328	102	24	ten	ten	NUM
dpc-328	102	25	)	)	PUNCT
dpc-328	102	26	.	.	PUNCT
dpc-328	103	1	2	2	X
dpc-328	103	2	.	.	X
dpc-328	103	3	severe	severe	ADJ
dpc-328	103	4	abdominal	abdominal	ADJ
dpc-328	103	5	pain	pain	NOUN
dpc-328	103	6	in	in	ADP
dpc-328	103	7	patients	patient	NOUN
dpc-328	103	8	receiving	receive	VERB
dpc-328	103	9	twice	twice	ADJ
dpc-328	103	10	-	-	PUNCT
dpc-328	103	11	weekly	weekly	NOUN
dpc-328	103	12	iv	iv	NUM
dpc-328	103	13	glutathione	glutathione	NOUN
dpc-328	103	14	3	3	NUM
dpc-328	103	15	.	.	PUNCT
dpc-328	103	16	thyroid	thyroid	NOUN
dpc-328	103	17	dysfunction	dysfunction	NOUN
dpc-328	103	18	4	4	NUM
dpc-328	103	19	.	.	PUNCT
dpc-328	104	1	kidney	kidney	NOUN
dpc-328	104	2	dysfunction	dysfunction	NOUN
dpc-328	104	3	with	with	ADP
dpc-328	104	4	potential	potential	NOUN
dpc-328	104	5	for	for	ADP
dpc-328	104	6	development	development	NOUN
dpc-328	104	7	of	of	ADP
dpc-328	104	8	renal	renal	ADJ
dpc-328	104	9	failure	failure	NOUN
dpc-328	104	10	5	5	NUM
dpc-328	104	11	.	.	PUNCT
dpc-328	104	12	liver	liver	NOUN
dpc-328	104	13	dysfunction	dysfunction	NOUN
dpc-328	104	14	—	—	PUNCT
dpc-328	104	15	reported	report	VERB
dpc-328	104	16	in	in	ADP
dpc-328	104	17	32	32	NUM
dpc-328	104	18	%	%	NOUN
dpc-328	104	19	of	of	ADP
dpc-328	104	20	the	the	DET
dpc-328	104	21	treated	treat	VERB
dpc-328	104	22	subjects	subject	NOUN
dpc-328	104	23	in	in	ADP
dpc-328	104	24	the	the	DET
dpc-328	104	25	iv	iv	NUM
dpc-328	104	26	gsh	gsh	NOUN
dpc-328	104	27	trial	trial	NOUN
dpc-328	104	28	by	by	ADP
dpc-328	104	29	zubair	zubair	PROPN
dpc-328	104	30	et	et	PROPN
dpc-328	104	31	 	 	SPACE
dpc-328	104	32	al	al	PROPN
dpc-328	104	33	.	.	PUNCT
dpc-328	105	1	[	[	X
dpc-328	105	2	7	7	NUM
dpc-328	105	3	]	]	SYM
dpc-328	105	4	6	6	NUM
dpc-328	105	5	.	.	PUNCT
dpc-328	105	6	lethal	lethal	ADJ
dpc-328	105	7	complications	complication	NOUN
dpc-328	105	8	—	—	PUNCT
dpc-328	105	9	air	air	NOUN
dpc-328	105	10	embolism	embolism	NOUN
dpc-328	105	11	,	,	PUNCT
dpc-328	105	12	bloodborne	bloodborne	NOUN
dpc-328	105	13	infections	infection	NOUN
dpc-328	105	14	and	and	CCONJ
dpc-328	105	15	potentially	potentially	ADV
dpc-328	105	16	fatal	fatal	ADJ
dpc-328	105	17	sepsis	sepsis	NOUN
dpc-328	105	18	stemming	stem	VERB
dpc-328	105	19	from	from	ADP
dpc-328	105	20	incorrect	incorrect	ADJ
dpc-328	105	21	technique	technique	NOUN
dpc-328	105	22	of	of	ADP
dpc-328	105	23	injections	injection	NOUN
dpc-328	105	24	by	by	ADP
dpc-328	105	25	untrained	untrained	ADJ
dpc-328	105	26	staff	staff	NOUN
dpc-328	105	27	,	,	PUNCT
dpc-328	105	28	use	use	NOUN
dpc-328	105	29	of	of	ADP
dpc-328	105	30	unsterile	unsterile	PROPN
dpc-328	105	31	or	or	CCONJ
dpc-328	105	32	used	used	ADJ
dpc-328	105	33	needles	needle	NOUN
dpc-328	105	34	,	,	PUNCT
dpc-328	105	35	and	and	CCONJ
dpc-328	105	36	use	use	NOUN
dpc-328	105	37	of	of	ADP
dpc-328	105	38	counterfeit	counterfeit	ADJ
dpc-328	105	39	intravenous	intravenous	ADJ
dpc-328	105	40	glutathione	glutathione	NOUN
dpc-328	105	41	figure	figure	NOUN
dpc-328	105	42	2	2	NUM
dpc-328	105	43	.	.	PUNCT
dpc-328	105	44	adverse	adverse	ADJ
dpc-328	105	45	effects	effect	NOUN
dpc-328	105	46	reported	report	VERB
dpc-328	105	47	with	with	ADP
dpc-328	105	48	intravenous	intravenous	ADJ
dpc-328	105	49	glutathione	glutathione	NOUN
dpc-328	105	50	injections	injection	NOUN
dpc-328	105	51	by	by	ADP
dpc-328	105	52	the	the	DET
dpc-328	105	53	food	food	NOUN
dpc-328	105	54	and	and	CCONJ
dpc-328	105	55	drug	drug	NOUN
dpc-328	105	56	administration	administration	NOUN
dpc-328	105	57	,	,	PUNCT
dpc-328	105	58	department	department	PROPN
dpc-328	105	59	of	of	ADP
dpc-328	105	60	health	health	PROPN
dpc-328	105	61	,	,	PUNCT
dpc-328	105	62	republic	republic	NOUN
dpc-328	105	63	of	of	ADP
dpc-328	105	64	the	the	DET
dpc-328	105	65	philippines	philippine	NOUN
dpc-328	105	66	[	[	X
dpc-328	105	67	5	5	NUM
dpc-328	105	68	]	]	PUNCT
dpc-328	105	69	and	and	CCONJ
dpc-328	105	70	the	the	DET
dpc-328	105	71	intravenous	intravenous	ADJ
dpc-328	105	72	gsh	gsh	PROPN
dpc-328	105	73	trial	trial	NOUN
dpc-328	105	74	by	by	ADP
dpc-328	105	75	zubair	zubair	PROPN
dpc-328	105	76	et	et	PROPN
dpc-328	105	77	al	al	PROPN
dpc-328	105	78	.	.	PUNCT
dpc-328	106	1	[	[	X
dpc-328	106	2	15	15	NUM
dpc-328	106	3	]	]	X
dpc-328	106	4	[	[	X
dpc-328	106	5	copyright	copyright	NOUN
dpc-328	106	6	:	:	PUNCT
dpc-328	106	7	©	©	PROPN
dpc-328	106	8	2018	2018	NUM
dpc-328	106	9	sonthalia	sonthalia	PROPN
dpc-328	106	10	et	et	PROPN
dpc-328	106	11	al	al	PROPN
dpc-328	106	12	.	.	PROPN
dpc-328	106	13	]	]	PUNCT
dpc-328	106	14	figure	figure	NOUN
dpc-328	106	15	4	4	NUM
dpc-328	106	16	.	.	PUNCT
dpc-328	107	1	limitations	limitation	NOUN
dpc-328	107	2	of	of	ADP
dpc-328	107	3	intravenous	intravenous	ADJ
dpc-328	107	4	glutathione	glutathione	NOUN
dpc-328	107	5	as	as	ADP
dpc-328	107	6	a	a	DET
dpc-328	107	7	skin	skin	NOUN
dpc-328	107	8	lightening	lighten	VERB
dpc-328	107	9	agent	agent	NOUN
dpc-328	107	10	.	.	PUNCT
dpc-328	108	1	[	[	X
dpc-328	108	2	copyright	copyright	NOUN
dpc-328	108	3	:	:	PUNCT
dpc-328	108	4	©	©	PROPN
dpc-328	108	5	2018	2018	NUM
dpc-328	108	6	sonthalia	sonthalia	PROPN
dpc-328	108	7	et	et	PROPN
dpc-328	108	8	al	al	PROPN
dpc-328	108	9	.	.	PROPN
dpc-328	108	10	]	]	PUNCT
dpc-328	109	1	1	1	X
dpc-328	109	2	.	.	X
dpc-328	109	3	lack	lack	NOUN
dpc-328	109	4	of	of	ADP
dpc-328	109	5	any	any	DET
dpc-328	109	6	published	publish	VERB
dpc-328	109	7	or	or	CCONJ
dpc-328	109	8	reliable	reliable	ADJ
dpc-328	109	9	source	source	NOUN
dpc-328	109	10	of	of	ADP
dpc-328	109	11	evidence	evidence	NOUN
dpc-328	109	12	supporting	support	VERB
dpc-328	109	13	the	the	DET
dpc-328	109	14	efficacy	efficacy	NOUN
dpc-328	109	15	of	of	ADP
dpc-328	109	16	intravenous	intravenous	ADJ
dpc-328	109	17	glutathione	glutathione	NOUN
dpc-328	109	18	in	in	ADP
dpc-328	109	19	skin	skin	NOUN
dpc-328	109	20	whitening	whiten	VERB
dpc-328	109	21	2	2	NUM
dpc-328	109	22	.	.	PUNCT
dpc-328	109	23	undefined	undefined	ADJ
dpc-328	109	24	dose	dose	NOUN
dpc-328	109	25	and	and	CCONJ
dpc-328	109	26	duration	duration	NOUN
dpc-328	109	27	of	of	ADP
dpc-328	109	28	intravenous	intravenous	ADJ
dpc-328	109	29	injections	injection	NOUN
dpc-328	109	30	,	,	PUNCT
dpc-328	109	31	excepting	except	VERB
dpc-328	109	32	the	the	DET
dpc-328	109	33	recommendations	recommendation	NOUN
dpc-328	109	34	of	of	ADP
dpc-328	109	35	manufacturers	manufacturer	NOUN
dpc-328	109	36	which	which	PRON
dpc-328	109	37	has	have	VERB
dpc-328	109	38	no	no	DET
dpc-328	109	39	apparent	apparent	ADJ
dpc-328	109	40	scientific	scientific	ADJ
dpc-328	109	41	basis	basis	NOUN
dpc-328	109	42	3	3	NUM
dpc-328	109	43	.	.	X
dpc-328	109	44	need	need	NOUN
dpc-328	109	45	for	for	ADP
dpc-328	109	46	indefinite	indefinite	ADJ
dpc-328	109	47	,	,	PUNCT
dpc-328	109	48	perhaps	perhaps	ADV
dpc-328	109	49	lifelong	lifelong	ADJ
dpc-328	109	50	maintenance	maintenance	NOUN
dpc-328	109	51	with	with	ADP
dpc-328	109	52	either	either	CCONJ
dpc-328	109	53	oral	oral	ADJ
dpc-328	109	54	or	or	CCONJ
dpc-328	109	55	intravenous	intravenous	ADJ
dpc-328	109	56	gsh	gsh	NOUN
dpc-328	109	57	,	,	PUNCT
dpc-328	109	58	even	even	ADV
dpc-328	109	59	if	if	SCONJ
dpc-328	109	60	the	the	DET
dpc-328	109	61	“	"	PUNCT
dpc-328	109	62	desirable	desirable	ADJ
dpc-328	109	63	”	"	PUNCT
dpc-328	109	64	skin	skin	NOUN
dpc-328	109	65	whitening	whitening	NOUN
dpc-328	109	66	has	have	AUX
dpc-328	109	67	been	be	AUX
dpc-328	109	68	attained	attain	VERB
dpc-328	109	69	4	4	NUM
dpc-328	109	70	.	.	NOUN
dpc-328	109	71	barrage	barrage	NOUN
dpc-328	109	72	of	of	ADP
dpc-328	109	73	adverse	adverse	ADJ
dpc-328	109	74	effects	effect	NOUN
dpc-328	109	75	reported	report	VERB
dpc-328	109	76	with	with	ADP
dpc-328	109	77	intravenous	intravenous	ADJ
dpc-328	109	78	administration	administration	NOUN
dpc-328	109	79	5	5	NUM
dpc-328	109	80	.	.	PUNCT
dpc-328	109	81	lack	lack	NOUN
dpc-328	109	82	of	of	ADP
dpc-328	109	83	approval	approval	NOUN
dpc-328	109	84	from	from	ADP
dpc-328	109	85	us	we	PRON
dpc-328	109	86	fda	fda	PROPN
dpc-328	109	87	and	and	CCONJ
dpc-328	109	88	warning	warn	VERB
dpc-328	109	89	against	against	ADP
dpc-328	109	90	the	the	DET
dpc-328	109	91	use	use	NOUN
dpc-328	109	92	of	of	ADP
dpc-328	109	93	intravenous	intravenous	ADJ
dpc-328	109	94	glutathione	glutathione	NOUN
dpc-328	109	95	by	by	ADP
dpc-328	109	96	the	the	DET
dpc-328	109	97	fda	fda	PROPN
dpc-328	109	98	of	of	ADP
dpc-328	109	99	philippines	philippine	NOUN
dpc-328	109	100	6	6	NUM
dpc-328	109	101	.	.	PUNCT
dpc-328	109	102	high	high	ADJ
dpc-328	109	103	cost	cost	NOUN
dpc-328	109	104	of	of	ADP
dpc-328	109	105	injectable	injectable	ADJ
dpc-328	109	106	glutathione	glutathione	NOUN
dpc-328	109	107	vials	vial	VERB
dpc-328	109	108	us	we	PRON
dpc-328	109	109	–	–	PUNCT
dpc-328	109	110	united	united	PROPN
dpc-328	109	111	states	states	PROPN
dpc-328	109	112	;	;	PUNCT
dpc-328	109	113	fda	fda	PROPN
dpc-328	109	114	–	–	PUNCT
dpc-328	109	115	food	food	NOUN
dpc-328	109	116	and	and	CCONJ
dpc-328	109	117	drug	drug	PROPN
dpc-328	109	118	administration	administration	NOUN
dpc-328	109	119	figure	figure	NOUN
dpc-328	109	120	3	3	NUM
dpc-328	109	121	.	.	PUNCT
dpc-328	110	1	public	public	ADJ
dpc-328	110	2	warning	warning	NOUN
dpc-328	110	3	issued	issue	VERB
dpc-328	110	4	by	by	ADP
dpc-328	110	5	the	the	DET
dpc-328	110	6	food	food	NOUN
dpc-328	110	7	and	and	CCONJ
dpc-328	110	8	drug	drug	NOUN
dpc-328	110	9	administration	administration	NOUN
dpc-328	110	10	,	,	PUNCT
dpc-328	110	11	department	department	PROPN
dpc-328	110	12	of	of	ADP
dpc-328	110	13	health	health	PROPN
dpc-328	110	14	,	,	PUNCT
dpc-328	110	15	republic	republic	NOUN
dpc-328	110	16	of	of	ADP
dpc-328	110	17	the	the	DET
dpc-328	110	18	philippines	philippine	NOUN
dpc-328	111	1	[	[	X
dpc-328	111	2	5	5	NUM
dpc-328	111	3	]	]	PUNCT
dpc-328	111	4	(	(	PUNCT
dpc-328	111	5	may	may	PROPN
dpc-328	111	6	12	12	NUM
dpc-328	111	7	,	,	PUNCT
dpc-328	111	8	2011	2011	NUM
dpc-328	111	9	)	)	PUNCT
dpc-328	111	10	.	.	PUNCT
dpc-328	112	1	[	[	X
dpc-328	112	2	copyright	copyright	NOUN
dpc-328	112	3	:	:	PUNCT
dpc-328	112	4	©	©	PROPN
dpc-328	112	5	2018	2018	NUM
dpc-328	112	6	sonthalia	sonthalia	PROPN
dpc-328	112	7	et	et	PROPN
dpc-328	112	8	al	al	PROPN
dpc-328	112	9	.	.	PROPN
dpc-328	112	10	]	]	PUNCT
dpc-328	113	1	“	"	PUNCT
dpc-328	113	2	the	the	DET
dpc-328	113	3	alarming	alarming	ADJ
dpc-328	113	4	increase	increase	NOUN
dpc-328	113	5	in	in	ADP
dpc-328	113	6	the	the	DET
dpc-328	113	7	unapproved	unapproved	ADJ
dpc-328	113	8	use	use	NOUN
dpc-328	113	9	of	of	ADP
dpc-328	113	10	glutathione	glutathione	NOUN
dpc-328	113	11	administered	administer	VERB
dpc-328	113	12	intravenously	intravenously	ADV
dpc-328	113	13	as	as	ADP
dpc-328	113	14	a	a	DET
dpc-328	113	15	skinwhitening	skinwhitene	VERB
dpc-328	113	16	agent	agent	NOUN
dpc-328	113	17	at	at	ADP
dpc-328	113	18	very	very	ADV
dpc-328	113	19	high	high	ADJ
dpc-328	113	20	doses	dose	NOUN
dpc-328	113	21	is	be	AUX
dpc-328	113	22	unsafe	unsafe	ADJ
dpc-328	113	23	and	and	CCONJ
dpc-328	113	24	may	may	AUX
dpc-328	113	25	result	result	VERB
dpc-328	113	26	in	in	ADP
dpc-328	113	27	serious	serious	ADJ
dpc-328	113	28	consequences	consequence	NOUN
dpc-328	113	29	to	to	ADP
dpc-328	113	30	the	the	DET
dpc-328	113	31	health	health	NOUN
dpc-328	113	32	of	of	ADP
dpc-328	113	33	users	user	NOUN
dpc-328	113	34	.	.	PUNCT
dpc-328	114	1	there	there	PRON
dpc-328	114	2	is	be	VERB
dpc-328	114	3	inadequate	inadequate	ADJ
dpc-328	114	4	safety	safety	NOUN
dpc-328	114	5	documentation	documentation	NOUN
dpc-328	114	6	on	on	ADP
dpc-328	114	7	the	the	DET
dpc-328	114	8	use	use	NOUN
dpc-328	114	9	of	of	ADP
dpc-328	114	10	high	high	ADJ
dpc-328	114	11	doses	dose	NOUN
dpc-328	114	12	of	of	ADP
dpc-328	114	13	glutathione	glutathione	NOUN
dpc-328	114	14	administered	administer	VERB
dpc-328	114	15	at	at	ADP
dpc-328	114	16	600	600	NUM
dpc-328	114	17	mg	mg	NOUN
dpc-328	114	18	to	to	ADP
dpc-328	114	19	1.2	1.2	NUM
dpc-328	114	20	grams	gram	NOUN
dpc-328	114	21	once	once	ADV
dpc-328	114	22	weekly	weekly	ADJ
dpc-328	114	23	and	and	CCONJ
dpc-328	114	24	even	even	ADV
dpc-328	114	25	up	up	ADP
dpc-328	114	26	to	to	PART
dpc-328	114	27	twice	twice	ADV
dpc-328	114	28	weekly	weekly	ADJ
dpc-328	114	29	.	.	PUNCT
dpc-328	115	1	the	the	DET
dpc-328	115	2	only	only	ADJ
dpc-328	115	3	approved	approve	VERB
dpc-328	115	4	indication	indication	NOUN
dpc-328	115	5	of	of	ADP
dpc-328	115	6	the	the	DET
dpc-328	115	7	intravenous	intravenous	ADJ
dpc-328	115	8	format	format	NOUN
dpc-328	115	9	of	of	ADP
dpc-328	115	10	glutathione	glutathione	NOUN
dpc-328	115	11	is	be	AUX
dpc-328	115	12	an	an	DET
dpc-328	115	13	adjunctive	adjunctive	ADJ
dpc-328	115	14	treatment	treatment	NOUN
dpc-328	115	15	to	to	PART
dpc-328	115	16	reduce	reduce	VERB
dpc-328	115	17	neurotoxicity	neurotoxicity	NOUN
dpc-328	115	18	associated	associate	VERB
dpc-328	115	19	with	with	ADP
dpc-328	115	20	cisplatin	cisplatin	NOUN
dpc-328	115	21	chemotherapy	chemotherapy	NOUN
dpc-328	115	22	.	.	PUNCT
dpc-328	115	23	”	"	PUNCT
dpc-328	116	1	20	20	NUM
dpc-328	116	2	review	review	NOUN
dpc-328	116	3	|	|	ADV
dpc-328	116	4	dermatol	dermatol	ADJ
dpc-328	116	5	pract	pract	NOUN
dpc-328	116	6	concept	concept	NOUN
dpc-328	116	7	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	116	8	4	4	NUM
dpc-328	116	9	.	.	PUNCT
dpc-328	117	1	cdsco	cdsco	PROPN
dpc-328	117	2	list	list	NOUN
dpc-328	117	3	of	of	ADP
dpc-328	117	4	approved	approve	VERB
dpc-328	117	5	drug	drug	NOUN
dpc-328	117	6	from	from	ADP
dpc-328	117	7	01	01	NUM
dpc-328	117	8	-	-	PUNCT
dpc-328	117	9	01	01	NUM
dpc-328	117	10	-	-	PUNCT
dpc-328	117	11	2011	2011	NUM
dpc-328	117	12	to	to	ADP
dpc-328	117	13	31	31	NUM
dpc-328	117	14	-	-	SYM
dpc-328	117	15	12	12	NUM
dpc-328	117	16	-	-	PUNCT
dpc-328	117	17	2011	2011	NUM
dpc-328	117	18	.	.	PUNCT
dpc-328	118	1	http://www.cdsco.nic.in/writereaddata/listof-approveddrug-from-2011.pdf	http://www.cdsco.nic.in/writereaddata/listof-approveddrug-from-2011.pdf	PROPN
dpc-328	118	2	.	.	PROPN
dpc-328	118	3	accessed	access	VERB
dpc-328	118	4	on	on	ADP
dpc-328	118	5	april	april	PROPN
dpc-328	118	6	26	26	NUM
dpc-328	118	7	,	,	PUNCT
dpc-328	118	8	2017	2017	NUM
dpc-328	118	9	.	.	PUNCT
dpc-328	119	1	5	5	NUM
dpc-328	119	2	.	.	X
dpc-328	119	3	lazo	lazo	PROPN
dpc-328	119	4	sh	sh	PROPN
dpc-328	119	5	.	.	PROPN
dpc-328	119	6	safety	safety	NOUN
dpc-328	119	7	on	on	ADP
dpc-328	119	8	the	the	DET
dpc-328	119	9	off	off	ADP
dpc-328	119	10	-	-	PUNCT
dpc-328	119	11	label	label	NOUN
dpc-328	119	12	use	use	NOUN
dpc-328	119	13	of	of	ADP
dpc-328	119	14	glutathione	glutathione	NOUN
dpc-328	119	15	solution	solution	NOUN
dpc-328	119	16	for	for	ADP
dpc-328	119	17	injection	injection	NOUN
dpc-328	119	18	(	(	PUNCT
dpc-328	119	19	iv	iv	X
dpc-328	119	20	)	)	PUNCT
dpc-328	119	21	.	.	PUNCT
dpc-328	120	1	food	food	NOUN
dpc-328	120	2	and	and	CCONJ
dpc-328	120	3	drug	drug	PROPN
dpc-328	120	4	administration	administration	NOUN
dpc-328	120	5	,	,	PUNCT
dpc-328	120	6	department	department	PROPN
dpc-328	120	7	of	of	ADP
dpc-328	120	8	health	health	PROPN
dpc-328	120	9	,	,	PUNCT
dpc-328	120	10	republic	republic	NOUN
dpc-328	120	11	of	of	ADP
dpc-328	120	12	the	the	DET
dpc-328	120	13	philippines	philippine	NOUN
dpc-328	120	14	;	;	PUNCT
dpc-328	120	15	2011	2011	NUM
dpc-328	120	16	.	.	PUNCT
dpc-328	121	1	http://www.doh.gov.ph/sites/	http://www.doh.gov.ph/sites/	ADJ
dpc-328	121	2	default	default	NOUN
dpc-328	121	3	/	/	SYM
dpc-328	121	4	files	file	NOUN
dpc-328	121	5	/	/	SYM
dpc-328	121	6	advisories_cosmetic_doh	advisories_cosmetic_doh	NOUN
dpc-328	121	7	-	-	PUNCT
dpc-328	121	8	fda%20advisory%	fda%20advisory%	ADJ
dpc-328	121	9	20no.%202011	20no.%202011	NUM
dpc-328	121	10	-	-	PUNCT
dpc-328	121	11	004.pdf	004.pdf	NOUN
dpc-328	121	12	.	.	PROPN
dpc-328	121	13	accessed	access	VERB
dpc-328	121	14	on	on	ADP
dpc-328	121	15	february	february	PROPN
dpc-328	121	16	26	26	NUM
dpc-328	121	17	,	,	PUNCT
dpc-328	121	18	2017	2017	NUM
dpc-328	121	19	]	]	PUNCT
dpc-328	121	20	.	.	PUNCT
dpc-328	122	1	6	6	NUM
dpc-328	122	2	.	.	NUM
dpc-328	122	3	sonthalia	sonthalia	PROPN
dpc-328	122	4	s	s	PART
dpc-328	122	5	,	,	PUNCT
dpc-328	122	6	sarkar	sarkar	PROPN
dpc-328	122	7	r.	r.	PROPN
dpc-328	122	8	glutathione	glutathione	PROPN
dpc-328	122	9	for	for	ADP
dpc-328	122	10	skin	skin	NOUN
dpc-328	122	11	lightening	lightening	NOUN
dpc-328	122	12	:	:	PUNCT
dpc-328	122	13	an	an	DET
dpc-328	122	14	update	update	NOUN
dpc-328	122	15	.	.	PUNCT
dpc-328	123	1	pigment	pigment	NOUN
dpc-328	123	2	int	int	PROPN
dpc-328	123	3	.	.	PUNCT
dpc-328	124	1	2017;4:3	2017;4:3	NUM
dpc-328	124	2	-	-	SYM
dpc-328	124	3	6	6	NUM
dpc-328	124	4	.	.	NOUN
dpc-328	125	1	7	7	NUM
dpc-328	125	2	.	.	PUNCT
dpc-328	125	3	exner	exner	NOUN
dpc-328	125	4	r	r	NOUN
dpc-328	125	5	,	,	PUNCT
dpc-328	125	6	wessner	wessner	NOUN
dpc-328	125	7	b	b	NOUN
dpc-328	125	8	,	,	PUNCT
dpc-328	125	9	manhart	manhart	NOUN
dpc-328	125	10	n	n	CCONJ
dpc-328	125	11	,	,	PUNCT
dpc-328	125	12	roth	roth	PROPN
dpc-328	125	13	e.	e.	PROPN
dpc-328	125	14	therapeutic	therapeutic	PROPN
dpc-328	125	15	potential	potential	NOUN
dpc-328	125	16	of	of	ADP
dpc-328	125	17	glutathione	glutathione	NOUN
dpc-328	125	18	.	.	PUNCT
dpc-328	126	1	wien	wien	PROPN
dpc-328	126	2	klin	klin	PROPN
dpc-328	126	3	wochenschr	wochenschr	PROPN
dpc-328	126	4	.	.	PUNCT
dpc-328	127	1	2000;112:610	2000;112:610	NUM
dpc-328	127	2	-	-	PUNCT
dpc-328	127	3	616	616	NUM
dpc-328	127	4	.	.	NOUN
dpc-328	128	1	8	8	NUM
dpc-328	128	2	.	.	X
dpc-328	128	3	villarama	villarama	PROPN
dpc-328	128	4	cd	cd	PROPN
dpc-328	128	5	,	,	PUNCT
dpc-328	128	6	maibach	maibach	PROPN
dpc-328	128	7	hi	hi	INTJ
dpc-328	128	8	.	.	PUNCT
dpc-328	128	9	glutathione	glutathione	NOUN
dpc-328	128	10	as	as	ADP
dpc-328	128	11	a	a	DET
dpc-328	128	12	depigmenting	depigmente	VERB
dpc-328	128	13	agent	agent	NOUN
dpc-328	128	14	:	:	PUNCT
dpc-328	128	15	an	an	DET
dpc-328	128	16	overview	overview	NOUN
dpc-328	128	17	.	.	PUNCT
dpc-328	129	1	int	int	NOUN
dpc-328	129	2	j	j	PROPN
dpc-328	129	3	cosmet	cosmet	PROPN
dpc-328	129	4	sci	sci	PROPN
dpc-328	129	5	.	.	PUNCT
dpc-328	130	1	2005;27:147	2005;27:147	NUM
dpc-328	130	2	-	-	SYM
dpc-328	130	3	153	153	NUM
dpc-328	130	4	.	.	NOUN
dpc-328	130	5	9	9	NUM
dpc-328	130	6	.	.	NUM
dpc-328	130	7	sonthalia	sonthalia	PROPN
dpc-328	130	8	s	s	PART
dpc-328	130	9	,	,	PUNCT
dpc-328	130	10	daulatabad	daulatabad	ADJ
dpc-328	130	11	d	d	PROPN
dpc-328	130	12	,	,	PUNCT
dpc-328	130	13	sarkar	sarkar	PROPN
dpc-328	130	14	r.	r.	PROPN
dpc-328	130	15	glutathione	glutathione	PROPN
dpc-328	130	16	as	as	ADP
dpc-328	130	17	a	a	DET
dpc-328	130	18	skin	skin	NOUN
dpc-328	130	19	whitening	whiten	VERB
dpc-328	130	20	agent	agent	NOUN
dpc-328	130	21	:	:	PUNCT
dpc-328	130	22	facts	fact	NOUN
dpc-328	130	23	,	,	PUNCT
dpc-328	130	24	myths	myth	NOUN
dpc-328	130	25	,	,	PUNCT
dpc-328	130	26	evidence	evidence	NOUN
dpc-328	130	27	and	and	CCONJ
dpc-328	130	28	controversies	controversy	NOUN
dpc-328	130	29	.	.	PUNCT
dpc-328	131	1	indian	indian	PROPN
dpc-328	131	2	j	j	PROPN
dpc-328	131	3	dermatol	dermatol	PROPN
dpc-328	131	4	venereol	venereol	ADJ
dpc-328	131	5	leprol	leprol	NOUN
dpc-328	131	6	.	.	PUNCT
dpc-328	132	1	2016;82:262	2016;82:262	NOUN
dpc-328	132	2	-	-	SYM
dpc-328	132	3	272	272	NUM
dpc-328	132	4	.	.	PUNCT
dpc-328	132	5	10	10	NUM
dpc-328	132	6	.	.	PUNCT
dpc-328	132	7	arjinpathana	arjinpathana	PROPN
dpc-328	132	8	n	n	CCONJ
dpc-328	132	9	,	,	PUNCT
dpc-328	132	10	asawanonda	asawanonda	NOUN
dpc-328	132	11	p.	p.	NOUN
dpc-328	132	12	glutathione	glutathione	NOUN
dpc-328	132	13	as	as	ADP
dpc-328	132	14	an	an	DET
dpc-328	132	15	oral	oral	ADJ
dpc-328	132	16	whitening	whiten	VERB
dpc-328	132	17	agent	agent	NOUN
dpc-328	132	18	:	:	PUNCT
dpc-328	132	19	a	a	DET
dpc-328	132	20	randomized	randomized	ADJ
dpc-328	132	21	,	,	PUNCT
dpc-328	132	22	double	double	ADJ
dpc-328	132	23	-	-	PUNCT
dpc-328	132	24	blind	blind	ADJ
dpc-328	132	25	,	,	PUNCT
dpc-328	132	26	placebo	placebo	NOUN
dpc-328	132	27	-	-	PUNCT
dpc-328	132	28	controlled	control	VERB
dpc-328	132	29	study	study	NOUN
dpc-328	132	30	.	.	PUNCT
dpc-328	133	1	j	j	PROPN
dpc-328	133	2	dermatolog	dermatolog	PROPN
dpc-328	133	3	treat	treat	NOUN
dpc-328	133	4	.	.	PUNCT
dpc-328	134	1	2012;23:97	2012;23:97	NUM
dpc-328	134	2	-	-	SYM
dpc-328	134	3	102	102	NUM
dpc-328	134	4	.	.	PUNCT
dpc-328	135	1	11	11	NUM
dpc-328	135	2	.	.	PUNCT
dpc-328	136	1	handog	handog	PROPN
dpc-328	136	2	eb	eb	PROPN
dpc-328	136	3	,	,	PUNCT
dpc-328	136	4	datuin	datuin	PROPN
dpc-328	136	5	ms	ms	PROPN
dpc-328	136	6	,	,	PUNCT
dpc-328	136	7	singzon	singzon	PROPN
dpc-328	136	8	ia	ia	PROPN
dpc-328	136	9	.	.	PUNCT
dpc-328	137	1	an	an	DET
dpc-328	137	2	open	open	ADJ
dpc-328	137	3	-	-	PUNCT
dpc-328	137	4	label	label	NOUN
dpc-328	137	5	,	,	PUNCT
dpc-328	137	6	single	single	ADJ
dpc-328	137	7	-	-	PUNCT
dpc-328	137	8	arm	arm	NOUN
dpc-328	137	9	trial	trial	NOUN
dpc-328	137	10	of	of	ADP
dpc-328	137	11	the	the	DET
dpc-328	137	12	safety	safety	NOUN
dpc-328	137	13	and	and	CCONJ
dpc-328	137	14	efficacy	efficacy	NOUN
dpc-328	137	15	of	of	ADP
dpc-328	137	16	a	a	DET
dpc-328	137	17	novel	novel	ADJ
dpc-328	137	18	preparation	preparation	NOUN
dpc-328	137	19	of	of	ADP
dpc-328	137	20	glutathione	glutathione	NOUN
dpc-328	137	21	as	as	ADP
dpc-328	137	22	a	a	DET
dpc-328	137	23	skin	skin	NOUN
dpc-328	137	24	-	-	PUNCT
dpc-328	137	25	lightening	lighten	VERB
dpc-328	137	26	agent	agent	NOUN
dpc-328	137	27	in	in	ADP
dpc-328	137	28	filipino	filipino	ADJ
dpc-328	137	29	women	woman	NOUN
dpc-328	137	30	.	.	PUNCT
dpc-328	138	1	int	int	NOUN
dpc-328	138	2	j	j	PROPN
dpc-328	138	3	dermatol	dermatol	NOUN
dpc-328	138	4	.	.	PUNCT
dpc-328	139	1	2016;55:153	2016;55:153	X
dpc-328	139	2	-	-	SYM
dpc-328	139	3	157	157	NUM
dpc-328	139	4	.	.	PUNCT
dpc-328	140	1	12	12	NUM
dpc-328	140	2	.	.	PUNCT
dpc-328	141	1	watanabe	watanabe	PROPN
dpc-328	141	2	f	f	PROPN
dpc-328	141	3	,	,	PUNCT
dpc-328	141	4	hashizume	hashizume	ADJ
dpc-328	141	5	e	e	NOUN
dpc-328	141	6	,	,	PUNCT
dpc-328	141	7	chan	chan	PROPN
dpc-328	141	8	gp	gp	PROPN
dpc-328	141	9	,	,	PUNCT
dpc-328	141	10	kamimura	kamimura	ADV
dpc-328	141	11	a.	a.	NOUN
dpc-328	141	12	skin	skin	NOUN
dpc-328	141	13	-	-	PUNCT
dpc-328	141	14	whitening	whiten	VERB
dpc-328	141	15	and	and	CCONJ
dpc-328	141	16	skin	skin	NOUN
dpc-328	141	17	-	-	PUNCT
dpc-328	141	18	condition	condition	NOUN
dpc-328	141	19	-	-	PUNCT
dpc-328	141	20	improving	improve	VERB
dpc-328	141	21	effects	effect	NOUN
dpc-328	141	22	of	of	ADP
dpc-328	141	23	topical	topical	ADJ
dpc-328	141	24	oxidized	oxidize	VERB
dpc-328	141	25	glutathione	glutathione	NOUN
dpc-328	141	26	:	:	PUNCT
dpc-328	141	27	a	a	DET
dpc-328	141	28	double	double	ADJ
dpc-328	141	29	-	-	PUNCT
dpc-328	141	30	blind	blind	ADJ
dpc-328	141	31	and	and	CCONJ
dpc-328	141	32	placebo	placebo	NOUN
dpc-328	141	33	-	-	PUNCT
dpc-328	141	34	controlled	control	VERB
dpc-328	141	35	clinical	clinical	ADJ
dpc-328	141	36	trial	trial	NOUN
dpc-328	141	37	in	in	ADP
dpc-328	141	38	healthy	healthy	ADJ
dpc-328	141	39	women	woman	NOUN
dpc-328	141	40	.	.	PUNCT
dpc-328	142	1	clin	clin	PROPN
dpc-328	142	2	cosmet	cosmet	PROPN
dpc-328	142	3	investig	investig	NOUN
dpc-328	142	4	dermatol	dermatol	NOUN
dpc-328	142	5	.	.	PUNCT
dpc-328	143	1	2014;7:267	2014;7:267	NUM
dpc-328	143	2	-	-	SYM
dpc-328	143	3	274	274	NUM
dpc-328	143	4	.	.	NOUN
dpc-328	143	5	13	13	NUM
dpc-328	143	6	.	.	X
dpc-328	144	1	oskin	oskin	PROPN
dpc-328	144	2	med	med	PROPN
dpc-328	144	3	spa	spa	NOUN
dpc-328	144	4	website	website	NOUN
dpc-328	144	5	.	.	PUNCT
dpc-328	145	1	http://www.oskinmedspa.com/portfolio/	http://www.oskinmedspa.com/portfolio/	PROPN
dpc-328	145	2	iv	iv	PROPN
dpc-328	145	3	-	-	PUNCT
dpc-328	145	4	glutathione	glutathione	NOUN
dpc-328	145	5	-	-	PUNCT
dpc-328	145	6	injections/	injections/	NUM
dpc-328	145	7	accessed	access	VERB
dpc-328	145	8	on	on	ADP
dpc-328	145	9	september	september	PROPN
dpc-328	145	10	8	8	NUM
dpc-328	145	11	,	,	PUNCT
dpc-328	145	12	2017	2017	NUM
dpc-328	145	13	.	.	PUNCT
dpc-328	146	1	14	14	NUM
dpc-328	146	2	.	.	PUNCT
dpc-328	146	3	magic	magic	ADJ
dpc-328	146	4	beauty	beauty	NOUN
dpc-328	146	5	website	website	NOUN
dpc-328	146	6	.	.	PUNCT
dpc-328	147	1	http://www.magicbeauty.in/product/gshultima-1500	http://www.magicbeauty.in/product/gshultima-1500	NOUN
dpc-328	147	2	mg	mg	PROPN
dpc-328	147	3	.	.	PUNCT
dpc-328	148	1	accessed	access	VERB
dpc-328	148	2	on	on	ADP
dpc-328	148	3	september	september	PROPN
dpc-328	148	4	8	8	NUM
dpc-328	148	5	,	,	PUNCT
dpc-328	148	6	2017	2017	NUM
dpc-328	148	7	]	]	PUNCT
dpc-328	148	8	.	.	PUNCT
dpc-328	149	1	tial	tial	PROPN
dpc-328	149	2	for	for	SCONJ
dpc-328	149	3	gsh	gsh	PROPN
dpc-328	149	4	to	to	PART
dpc-328	149	5	inhibit	inhibit	VERB
dpc-328	149	6	tyrosinase	tyrosinase	NOUN
dpc-328	149	7	and	and	CCONJ
dpc-328	149	8	switch	switch	NOUN
dpc-328	149	9	melanogenesis	melanogenesis	NOUN
dpc-328	149	10	from	from	ADP
dpc-328	149	11	eumelanin	eumelanin	NOUN
dpc-328	149	12	to	to	ADP
dpc-328	149	13	pheomelanin	pheomelanin	NOUN
dpc-328	149	14	.	.	PUNCT
dpc-328	150	1	trans	trans	ADJ
dpc-328	150	2	-	-	ADJ
dpc-328	150	3	melanosomal	melanosomal	ADJ
dpc-328	150	4	transportation	transportation	NOUN
dpc-328	150	5	can	can	AUX
dpc-328	150	6	be	be	AUX
dpc-328	150	7	achieved	achieve	VERB
dpc-328	150	8	through	through	ADP
dpc-328	150	9	a	a	DET
dpc-328	150	10	membrane	membrane	NOUN
dpc-328	150	11	channel	channel	NOUN
dpc-328	150	12	or	or	CCONJ
dpc-328	150	13	diffusion	diffusion	NOUN
dpc-328	150	14	,	,	PUNCT
dpc-328	150	15	both	both	PRON
dpc-328	150	16	of	of	ADP
dpc-328	150	17	which	which	PRON
dpc-328	150	18	seem	seem	VERB
dpc-328	150	19	to	to	PART
dpc-328	150	20	be	be	AUX
dpc-328	150	21	lacking	lack	VERB
dpc-328	150	22	for	for	ADP
dpc-328	150	23	gsh	gsh	PROPN
dpc-328	150	24	,	,	PUNCT
dpc-328	150	25	a	a	DET
dpc-328	150	26	fact	fact	NOUN
dpc-328	150	27	well	well	INTJ
dpc-328	150	28	established	establish	VERB
dpc-328	150	29	in	in	ADP
dpc-328	150	30	previous	previous	ADJ
dpc-328	150	31	research	research	NOUN
dpc-328	150	32	[	[	X
dpc-328	150	33	20,21	20,21	NUM
dpc-328	150	34	]	]	PUNCT
dpc-328	150	35	.	.	PUNCT
dpc-328	151	1	chung	chung	PROPN
dpc-328	151	2	et	et	PROPN
dpc-328	151	3	al	al	PROPN
dpc-328	151	4	.	.	PROPN
dpc-328	152	1	recently	recently	ADV
dpc-328	152	2	evaluated	evaluate	VERB
dpc-328	152	3	the	the	DET
dpc-328	152	4	in	in	ADV
dpc-328	152	5	vitro	vitro	X
dpc-328	152	6	antimelanogenic	antimelanogenic	ADJ
dpc-328	152	7	effects	effect	NOUN
dpc-328	152	8	and	and	CCONJ
dpc-328	152	9	cytotoxicity	cytotoxicity	NOUN
dpc-328	152	10	of	of	ADP
dpc-328	152	11	gsh	gsh	PROPN
dpc-328	152	12	and	and	CCONJ
dpc-328	152	13	its	its	PRON
dpc-328	152	14	three	three	NUM
dpc-328	152	15	esterified	esterify	VERB
dpc-328	152	16	derivatives	derivative	NOUN
dpc-328	152	17	—	—	PUNCT
dpc-328	152	18	gsh	gsh	PROPN
dpc-328	152	19	monoethyl	monoethyl	PROPN
dpc-328	152	20	ester	ester	NOUN
dpc-328	152	21	(	(	PUNCT
dpc-328	152	22	gsh	gsh	PROPN
dpc-328	152	23	-	-	PUNCT
dpc-328	152	24	mee	mee	PROPN
dpc-328	152	25	)	)	PUNCT
dpc-328	152	26	,	,	PUNCT
dpc-328	152	27	gsh	gsh	PROPN
dpc-328	152	28	diethyl	diethyl	PROPN
dpc-328	152	29	ester	ester	NOUN
dpc-328	152	30	(	(	PUNCT
dpc-328	152	31	gsh	gsh	PROPN
dpc-328	152	32	-	-	PUNCT
dpc-328	152	33	dee	dee	PROPN
dpc-328	152	34	)	)	PUNCT
dpc-328	152	35	,	,	PUNCT
dpc-328	152	36	and	and	CCONJ
dpc-328	152	37	gsh	gsh	PROPN
dpc-328	152	38	monoisopropyl	monoisopropyl	PROPN
dpc-328	152	39	ester	ester	NOUN
dpc-328	152	40	(	(	PUNCT
dpc-328	152	41	gsh	gsh	PROPN
dpc-328	152	42	-	-	PUNCT
dpc-328	152	43	mipe)—in	mipe)—in	NOUN
dpc-328	152	44	three	three	NUM
dpc-328	152	45	cell	cell	NOUN
dpc-328	152	46	culture	culture	NOUN
dpc-328	152	47	lines	line	NOUN
dpc-328	153	1	[	[	X
dpc-328	153	2	22	22	NUM
dpc-328	153	3	]	]	PUNCT
dpc-328	153	4	.	.	PUNCT
dpc-328	154	1	the	the	DET
dpc-328	154	2	results	result	NOUN
dpc-328	154	3	of	of	ADP
dpc-328	154	4	their	their	PRON
dpc-328	154	5	research	research	NOUN
dpc-328	154	6	demonstrated	demonstrate	VERB
dpc-328	154	7	significant	significant	ADJ
dpc-328	154	8	inhibitory	inhibitory	ADJ
dpc-328	154	9	effect	effect	NOUN
dpc-328	154	10	of	of	ADP
dpc-328	154	11	gsh	gsh	PROPN
dpc-328	154	12	-	-	PUNCT
dpc-328	154	13	mee	mee	PROPN
dpc-328	154	14	and	and	CCONJ
dpc-328	154	15	gsh	gsh	NOUN
dpc-328	154	16	-	-	PUNCT
dpc-328	154	17	mipe	mipe	NOUN
dpc-328	154	18	,	,	PUNCT
dpc-328	154	19	but	but	CCONJ
dpc-328	154	20	not	not	PART
dpc-328	154	21	gsh	gsh	PROPN
dpc-328	154	22	,	,	PUNCT
dpc-328	154	23	on	on	ADP
dpc-328	154	24	intracellular	intracellular	ADJ
dpc-328	154	25	tyrosinase	tyrosinase	NOUN
dpc-328	154	26	activity	activity	NOUN
dpc-328	154	27	and	and	CCONJ
dpc-328	154	28	melanin	melanin	NOUN
dpc-328	154	29	production	production	NOUN
dpc-328	154	30	.	.	PUNCT
dpc-328	155	1	the	the	DET
dpc-328	155	2	authors	author	NOUN
dpc-328	155	3	attributed	attribute	VERB
dpc-328	155	4	this	this	DET
dpc-328	155	5	effect	effect	NOUN
dpc-328	155	6	to	to	ADP
dpc-328	155	7	the	the	DET
dpc-328	155	8	lipophilicity	lipophilicity	NOUN
dpc-328	155	9	of	of	ADP
dpc-328	155	10	the	the	DET
dpc-328	155	11	esterified	esterify	VERB
dpc-328	155	12	derivatives	derivative	NOUN
dpc-328	155	13	of	of	ADP
dpc-328	155	14	gsh	gsh	PROPN
dpc-328	155	15	.	.	PUNCT
dpc-328	156	1	of	of	ADP
dpc-328	156	2	the	the	DET
dpc-328	156	3	three	three	NUM
dpc-328	156	4	esters	ester	NOUN
dpc-328	156	5	,	,	PUNCT
dpc-328	156	6	gsh	gsh	PROPN
dpc-328	156	7	-	-	PUNCT
dpc-328	156	8	dee	dee	PROPN
dpc-328	156	9	and	and	CCONJ
dpc-328	156	10	gsh	gsh	PROPN
dpc-328	156	11	-	-	PUNCT
dpc-328	156	12	mipe	mipe	NOUN
dpc-328	156	13	demonstrated	demonstrate	VERB
dpc-328	156	14	additional	additional	ADJ
dpc-328	156	15	cytotoxic	cytotoxic	ADJ
dpc-328	156	16	activity	activity	NOUN
dpc-328	156	17	,	,	PUNCT
dpc-328	156	18	rendering	render	VERB
dpc-328	156	19	them	they	PRON
dpc-328	156	20	unsuitable	unsuitable	ADJ
dpc-328	156	21	for	for	ADP
dpc-328	156	22	clinical	clinical	ADJ
dpc-328	156	23	use	use	NOUN
dpc-328	156	24	.	.	PUNCT
dpc-328	157	1	given	give	VERB
dpc-328	157	2	in	in	ADP
dpc-328	157	3	vitro	vitro	X
dpc-328	157	4	efficacy	efficacy	NOUN
dpc-328	157	5	and	and	CCONJ
dpc-328	157	6	lack	lack	NOUN
dpc-328	157	7	of	of	ADP
dpc-328	157	8	cytotoxicity	cytotoxicity	NOUN
dpc-328	157	9	of	of	ADP
dpc-328	157	10	gsh	gsh	PROPN
dpc-328	157	11	-	-	PUNCT
dpc-328	157	12	mee	mee	PROPN
dpc-328	157	13	,	,	PUNCT
dpc-328	157	14	the	the	DET
dpc-328	157	15	researchers	researcher	NOUN
dpc-328	157	16	suggested	suggest	VERB
dpc-328	157	17	the	the	DET
dpc-328	157	18	development	development	NOUN
dpc-328	157	19	of	of	ADP
dpc-328	157	20	gsh	gsh	PROPN
dpc-328	157	21	-	-	PUNCT
dpc-328	157	22	mee	mee	PROPN
dpc-328	157	23	,	,	PUNCT
dpc-328	157	24	instead	instead	ADV
dpc-328	157	25	of	of	ADP
dpc-328	157	26	gsh	gsh	PROPN
dpc-328	157	27	,	,	PUNCT
dpc-328	157	28	as	as	ADP
dpc-328	157	29	an	an	DET
dpc-328	157	30	efficacious	efficacious	ADJ
dpc-328	157	31	and	and	CCONJ
dpc-328	157	32	safe	safe	ADJ
dpc-328	157	33	molecule	molecule	NOUN
dpc-328	157	34	for	for	ADP
dpc-328	157	35	the	the	DET
dpc-328	157	36	treatment	treatment	NOUN
dpc-328	157	37	of	of	ADP
dpc-328	157	38	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	157	39	[	[	X
dpc-328	157	40	22	22	NUM
dpc-328	157	41	]	]	PUNCT
dpc-328	157	42	.	.	PUNCT
dpc-328	158	1	however	however	ADV
dpc-328	158	2	,	,	PUNCT
dpc-328	158	3	these	these	DET
dpc-328	158	4	results	result	NOUN
dpc-328	158	5	need	need	VERB
dpc-328	158	6	further	further	ADJ
dpc-328	158	7	validation	validation	NOUN
dpc-328	158	8	in	in	ADP
dpc-328	158	9	both	both	CCONJ
dpc-328	158	10	in	in	ADP
dpc-328	158	11	vitro	vitro	X
dpc-328	158	12	and	and	CCONJ
dpc-328	158	13	clinical	clinical	ADJ
dpc-328	158	14	trials	trial	NOUN
dpc-328	158	15	before	before	ADP
dpc-328	158	16	drawing	draw	VERB
dpc-328	158	17	definitive	definitive	ADJ
dpc-328	158	18	conclusions	conclusion	NOUN
dpc-328	158	19	.	.	PUNCT
dpc-328	159	1	conclusion	conclusion	NOUN
dpc-328	159	2	there	there	PRON
dpc-328	159	3	is	be	VERB
dpc-328	159	4	little	little	ADJ
dpc-328	159	5	convincing	convincing	ADJ
dpc-328	159	6	evidence	evidence	NOUN
dpc-328	159	7	in	in	ADP
dpc-328	159	8	favor	favor	NOUN
dpc-328	159	9	of	of	ADP
dpc-328	159	10	glutathione	glutathione	NOUN
dpc-328	159	11	as	as	ADP
dpc-328	159	12	a	a	DET
dpc-328	159	13	therapy	therapy	NOUN
dpc-328	159	14	for	for	ADP
dpc-328	159	15	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	159	16	at	at	ADP
dpc-328	159	17	the	the	DET
dpc-328	159	18	present	present	ADJ
dpc-328	159	19	time	time	NOUN
dpc-328	159	20	,	,	PUNCT
dpc-328	159	21	and	and	CCONJ
dpc-328	159	22	there	there	PRON
dpc-328	159	23	are	be	VERB
dpc-328	159	24	many	many	ADJ
dpc-328	159	25	unresolved	unresolved	ADJ
dpc-328	159	26	controversies	controversy	NOUN
dpc-328	159	27	that	that	PRON
dpc-328	159	28	surround	surround	VERB
dpc-328	159	29	its	its	PRON
dpc-328	159	30	use	use	NOUN
dpc-328	159	31	(	(	PUNCT
dpc-328	159	32	figure	figure	NOUN
dpc-328	159	33	5	5	NUM
dpc-328	159	34	)	)	PUNCT
dpc-328	159	35	.	.	PUNCT
dpc-328	160	1	the	the	DET
dpc-328	160	2	trials	trial	NOUN
dpc-328	160	3	available	available	ADJ
dpc-328	160	4	to	to	ADP
dpc-328	160	5	date	date	NOUN
dpc-328	160	6	that	that	PRON
dpc-328	160	7	have	have	AUX
dpc-328	160	8	evaluated	evaluate	VERB
dpc-328	160	9	the	the	DET
dpc-328	160	10	role	role	NOUN
dpc-328	160	11	of	of	ADP
dpc-328	160	12	glutathione	glutathione	NOUN
dpc-328	160	13	in	in	ADP
dpc-328	160	14	skin	skin	NOUN
dpc-328	160	15	lightening	lighten	VERB
dpc-328	160	16	administered	administer	VERB
dpc-328	160	17	through	through	ADP
dpc-328	160	18	different	different	ADJ
dpc-328	160	19	modes	mode	NOUN
dpc-328	160	20	have	have	VERB
dpc-328	160	21	numerous	numerous	ADJ
dpc-328	160	22	limitations	limitation	NOUN
dpc-328	160	23	.	.	PUNCT
dpc-328	161	1	although	although	SCONJ
dpc-328	161	2	the	the	DET
dpc-328	161	3	safety	safety	NOUN
dpc-328	161	4	of	of	ADP
dpc-328	161	5	topical	topical	ADJ
dpc-328	161	6	and	and	CCONJ
dpc-328	161	7	oral	oral	ADJ
dpc-328	161	8	gsh	gsh	NOUN
dpc-328	161	9	seems	seem	VERB
dpc-328	161	10	to	to	PART
dpc-328	161	11	be	be	AUX
dpc-328	161	12	good	good	ADJ
dpc-328	161	13	,	,	PUNCT
dpc-328	161	14	their	their	PRON
dpc-328	161	15	efficacy	efficacy	NOUN
dpc-328	161	16	(	(	PUNCT
dpc-328	161	17	especially	especially	ADV
dpc-328	161	18	long	long	ADJ
dpc-328	161	19	-	-	PUNCT
dpc-328	161	20	term	term	NOUN
dpc-328	161	21	)	)	PUNCT
dpc-328	161	22	remains	remain	VERB
dpc-328	161	23	questionable	questionable	ADJ
dpc-328	161	24	.	.	PUNCT
dpc-328	162	1	the	the	DET
dpc-328	162	2	extant	extant	ADJ
dpc-328	162	3	evidence	evidence	NOUN
dpc-328	162	4	to	to	PART
dpc-328	162	5	support	support	VERB
dpc-328	162	6	or	or	CCONJ
dpc-328	162	7	discourage	discourage	VERB
dpc-328	162	8	use	use	NOUN
dpc-328	162	9	of	of	ADP
dpc-328	162	10	iv	iv	NUM
dpc-328	162	11	gsh	gsh	NOUN
dpc-328	162	12	as	as	ADP
dpc-328	162	13	a	a	DET
dpc-328	162	14	therapeutic	therapeutic	ADJ
dpc-328	162	15	modality	modality	NOUN
dpc-328	162	16	for	for	ADP
dpc-328	162	17	improving	improve	VERB
dpc-328	162	18	skin	skin	NOUN
dpc-328	162	19	tone	tone	NOUN
dpc-328	162	20	or	or	CCONJ
dpc-328	162	21	pigmentation	pigmentation	NOUN
dpc-328	162	22	is	be	AUX
dpc-328	162	23	minimal	minimal	ADJ
dpc-328	162	24	and	and	CCONJ
dpc-328	162	25	contradictory	contradictory	ADJ
dpc-328	162	26	;	;	PUNCT
dpc-328	162	27	notwithstanding	notwithstanding	ADP
dpc-328	162	28	the	the	DET
dpc-328	162	29	austere	austere	ADJ
dpc-328	162	30	concern	concern	NOUN
dpc-328	162	31	regarding	regard	VERB
dpc-328	162	32	the	the	DET
dpc-328	162	33	potential	potential	ADJ
dpc-328	162	34	adverse	adverse	ADJ
dpc-328	162	35	effects	effect	NOUN
dpc-328	162	36	associated	associate	VERB
dpc-328	162	37	with	with	ADP
dpc-328	162	38	this	this	DET
dpc-328	162	39	mode	mode	NOUN
dpc-328	162	40	of	of	ADP
dpc-328	162	41	administration	administration	NOUN
dpc-328	162	42	.	.	PUNCT
dpc-328	163	1	more	more	ADJ
dpc-328	163	2	evidence	evidence	NOUN
dpc-328	163	3	in	in	ADP
dpc-328	163	4	the	the	DET
dpc-328	163	5	form	form	NOUN
dpc-328	163	6	of	of	ADP
dpc-328	163	7	high	high	ADJ
dpc-328	163	8	quality	quality	NOUN
dpc-328	163	9	trials	trial	NOUN
dpc-328	163	10	with	with	ADP
dpc-328	163	11	better	well	ADJ
dpc-328	163	12	study	study	NOUN
dpc-328	163	13	design	design	NOUN
dpc-328	163	14	,	,	PUNCT
dpc-328	163	15	larger	large	ADJ
dpc-328	163	16	sample	sample	NOUN
dpc-328	163	17	size	size	NOUN
dpc-328	163	18	,	,	PUNCT
dpc-328	163	19	and	and	CCONJ
dpc-328	163	20	long	long	ADJ
dpc-328	163	21	-	-	PUNCT
dpc-328	163	22	term	term	NOUN
dpc-328	163	23	follow	follow	NOUN
dpc-328	163	24	-	-	PUNCT
dpc-328	163	25	up	up	NOUN
dpc-328	163	26	is	be	AUX
dpc-328	163	27	vital	vital	ADJ
dpc-328	163	28	,	,	PUNCT
dpc-328	163	29	before	before	SCONJ
dpc-328	163	30	our	our	PRON
dpc-328	163	31	patients	patient	NOUN
dpc-328	163	32	are	be	AUX
dpc-328	163	33	subjected	subject	VERB
dpc-328	163	34	to	to	ADP
dpc-328	163	35	glutathione	glutathione	NOUN
dpc-328	163	36	-	-	PUNCT
dpc-328	163	37	based	base	VERB
dpc-328	163	38	treatments	treatment	NOUN
dpc-328	163	39	.	.	PUNCT
dpc-328	164	1	references	reference	NOUN
dpc-328	164	2	1	1	NUM
dpc-328	164	3	.	.	PUNCT
dpc-328	164	4	sarkar	sarkar	PROPN
dpc-328	164	5	r	r	PROPN
dpc-328	164	6	,	,	PUNCT
dpc-328	164	7	chugh	chugh	NOUN
dpc-328	164	8	s	s	PROPN
dpc-328	164	9	,	,	PUNCT
dpc-328	164	10	garg	garg	NOUN
dpc-328	164	11	vk	vk	PROPN
dpc-328	164	12	.	.	PUNCT
dpc-328	165	1	newer	new	ADJ
dpc-328	165	2	and	and	CCONJ
dpc-328	165	3	upcoming	upcoming	ADJ
dpc-328	165	4	therapies	therapy	NOUN
dpc-328	165	5	for	for	ADP
dpc-328	165	6	melasma	melasma	NOUN
dpc-328	165	7	.	.	PUNCT
dpc-328	166	1	indian	indian	PROPN
dpc-328	166	2	j	j	PROPN
dpc-328	166	3	dermatol	dermatol	PROPN
dpc-328	166	4	venereol	venereol	ADJ
dpc-328	166	5	leprol	leprol	NOUN
dpc-328	166	6	.	.	PUNCT
dpc-328	167	1	2012;78:417	2012;78:417	NUM
dpc-328	167	2	-	-	SYM
dpc-328	167	3	428	428	NUM
dpc-328	167	4	.	.	NOUN
dpc-328	168	1	2	2	NUM
dpc-328	168	2	.	.	X
dpc-328	168	3	dickinson	dickinson	PROPN
dpc-328	168	4	da	da	PROPN
dpc-328	168	5	,	,	PUNCT
dpc-328	168	6	forman	forman	PROPN
dpc-328	168	7	hj	hj	PROPN
dpc-328	168	8	.	.	PUNCT
dpc-328	168	9	glutathione	glutathione	PROPN
dpc-328	168	10	in	in	ADP
dpc-328	168	11	defense	defense	NOUN
dpc-328	168	12	and	and	CCONJ
dpc-328	168	13	signaling	signal	VERB
dpc-328	168	14	:	:	PUNCT
dpc-328	168	15	lessons	lesson	NOUN
dpc-328	168	16	from	from	ADP
dpc-328	168	17	a	a	DET
dpc-328	168	18	small	small	ADJ
dpc-328	168	19	thiol	thiol	NOUN
dpc-328	168	20	.	.	PUNCT
dpc-328	169	1	ann	ann	PROPN
dpc-328	169	2	n	n	PROPN
dpc-328	169	3	y	y	PROPN
dpc-328	169	4	acad	acad	PROPN
dpc-328	169	5	sci	sci	PROPN
dpc-328	169	6	.	.	PROPN
dpc-328	169	7	2002;973:488	2002;973:488	NUM
dpc-328	169	8	-	-	SYM
dpc-328	169	9	504	504	NUM
dpc-328	169	10	.	.	PUNCT
dpc-328	170	1	3	3	X
dpc-328	170	2	.	.	X
dpc-328	170	3	murray	murray	PROPN
dpc-328	170	4	rk	rk	PROPN
dpc-328	170	5	.	.	PUNCT
dpc-328	170	6	metabolism	metabolism	NOUN
dpc-328	170	7	of	of	ADP
dpc-328	170	8	xenobiotics	xenobiotics	PROPN
dpc-328	170	9	.	.	PUNCT
dpc-328	171	1	in	in	ADP
dpc-328	171	2	:	:	PUNCT
dpc-328	171	3	murray	murray	PROPN
dpc-328	171	4	rk	rk	PROPN
dpc-328	171	5	,	,	PUNCT
dpc-328	171	6	bender	bender	NOUN
dpc-328	171	7	da	da	PROPN
dpc-328	171	8	,	,	PUNCT
dpc-328	171	9	botham	botham	PROPN
dpc-328	171	10	km	km	PROPN
dpc-328	171	11	,	,	PUNCT
dpc-328	171	12	kennelly	kennelly	PROPN
dpc-328	171	13	pj	pj	PROPN
dpc-328	171	14	,	,	PUNCT
dpc-328	171	15	rodwell	rodwell	PROPN
dpc-328	171	16	vw	vw	PROPN
dpc-328	171	17	,	,	PUNCT
dpc-328	171	18	weil	weil	PROPN
dpc-328	171	19	pa	pa	PROPN
dpc-328	171	20	,	,	PUNCT
dpc-328	171	21	eds	eds	PROPN
dpc-328	171	22	.	.	PUNCT
dpc-328	171	23	harper	harper	NOUN
dpc-328	171	24	’s	’s	PART
dpc-328	171	25	illustrated	illustrate	VERB
dpc-328	171	26	biochemistry	biochemistry	NOUN
dpc-328	171	27	.	.	PUNCT
dpc-328	172	1	28th	28th	ADJ
dpc-328	172	2	ed	ed	NOUN
dpc-328	172	3	.	.	PUNCT
dpc-328	172	4	michigan	michigan	PROPN
dpc-328	172	5	:	:	PUNCT
dpc-328	172	6	mcgraw	mcgraw	PROPN
dpc-328	172	7	-	-	PUNCT
dpc-328	172	8	hill	hill	PROPN
dpc-328	172	9	;	;	PUNCT
dpc-328	173	1	2009:612	2009:612	NUM
dpc-328	173	2	-	-	SYM
dpc-328	173	3	613	613	PROPN
dpc-328	173	4	.	.	PUNCT
dpc-328	173	5	figure	figure	NOUN
dpc-328	173	6	5	5	NUM
dpc-328	173	7	.	.	PUNCT
dpc-328	173	8	controversial	controversial	ADJ
dpc-328	173	9	aspects	aspect	NOUN
dpc-328	173	10	of	of	ADP
dpc-328	173	11	glutathione	glutathione	NOUN
dpc-328	173	12	as	as	ADP
dpc-328	173	13	a	a	DET
dpc-328	173	14	potential	potential	ADJ
dpc-328	173	15	skin	skin	NOUN
dpc-328	173	16	lightening	lighten	VERB
dpc-328	173	17	therapy	therapy	NOUN
dpc-328	173	18	.	.	PUNCT
dpc-328	174	1	[	[	X
dpc-328	174	2	copyright	copyright	NOUN
dpc-328	174	3	:	:	PUNCT
dpc-328	174	4	©	©	PROPN
dpc-328	174	5	2018	2018	NUM
dpc-328	174	6	sonthalia	sonthalia	PROPN
dpc-328	174	7	et	et	PROPN
dpc-328	174	8	al	al	PROPN
dpc-328	174	9	.	.	PROPN
dpc-328	174	10	]	]	PUNCT
dpc-328	175	1	•	•	NUM
dpc-328	175	2	paucity	paucity	NOUN
dpc-328	175	3	of	of	ADP
dpc-328	175	4	high	high	ADJ
dpc-328	175	5	quality	quality	NOUN
dpc-328	175	6	,	,	PUNCT
dpc-328	175	7	well	well	ADV
dpc-328	175	8	-	-	PUNCT
dpc-328	175	9	designed	design	VERB
dpc-328	175	10	controlled	control	VERB
dpc-328	175	11	trials	trial	NOUN
dpc-328	175	12	with	with	ADP
dpc-328	175	13	large	large	ADJ
dpc-328	175	14	sample	sample	NOUN
dpc-328	175	15	size	size	NOUN
dpc-328	175	16	and	and	CCONJ
dpc-328	175	17	long	long	ADJ
dpc-328	175	18	follow	follow	VERB
dpc-328	175	19	-	-	PUNCT
dpc-328	175	20	up	up	NOUN
dpc-328	175	21	duration	duration	NOUN
dpc-328	175	22	•	•	NOUN
dpc-328	175	23	controversial	controversial	ADJ
dpc-328	175	24	aspects	aspect	NOUN
dpc-328	175	25	of	of	ADP
dpc-328	175	26	absorption	absorption	NOUN
dpc-328	175	27	of	of	ADP
dpc-328	175	28	orally	orally	ADV
dpc-328	175	29	administered	administer	VERB
dpc-328	175	30	glutathione	glutathione	NOUN
dpc-328	175	31	and	and	CCONJ
dpc-328	175	32	plasma	plasma	NOUN
dpc-328	175	33	levels	level	NOUN
dpc-328	175	34	achieved	achieve	VERB
dpc-328	175	35	in	in	ADP
dpc-328	175	36	different	different	ADJ
dpc-328	175	37	studies	study	NOUN
dpc-328	175	38	involving	involve	VERB
dpc-328	175	39	animal	animal	NOUN
dpc-328	175	40	models	model	NOUN
dpc-328	175	41	as	as	ADV
dpc-328	175	42	well	well	ADV
dpc-328	175	43	as	as	ADP
dpc-328	175	44	human	human	ADJ
dpc-328	175	45	volunteers	volunteer	NOUN
dpc-328	175	46	•	•	ADV
dpc-328	175	47	tendency	tendency	NOUN
dpc-328	175	48	to	to	ADP
dpc-328	175	49	quick	quick	ADJ
dpc-328	175	50	reversal	reversal	NOUN
dpc-328	175	51	of	of	ADP
dpc-328	175	52	any	any	DET
dpc-328	175	53	skin	skin	NOUN
dpc-328	175	54	benefit	benefit	NOUN
dpc-328	175	55	after	after	ADP
dpc-328	175	56	stoppage	stoppage	NOUN
dpc-328	175	57	of	of	ADP
dpc-328	175	58	oral	oral	ADJ
dpc-328	175	59	/	/	SYM
dpc-328	175	60	topical	topical	ADJ
dpc-328	175	61	/	/	SYM
dpc-328	175	62	parenteral	parenteral	ADJ
dpc-328	175	63	glutathione	glutathione	NOUN
dpc-328	175	64	•	•	ADP
dpc-328	175	65	no	no	DET
dpc-328	175	66	well	well	ADV
dpc-328	175	67	-	-	PUNCT
dpc-328	175	68	defined	define	VERB
dpc-328	175	69	dosage	dosage	NOUN
dpc-328	175	70	and/or	and/or	CCONJ
dpc-328	175	71	safe	safe	ADJ
dpc-328	175	72	duration	duration	NOUN
dpc-328	175	73	of	of	ADP
dpc-328	175	74	administration	administration	NOUN
dpc-328	175	75	of	of	ADP
dpc-328	175	76	systemic	systemic	ADJ
dpc-328	175	77	glutathione	glutathione	NOUN
dpc-328	175	78	•	•	ADP
dpc-328	176	1	adverse	adverse	ADJ
dpc-328	176	2	effects	effect	NOUN
dpc-328	176	3	reported	report	VERB
dpc-328	176	4	with	with	ADP
dpc-328	176	5	intravenous	intravenous	ADJ
dpc-328	176	6	glutathione	glutathione	NOUN
dpc-328	176	7	•	•	NOUN
dpc-328	176	8	prohibitory	prohibitory	NOUN
dpc-328	176	9	or	or	CCONJ
dpc-328	176	10	ill	ill	ADV
dpc-328	176	11	-	-	PUNCT
dpc-328	176	12	defined	define	VERB
dpc-328	176	13	statutory	statutory	ADJ
dpc-328	176	14	laws	law	NOUN
dpc-328	176	15	on	on	ADP
dpc-328	176	16	the	the	DET
dpc-328	176	17	use	use	NOUN
dpc-328	176	18	of	of	ADP
dpc-328	176	19	intravenous	intravenous	ADJ
dpc-328	176	20	glutathione	glutathione	NOUN
dpc-328	176	21	for	for	ADP
dpc-328	176	22	skin	skin	NOUN
dpc-328	176	23	lightening	lighten	VERB
dpc-328	176	24	in	in	ADP
dpc-328	176	25	different	different	ADJ
dpc-328	176	26	countries	country	NOUN
dpc-328	176	27	•	•	ADP
dpc-328	176	28	the	the	DET
dpc-328	176	29	recent	recent	ADJ
dpc-328	176	30	finding	finding	NOUN
dpc-328	176	31	of	of	ADP
dpc-328	176	32	discordant	discordant	ADJ
dpc-328	176	33	effect	effect	NOUN
dpc-328	176	34	of	of	ADP
dpc-328	176	35	gsh	gsh	PROPN
dpc-328	176	36	vs.	vs.	ADP
dpc-328	176	37	esterified	esterify	VERB
dpc-328	176	38	gsh	gsh	NOUN
dpc-328	176	39	over	over	ADP
dpc-328	176	40	inhibiting	inhibit	VERB
dpc-328	176	41	melanogenesis	melanogenesis	NOUN
dpc-328	176	42	http://www.cdsco.nic.in/writereaddata/listof-approved-drug-from-2011.pdf	http://www.cdsco.nic.in/writereaddata/listof-approved-drug-from-2011.pdf	PROPN
dpc-328	176	43	http://www.cdsco.nic.in/writereaddata/listof-approved-drug-from-2011.pdf	http://www.cdsco.nic.in/writereaddata/listof-approved-drug-from-2011.pdf	PROPN
dpc-328	176	44	review	review	VERB
dpc-328	176	45	|	|	ADV
dpc-328	176	46	dermatol	dermatol	ADJ
dpc-328	176	47	pract	pract	NOUN
dpc-328	176	48	concept	concept	NOUN
dpc-328	176	49	2018;8(1):4	2018;8(1):4	PROPN
dpc-328	176	50	21	21	NUM
dpc-328	176	51	19	19	NUM
dpc-328	176	52	.	.	PUNCT
dpc-328	177	1	cook	cook	PROPN
dpc-328	177	2	gc	gc	PROPN
dpc-328	177	3	,	,	PUNCT
dpc-328	177	4	sherlock	sherlock	PROPN
dpc-328	177	5	s.	s.	PROPN
dpc-328	177	6	results	result	NOUN
dpc-328	177	7	of	of	ADP
dpc-328	177	8	a	a	DET
dpc-328	177	9	controlled	control	VERB
dpc-328	177	10	clinical	clinical	ADJ
dpc-328	177	11	trial	trial	NOUN
dpc-328	177	12	of	of	ADP
dpc-328	177	13	glutathione	glutathione	NOUN
dpc-328	177	14	in	in	ADP
dpc-328	177	15	cases	case	NOUN
dpc-328	177	16	of	of	ADP
dpc-328	177	17	hepatic	hepatic	ADJ
dpc-328	177	18	cirrhosis	cirrhosis	NOUN
dpc-328	177	19	.	.	PUNCT
dpc-328	178	1	gut	gut	NOUN
dpc-328	178	2	.	.	PUNCT
dpc-328	179	1	1965;6:472	1965;6:472	NUM
dpc-328	179	2	-	-	PUNCT
dpc-328	180	1	476	476	NUM
dpc-328	180	2	.	.	NOUN
dpc-328	181	1	20	20	NUM
dpc-328	181	2	.	.	PUNCT
dpc-328	181	3	potterf	potterf	PROPN
dpc-328	181	4	sb	sb	PROPN
dpc-328	181	5	,	,	PUNCT
dpc-328	181	6	virador	virador	NOUN
dpc-328	181	7	v	v	NOUN
dpc-328	181	8	,	,	PUNCT
dpc-328	181	9	wakamatsu	wakamatsu	PROPN
dpc-328	181	10	k	k	PROPN
dpc-328	181	11	,	,	PUNCT
dpc-328	181	12	et	et	PROPN
dpc-328	181	13	al	al	PROPN
dpc-328	181	14	.	.	PROPN
dpc-328	181	15	cysteine	cysteine	PROPN
dpc-328	181	16	transport	transport	NOUN
dpc-328	181	17	in	in	ADP
dpc-328	181	18	melanosomes	melanosome	NOUN
dpc-328	181	19	from	from	ADP
dpc-328	181	20	murine	murine	ADJ
dpc-328	181	21	melanocytes	melanocyte	NOUN
dpc-328	181	22	.	.	PUNCT
dpc-328	182	1	pigment	pigment	ADJ
dpc-328	182	2	cell	cell	NOUN
dpc-328	182	3	res	re	NOUN
dpc-328	182	4	.	.	PUNCT
dpc-328	183	1	1999;12:4–12	1999;12:4–12	NUM
dpc-328	183	2	.	.	PUNCT
dpc-328	184	1	21	21	NUM
dpc-328	184	2	.	.	PUNCT
dpc-328	185	1	wellner	wellner	PROPN
dpc-328	185	2	vp	vp	PROPN
dpc-328	185	3	,	,	PUNCT
dpc-328	185	4	anderson	anderson	PROPN
dpc-328	185	5	me	me	PROPN
dpc-328	185	6	,	,	PUNCT
dpc-328	185	7	puri	puri	PROPN
dpc-328	185	8	rn	rn	PROPN
dpc-328	185	9	,	,	PUNCT
dpc-328	185	10	jensen	jensen	PROPN
dpc-328	185	11	gl	gl	PROPN
dpc-328	185	12	,	,	PUNCT
dpc-328	185	13	meister	meister	PROPN
dpc-328	185	14	a.	a.	NOUN
dpc-328	185	15	radioprotection	radioprotection	NOUN
dpc-328	185	16	by	by	ADP
dpc-328	185	17	glutathione	glutathione	NOUN
dpc-328	185	18	ester	ester	NOUN
dpc-328	185	19	:	:	PUNCT
dpc-328	185	20	transport	transport	NOUN
dpc-328	185	21	of	of	ADP
dpc-328	185	22	glutathione	glutathione	NOUN
dpc-328	185	23	ester	ester	NOUN
dpc-328	185	24	into	into	ADP
dpc-328	185	25	human	human	ADJ
dpc-328	185	26	lymphoid	lymphoid	NOUN
dpc-328	185	27	cells	cell	NOUN
dpc-328	185	28	and	and	CCONJ
dpc-328	185	29	fibroblasts	fibroblast	NOUN
dpc-328	185	30	.	.	PUNCT
dpc-328	186	1	proc	proc	PROPN
dpc-328	186	2	natl	natl	PROPN
dpc-328	186	3	acad	acad	PROPN
dpc-328	186	4	sci	sci	PROPN
dpc-328	186	5	usa	usa	PROPN
dpc-328	186	6	.	.	PROPN
dpc-328	186	7	1984;81:4732–4735	1984;81:4732–4735	NUM
dpc-328	186	8	.	.	PUNCT
dpc-328	187	1	22	22	NUM
dpc-328	187	2	.	.	PUNCT
dpc-328	188	1	chung	chung	VERB
dpc-328	188	2	by	by	ADP
dpc-328	188	3	,	,	PUNCT
dpc-328	188	4	choi	choi	PROPN
dpc-328	188	5	sr	sr	PROPN
dpc-328	188	6	,	,	PUNCT
dpc-328	188	7	moon	moon	PROPN
dpc-328	188	8	ij	ij	NOUN
dpc-328	188	9	,	,	PUNCT
dpc-328	188	10	park	park	NOUN
dpc-328	188	11	cw	cw	PROPN
dpc-328	188	12	,	,	PUNCT
dpc-328	188	13	kim	kim	PROPN
dpc-328	188	14	yh	yh	PROPN
dpc-328	188	15	,	,	PUNCT
dpc-328	188	16	chang	chang	PROPN
dpc-328	188	17	se	se	PROPN
dpc-328	188	18	.	.	PUNCT
dpc-328	189	1	the	the	DET
dpc-328	189	2	glutathione	glutathione	NOUN
dpc-328	189	3	derivative	derivative	NOUN
dpc-328	189	4	,	,	PUNCT
dpc-328	189	5	gsh	gsh	PROPN
dpc-328	189	6	monoethyl	monoethyl	PROPN
dpc-328	189	7	ester	ester	PROPN
dpc-328	189	8	,	,	PUNCT
dpc-328	189	9	may	may	AUX
dpc-328	189	10	effectively	effectively	ADV
dpc-328	189	11	whiten	whiten	VERB
dpc-328	189	12	skin	skin	NOUN
dpc-328	189	13	but	but	CCONJ
dpc-328	189	14	gsh	gsh	PROPN
dpc-328	189	15	does	do	VERB
dpc-328	189	16	not	not	PART
dpc-328	189	17	.	.	PUNCT
dpc-328	190	1	int	int	PROPN
dpc-328	190	2	j	j	PROPN
dpc-328	190	3	mol	mol	ADP
dpc-328	190	4	sci	sci	PROPN
dpc-328	190	5	.	.	PUNCT
dpc-328	191	1	2016;27;17:629	2016;27;17:629	NUM
dpc-328	191	2	.	.	PUNCT
dpc-328	192	1	15	15	NUM
dpc-328	192	2	.	.	PUNCT
dpc-328	192	3	zubair	zubair	PROPN
dpc-328	192	4	s	s	PROPN
dpc-328	192	5	,	,	PUNCT
dpc-328	192	6	hafeez	hafeez	PROPN
dpc-328	192	7	s	s	PROPN
dpc-328	192	8	,	,	PUNCT
dpc-328	192	9	mujtaba	mujtaba	PROPN
dpc-328	192	10	g.	g.	PROPN
dpc-328	192	11	efficacy	efficacy	PROPN
dpc-328	192	12	of	of	ADP
dpc-328	192	13	intravenous	intravenous	ADJ
dpc-328	192	14	glutathione	glutathione	NOUN
dpc-328	192	15	vs.	vs.	ADP
dpc-328	192	16	placebo	placebo	NOUN
dpc-328	192	17	for	for	ADP
dpc-328	192	18	skin	skin	NOUN
dpc-328	192	19	tone	tone	NOUN
dpc-328	192	20	lightening	lightening	NOUN
dpc-328	192	21	.	.	PUNCT
dpc-328	193	1	j	j	PROPN
dpc-328	193	2	pak	pak	PROPN
dpc-328	193	3	ass	ass	NOUN
dpc-328	193	4	dermatol	dermatol	NOUN
dpc-328	193	5	.	.	PUNCT
dpc-328	194	1	2016;26:177	2016;26:177	NOUN
dpc-328	194	2	-	-	SYM
dpc-328	194	3	181	181	NUM
dpc-328	194	4	.	.	PUNCT
dpc-328	195	1	16	16	NUM
dpc-328	195	2	.	.	PUNCT
dpc-328	196	1	taylor	taylor	PROPN
dpc-328	196	2	sc	sc	PROPN
dpc-328	196	3	,	,	PUNCT
dpc-328	196	4	arsonnaud	arsonnaud	VERB
dpc-328	196	5	s	s	PROPN
dpc-328	196	6	,	,	PUNCT
dpc-328	196	7	czernielewski	czernielewski	PROPN
dpc-328	196	8	j	j	PROPN
dpc-328	196	9	;	;	PUNCT
dpc-328	196	10	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	196	11	scale	scale	NOUN
dpc-328	196	12	study	study	NOUN
dpc-328	196	13	group	group	NOUN
dpc-328	196	14	.	.	PUNCT
dpc-328	197	1	the	the	DET
dpc-328	197	2	taylor	taylor	PROPN
dpc-328	197	3	hyperpigmentation	hyperpigmentation	NOUN
dpc-328	197	4	scale	scale	NOUN
dpc-328	197	5	:	:	PUNCT
dpc-328	197	6	a	a	DET
dpc-328	197	7	new	new	ADJ
dpc-328	197	8	visual	visual	ADJ
dpc-328	197	9	assessment	assessment	NOUN
dpc-328	197	10	tool	tool	NOUN
dpc-328	197	11	for	for	ADP
dpc-328	197	12	the	the	DET
dpc-328	197	13	evaluation	evaluation	NOUN
dpc-328	197	14	of	of	ADP
dpc-328	197	15	skin	skin	NOUN
dpc-328	197	16	color	color	NOUN
dpc-328	197	17	and	and	CCONJ
dpc-328	197	18	pigmentation	pigmentation	NOUN
dpc-328	197	19	.	.	PUNCT
dpc-328	198	1	cutis	cutis	NOUN
dpc-328	198	2	.	.	PUNCT
dpc-328	199	1	2005;76:270	2005;76:270	NUM
dpc-328	199	2	-	-	SYM
dpc-328	199	3	274	274	NUM
dpc-328	199	4	.	.	PUNCT
dpc-328	199	5	17	17	NUM
dpc-328	199	6	.	.	PUNCT
dpc-328	200	1	gras	gras	PROPN
dpc-328	200	2	notice	notice	VERB
dpc-328	200	3	for	for	ADP
dpc-328	200	4	glutathione	glutathione	NOUN
dpc-328	200	5	.	.	PUNCT
dpc-328	201	1	(	(	PUNCT
dpc-328	201	2	2009	2009	NUM
dpc-328	201	3	)	)	PUNCT
dpc-328	201	4	url	url	PROPN
dpc-328	201	5	http://www.fda	http://www.fda	PROPN
dpc-328	201	6	.	.	PUNCT
dpc-328	202	1	gov	gov	PROPN
dpc-328	202	2	/	/	SYM
dpc-328	202	3	ucm	ucm	PROPN
dpc-328	202	4	/	/	SYM
dpc-328	202	5	groups	group	NOUN
dpc-328	202	6	/	/	SYM
dpc-328	202	7	fdagov	fdagov	NOUN
dpc-328	202	8	-	-	PUNCT
dpc-328	202	9	public/@fdagov	public/@fdagov	ADJ
dpc-328	202	10	-	-	PUNCT
dpc-328	202	11	foods	food	NOUN
dpc-328	202	12	-	-	PUNCT
dpc-328	202	13	gen	gen	NOUN
dpc-328	202	14	/	/	SYM
dpc-328	202	15	documents/	documents/	NOUN
dpc-328	202	16	document	document	NOUN
dpc-328	202	17	/	/	SYM
dpc-328	202	18	ucm269318.pdf	ucm269318.pdf	NOUN
dpc-328	202	19	.	.	PUNCT
dpc-328	202	20	accessed	access	VERB
dpc-328	202	21	on	on	ADP
dpc-328	202	22	april	april	PROPN
dpc-328	202	23	26	26	NUM
dpc-328	202	24	,	,	PUNCT
dpc-328	202	25	2017	2017	NUM
dpc-328	202	26	.	.	PUNCT
dpc-328	203	1	18	18	NUM
dpc-328	203	2	.	.	PUNCT
dpc-328	203	3	lenzi	lenzi	PROPN
dpc-328	203	4	a	a	PROPN
dpc-328	203	5	,	,	PUNCT
dpc-328	203	6	 	 	SPACE
dpc-328	203	7	lombardo	lombardo	PROPN
dpc-328	203	8	f	f	PROPN
dpc-328	203	9	,	,	PUNCT
dpc-328	203	10	 	 	SPACE
dpc-328	203	11	gandini	gandini	NOUN
dpc-328	203	12	l	l	NOUN
dpc-328	203	13	,	,	PUNCT
dpc-328	203	14	 	 	SPACE
dpc-328	203	15	culasso	culasso	PROPN
dpc-328	203	16	f	f	PROPN
dpc-328	203	17	,	,	PUNCT
dpc-328	203	18	dondero	dondero	PROPN
dpc-328	203	19	f.	f.	PROPN
dpc-328	203	20	glutathione	glutathione	PROPN
dpc-328	203	21	 	 	SPACE
dpc-328	203	22	therapy	therapy	NOUN
dpc-328	203	23	 	 	SPACE
dpc-328	203	24	for	for	ADP
dpc-328	203	25	 	 	SPACE
dpc-328	203	26	male	male	ADJ
dpc-328	203	27	infertility	infertility	NOUN
dpc-328	203	28	.	.	PUNCT
dpc-328	204	1	arch	arch	PROPN
dpc-328	204	2	androl	androl	PROPN
dpc-328	204	3	.	.	PUNCT
dpc-328	204	4	 	 	SPACE
dpc-328	205	1	1992;29:65	1992;29:65	NUM
dpc-328	205	2	-	-	SYM
dpc-328	205	3	68	68	NUM
dpc-328	205	4	.	.	PUNCT
dpc-328	205	5	http://www.ncbi.nlm.nih.gov/pubmed/?term=lenzi%2520a%255bauthor%255d&cauthor=true&cauthor_uid=1503526	http://www.ncbi.nlm.nih.gov/pubmed/?term=lenzi%2520a%255bauthor%255d&cauthor=true&cauthor_uid=1503526	VERB